6	POTIGA.xml:S1:4:1	O
ADVERSE	POTIGA.xml:S1:6:7	O
REACTIONS	POTIGA.xml:S1:14:9	O

The	POTIGA.xml:S1:27:3	O
following	POTIGA.xml:S1:31:9	O
adverse	POTIGA.xml:S1:41:7	O
reactions	POTIGA.xml:S1:49:9	O
are	POTIGA.xml:S1:59:3	O
described	POTIGA.xml:S1:63:9	O
in	POTIGA.xml:S1:73:2	O
more	POTIGA.xml:S1:76:4	O
detail	POTIGA.xml:S1:81:6	O
in	POTIGA.xml:S1:88:2	O
the	POTIGA.xml:S1:91:3	O
Warnings	POTIGA.xml:S1:96:8	O
and	POTIGA.xml:S1:105:3	O
Precautions	POTIGA.xml:S1:109:11	O
section	POTIGA.xml:S1:122:7	O
of	POTIGA.xml:S1:130:2	O
the	POTIGA.xml:S1:133:3	O
label	POTIGA.xml:S1:137:5	O
:	POTIGA.xml:S1:142:1	O

Retinal	POTIGA.xml:S1:153:7	B-AdverseReaction
abnormalities	POTIGA.xml:S1:161:13	I-AdverseReaction
and	POTIGA.xml:S1:175:3	O
potential	POTIGA.xml:S1:179:9	B-Factor
vision	POTIGA.xml:S1:189:6	B-AdverseReaction
loss	POTIGA.xml:S1:196:4	I-AdverseReaction
[	POTIGA.xml:S1:201:1	O
see	POTIGA.xml:S1:202:3	O
Warnings	POTIGA.xml:S1:206:8	O
and	POTIGA.xml:S1:215:3	O
Precautions	POTIGA.xml:S1:219:11	O
(	POTIGA.xml:S1:231:1	O
5.1	POTIGA.xml:S1:232:3	O
)]	POTIGA.xml:S1:235:2	O

Urinary	POTIGA.xml:S1:246:7	B-AdverseReaction
retention	POTIGA.xml:S1:254:9	I-AdverseReaction
[	POTIGA.xml:S1:264:1	O
see	POTIGA.xml:S1:265:3	O
Warnings	POTIGA.xml:S1:269:8	O
and	POTIGA.xml:S1:278:3	O
Precautions	POTIGA.xml:S1:282:11	O
(	POTIGA.xml:S1:294:1	O
5.2	POTIGA.xml:S1:295:3	O
)]	POTIGA.xml:S1:298:2	O

Skin	POTIGA.xml:S1:309:4	B-AdverseReaction
discoloration	POTIGA.xml:S1:314:13	I-AdverseReaction
[	POTIGA.xml:S1:328:1	O
see	POTIGA.xml:S1:329:3	O
Warnings	POTIGA.xml:S1:333:8	O
and	POTIGA.xml:S1:342:3	O
Precautions	POTIGA.xml:S1:346:11	O
(	POTIGA.xml:S1:358:1	O
5.3	POTIGA.xml:S1:359:3	O
)]	POTIGA.xml:S1:362:2	O

Neuropsychiatric	POTIGA.xml:S1:373:16	B-AdverseReaction
symptoms	POTIGA.xml:S1:390:8	I-AdverseReaction
[	POTIGA.xml:S1:399:1	O
see	POTIGA.xml:S1:400:3	O
Warnings	POTIGA.xml:S1:404:8	O
and	POTIGA.xml:S1:413:3	O
Precautions	POTIGA.xml:S1:417:11	O
(	POTIGA.xml:S1:429:1	O
5.4	POTIGA.xml:S1:430:3	O
)]	POTIGA.xml:S1:433:2	O

Dizziness	POTIGA.xml:S1:444:9	B-AdverseReaction
and	POTIGA.xml:S1:454:3	O
somnolence	POTIGA.xml:S1:458:10	B-AdverseReaction
[	POTIGA.xml:S1:469:1	O
see	POTIGA.xml:S1:470:3	O
Warnings	POTIGA.xml:S1:474:8	O
and	POTIGA.xml:S1:483:3	O
Precautions	POTIGA.xml:S1:487:11	O
(	POTIGA.xml:S1:499:1	O
5.5	POTIGA.xml:S1:500:3	O
)]	POTIGA.xml:S1:503:2	O

QT	POTIGA.xml:S1:514:2	B-AdverseReaction
interval	POTIGA.xml:S1:517:8	I-AdverseReaction
effect	POTIGA.xml:S1:526:6	I-AdverseReaction
[	POTIGA.xml:S1:533:1	O
see	POTIGA.xml:S1:534:3	O
Warnings	POTIGA.xml:S1:538:8	O
and	POTIGA.xml:S1:547:3	O
Precautions	POTIGA.xml:S1:551:11	O
(	POTIGA.xml:S1:563:1	O
5.6	POTIGA.xml:S1:564:3	O
)]	POTIGA.xml:S1:567:2	O

Suicidal	POTIGA.xml:S1:578:8	B-AdverseReaction
behavior	POTIGA.xml:S1:587:8	I-AdverseReaction
and	POTIGA.xml:S1:596:3	O
ideation	POTIGA.xml:S1:600:8	I-AdverseReaction
[	POTIGA.xml:S1:609:1	O
see	POTIGA.xml:S1:610:3	O
Warnings	POTIGA.xml:S1:614:8	O
and	POTIGA.xml:S1:623:3	O
Precautions	POTIGA.xml:S1:627:11	O
(	POTIGA.xml:S1:639:1	O
5.7	POTIGA.xml:S1:640:3	O
)]	POTIGA.xml:S1:643:2	O

Withdrawal	POTIGA.xml:S1:654:10	B-AdverseReaction
seizures	POTIGA.xml:S1:665:8	I-AdverseReaction
[	POTIGA.xml:S1:674:1	O
see	POTIGA.xml:S1:675:3	O
Warnings	POTIGA.xml:S1:679:8	O
and	POTIGA.xml:S1:688:3	O
Precautions	POTIGA.xml:S1:692:11	O
(	POTIGA.xml:S1:704:1	O
5.8	POTIGA.xml:S1:705:3	O
)]	POTIGA.xml:S1:708:2	O

EXCERPT	POTIGA.xml:S1:719:7	O
:	POTIGA.xml:S1:726:1	O
Most	POTIGA.xml:S1:730:4	O
common	POTIGA.xml:S1:735:6	O
adverse	POTIGA.xml:S1:742:7	O
reactions	POTIGA.xml:S1:750:9	O
(	POTIGA.xml:S1:760:1	O
incidence	POTIGA.xml:S1:761:9	O
4%	POTIGA.xml:S1:773:2	O
and	POTIGA.xml:S1:776:3	O
twice	POTIGA.xml:S1:780:5	O
placebo	POTIGA.xml:S1:786:7	O
)	POTIGA.xml:S1:793:1	O
were	POTIGA.xml:S1:795:4	O
dizziness	POTIGA.xml:S1:800:9	B-AdverseReaction
,	POTIGA.xml:S1:809:1	O
somnolence	POTIGA.xml:S1:811:10	B-AdverseReaction
,	POTIGA.xml:S1:821:1	O
fatigue	POTIGA.xml:S1:823:7	B-AdverseReaction
,	POTIGA.xml:S1:830:1	O
confusional	POTIGA.xml:S1:832:11	B-AdverseReaction
state	POTIGA.xml:S1:844:5	I-AdverseReaction
,	POTIGA.xml:S1:849:1	O
vertigo	POTIGA.xml:S1:851:7	B-AdverseReaction
,	POTIGA.xml:S1:858:1	O
tremor	POTIGA.xml:S1:860:6	B-AdverseReaction
,	POTIGA.xml:S1:866:1	O
abnormal	POTIGA.xml:S1:868:8	B-AdverseReaction
coordination	POTIGA.xml:S1:877:12	I-AdverseReaction
,	POTIGA.xml:S1:889:1	O
diplopia	POTIGA.xml:S1:891:8	B-AdverseReaction
,	POTIGA.xml:S1:899:1	O
disturbance	POTIGA.xml:S1:901:11	B-AdverseReaction
in	POTIGA.xml:S1:913:2	I-AdverseReaction
attention	POTIGA.xml:S1:916:9	I-AdverseReaction
,	POTIGA.xml:S1:925:1	O
memory	POTIGA.xml:S1:927:6	B-AdverseReaction
impairment	POTIGA.xml:S1:934:10	I-AdverseReaction
,	POTIGA.xml:S1:944:1	O
asthenia	POTIGA.xml:S1:946:8	B-AdverseReaction
,	POTIGA.xml:S1:954:1	O
blurred	POTIGA.xml:S1:956:7	B-AdverseReaction
vision	POTIGA.xml:S1:964:6	I-AdverseReaction
,	POTIGA.xml:S1:970:1	O
gait	POTIGA.xml:S1:972:4	B-AdverseReaction
disturbance	POTIGA.xml:S1:977:11	I-AdverseReaction
,	POTIGA.xml:S1:988:1	O
aphasia	POTIGA.xml:S1:990:7	B-AdverseReaction
,	POTIGA.xml:S1:997:1	O
dysarthria	POTIGA.xml:S1:999:10	B-AdverseReaction
,	POTIGA.xml:S1:1009:1	O
and	POTIGA.xml:S1:1011:3	O
balance	POTIGA.xml:S1:1015:7	B-AdverseReaction
disorder	POTIGA.xml:S1:1023:8	I-AdverseReaction
.	POTIGA.xml:S1:1031:1	O

(	POTIGA.xml:S1:1033:1	O
6.1	POTIGA.xml:S1:1036:3	O
)	POTIGA.xml:S1:1041:1	O

To	POTIGA.xml:S1:1049:2	O

report	POTIGA.xml:S1:1052:6	O
SUSPECTED	POTIGA.xml:S1:1059:9	O
ADVERSE	POTIGA.xml:S1:1069:7	O
REACTIONS	POTIGA.xml:S1:1077:9	O
,	POTIGA.xml:S1:1086:1	O
contact	POTIGA.xml:S1:1088:7	O
GlaxoSmithKline	POTIGA.xml:S1:1096:15	O
at	POTIGA.xml:S1:1112:2	O
1	POTIGA.xml:S1:1115:1	O
-	POTIGA.xml:S1:1116:1	O
888	POTIGA.xml:S1:1117:3	O
-	POTIGA.xml:S1:1120:1	O
825	POTIGA.xml:S1:1121:3	O
-	POTIGA.xml:S1:1124:1	O
5249	POTIGA.xml:S1:1125:4	O
or	POTIGA.xml:S1:1130:2	O
FDA	POTIGA.xml:S1:1133:3	O
at	POTIGA.xml:S1:1137:2	O
1	POTIGA.xml:S1:1140:1	O
-	POTIGA.xml:S1:1141:1	O
800	POTIGA.xml:S1:1142:3	O
-	POTIGA.xml:S1:1145:1	O
FDA	POTIGA.xml:S1:1146:3	O
-	POTIGA.xml:S1:1149:1	O
1088	POTIGA.xml:S1:1150:4	O
or	POTIGA.xml:S1:1155:2	O
www	POTIGA.xml:S1:1159:3	O
.	POTIGA.xml:S1:1162:1	O
fda	POTIGA.xml:S1:1163:3	O
.	POTIGA.xml:S1:1166:1	O
gov	POTIGA.xml:S1:1167:3	O
medwatch	POTIGA.xml:S1:1171:8	O
.	POTIGA.xml:S1:1181:1	O

6.1	POTIGA.xml:S1:1193:3	O

Clinical	POTIGA.xml:S1:1197:8	O
Trials	POTIGA.xml:S1:1206:6	O
Experience	POTIGA.xml:S1:1213:10	O

Because	POTIGA.xml:S1:1227:7	O
clinical	POTIGA.xml:S1:1235:8	O
trials	POTIGA.xml:S1:1244:6	O
are	POTIGA.xml:S1:1251:3	O
conducted	POTIGA.xml:S1:1255:9	O
under	POTIGA.xml:S1:1265:5	O
widely	POTIGA.xml:S1:1271:6	O
varying	POTIGA.xml:S1:1278:7	O
conditions	POTIGA.xml:S1:1286:10	O
,	POTIGA.xml:S1:1296:1	O
adverse	POTIGA.xml:S1:1298:7	O
reaction	POTIGA.xml:S1:1306:8	O
rates	POTIGA.xml:S1:1315:5	O
observed	POTIGA.xml:S1:1321:8	O
in	POTIGA.xml:S1:1330:2	O
the	POTIGA.xml:S1:1333:3	O
clinical	POTIGA.xml:S1:1337:8	O
trials	POTIGA.xml:S1:1346:6	O
of	POTIGA.xml:S1:1353:2	O
a	POTIGA.xml:S1:1356:1	O
drug	POTIGA.xml:S1:1358:4	O
cannot	POTIGA.xml:S1:1363:6	O
be	POTIGA.xml:S1:1370:2	O
directly	POTIGA.xml:S1:1373:8	O
compared	POTIGA.xml:S1:1382:8	O
with	POTIGA.xml:S1:1391:4	O
rates	POTIGA.xml:S1:1396:5	O
in	POTIGA.xml:S1:1402:2	O
the	POTIGA.xml:S1:1405:3	O
clinical	POTIGA.xml:S1:1409:8	O
trials	POTIGA.xml:S1:1418:6	O
of	POTIGA.xml:S1:1425:2	O
another	POTIGA.xml:S1:1428:7	O
drug	POTIGA.xml:S1:1436:4	O
and	POTIGA.xml:S1:1441:3	O
may	POTIGA.xml:S1:1445:3	O
not	POTIGA.xml:S1:1449:3	O
reflect	POTIGA.xml:S1:1453:7	O
the	POTIGA.xml:S1:1461:3	O
rates	POTIGA.xml:S1:1465:5	O
observed	POTIGA.xml:S1:1471:8	O
in	POTIGA.xml:S1:1480:2	O
practice	POTIGA.xml:S1:1483:8	O
.	POTIGA.xml:S1:1491:1	O

POTIGA	POTIGA.xml:S1:1497:6	O
was	POTIGA.xml:S1:1504:3	O
administered	POTIGA.xml:S1:1508:12	O
as	POTIGA.xml:S1:1521:2	O
adjunctive	POTIGA.xml:S1:1524:10	O
therapy	POTIGA.xml:S1:1535:7	O
to	POTIGA.xml:S1:1543:2	O
1	POTIGA.xml:S1:1546:1	O
,	POTIGA.xml:S1:1547:1	O
365	POTIGA.xml:S1:1548:3	O
patients	POTIGA.xml:S1:1552:8	O
with	POTIGA.xml:S1:1561:4	O
epilepsy	POTIGA.xml:S1:1566:8	O
in	POTIGA.xml:S1:1575:2	O
all	POTIGA.xml:S1:1578:3	O
controlled	POTIGA.xml:S1:1582:10	O
and	POTIGA.xml:S1:1593:3	O
uncontrolled	POTIGA.xml:S1:1597:12	O
clinical	POTIGA.xml:S1:1610:8	O
studies	POTIGA.xml:S1:1619:7	O
during	POTIGA.xml:S1:1627:6	O
the	POTIGA.xml:S1:1634:3	O
premarketing	POTIGA.xml:S1:1638:12	O
development	POTIGA.xml:S1:1651:11	O
.	POTIGA.xml:S1:1662:1	O

A	POTIGA.xml:S1:1664:1	O
total	POTIGA.xml:S1:1666:5	O
of	POTIGA.xml:S1:1672:2	O
801	POTIGA.xml:S1:1675:3	O
patients	POTIGA.xml:S1:1679:8	O
were	POTIGA.xml:S1:1688:4	O
treated	POTIGA.xml:S1:1693:7	O
for	POTIGA.xml:S1:1701:3	O
at	POTIGA.xml:S1:1705:2	O
least	POTIGA.xml:S1:1708:5	O
6	POTIGA.xml:S1:1714:1	O
months	POTIGA.xml:S1:1716:6	O
,	POTIGA.xml:S1:1722:1	O
585	POTIGA.xml:S1:1724:3	O
patients	POTIGA.xml:S1:1728:8	O
were	POTIGA.xml:S1:1737:4	O
treated	POTIGA.xml:S1:1742:7	O
for	POTIGA.xml:S1:1750:3	O
1	POTIGA.xml:S1:1754:1	O
year	POTIGA.xml:S1:1756:4	O
or	POTIGA.xml:S1:1761:2	O
longer	POTIGA.xml:S1:1764:6	O
,	POTIGA.xml:S1:1770:1	O
and	POTIGA.xml:S1:1772:3	O
311	POTIGA.xml:S1:1776:3	O
patients	POTIGA.xml:S1:1780:8	O
were	POTIGA.xml:S1:1789:4	O
treated	POTIGA.xml:S1:1794:7	O
for	POTIGA.xml:S1:1802:3	O
at	POTIGA.xml:S1:1806:2	O
least	POTIGA.xml:S1:1809:5	O
2	POTIGA.xml:S1:1815:1	O
years	POTIGA.xml:S1:1817:5	O
.	POTIGA.xml:S1:1822:1	O

Adverse	POTIGA.xml:S1:1830:7	O
Reactions	POTIGA.xml:S1:1838:9	O
Leading	POTIGA.xml:S1:1848:7	O
to	POTIGA.xml:S1:1856:2	O
Discontinuation	POTIGA.xml:S1:1859:15	O
in	POTIGA.xml:S1:1875:2	O
All	POTIGA.xml:S1:1878:3	O
Controlled	POTIGA.xml:S1:1882:10	O
Clinical	POTIGA.xml:S1:1893:8	O
Studies	POTIGA.xml:S1:1902:7	O

In	POTIGA.xml:S1:1916:2	O
the	POTIGA.xml:S1:1919:3	O
3	POTIGA.xml:S1:1923:1	O
randomized	POTIGA.xml:S1:1925:10	O
,	POTIGA.xml:S1:1935:1	O
double	POTIGA.xml:S1:1937:6	O
-	POTIGA.xml:S1:1943:1	O
blind	POTIGA.xml:S1:1944:5	O
,	POTIGA.xml:S1:1949:1	O
placebo	POTIGA.xml:S1:1951:7	O
-	POTIGA.xml:S1:1958:1	O
controlled	POTIGA.xml:S1:1959:10	O
studies	POTIGA.xml:S1:1970:7	O
,	POTIGA.xml:S1:1977:1	O
199	POTIGA.xml:S1:1979:3	O
of	POTIGA.xml:S1:1983:2	O
813	POTIGA.xml:S1:1986:3	O
patients	POTIGA.xml:S1:1990:8	O
(	POTIGA.xml:S1:1999:1	O
25%	POTIGA.xml:S1:2000:3	O
)	POTIGA.xml:S1:2003:1	O
receiving	POTIGA.xml:S1:2005:9	O
POTIGA	POTIGA.xml:S1:2015:6	O
and	POTIGA.xml:S1:2022:3	O
45	POTIGA.xml:S1:2026:2	O
of	POTIGA.xml:S1:2029:2	O
427	POTIGA.xml:S1:2032:3	O
patients	POTIGA.xml:S1:2036:8	O
(	POTIGA.xml:S1:2045:1	O
11%	POTIGA.xml:S1:2046:3	O
)	POTIGA.xml:S1:2049:1	O
receiving	POTIGA.xml:S1:2051:9	O
placebo	POTIGA.xml:S1:2061:7	O
discontinued	POTIGA.xml:S1:2069:12	O
treatment	POTIGA.xml:S1:2082:9	O
because	POTIGA.xml:S1:2092:7	O
of	POTIGA.xml:S1:2100:2	O
adverse	POTIGA.xml:S1:2103:7	O
reactions	POTIGA.xml:S1:2111:9	O
.	POTIGA.xml:S1:2120:1	O

The	POTIGA.xml:S1:2122:3	O
most	POTIGA.xml:S1:2126:4	O
common	POTIGA.xml:S1:2131:6	O
adverse	POTIGA.xml:S1:2138:7	O
reactions	POTIGA.xml:S1:2146:9	O
leading	POTIGA.xml:S1:2156:7	O
to	POTIGA.xml:S1:2164:2	O
withdrawal	POTIGA.xml:S1:2167:10	O
in	POTIGA.xml:S1:2178:2	O
patients	POTIGA.xml:S1:2181:8	O
receiving	POTIGA.xml:S1:2190:9	O
POTIGA	POTIGA.xml:S1:2200:6	O
were	POTIGA.xml:S1:2207:4	O
dizziness	POTIGA.xml:S1:2212:9	B-AdverseReaction
(	POTIGA.xml:S1:2222:1	O
6%	POTIGA.xml:S1:2223:2	O
)	POTIGA.xml:S1:2225:1	O
,	POTIGA.xml:S1:2226:1	O
confusional	POTIGA.xml:S1:2228:11	B-AdverseReaction
state	POTIGA.xml:S1:2240:5	I-AdverseReaction
(	POTIGA.xml:S1:2246:1	O
4%	POTIGA.xml:S1:2247:2	O
)	POTIGA.xml:S1:2249:1	O
,	POTIGA.xml:S1:2250:1	O
fatigue	POTIGA.xml:S1:2252:7	B-AdverseReaction
(	POTIGA.xml:S1:2260:1	O
3%	POTIGA.xml:S1:2261:2	O
)	POTIGA.xml:S1:2263:1	O
,	POTIGA.xml:S1:2264:1	O
and	POTIGA.xml:S1:2266:3	O
somnolence	POTIGA.xml:S1:2270:10	B-AdverseReaction
(	POTIGA.xml:S1:2281:1	O
3%	POTIGA.xml:S1:2282:2	O
)	POTIGA.xml:S1:2284:1	O
.	POTIGA.xml:S1:2285:1	O

Common	POTIGA.xml:S1:2293:6	O
Adverse	POTIGA.xml:S1:2300:7	O
Reactions	POTIGA.xml:S1:2308:9	O
in	POTIGA.xml:S1:2318:2	O
All	POTIGA.xml:S1:2321:3	O
Controlled	POTIGA.xml:S1:2325:10	O
Clinical	POTIGA.xml:S1:2336:8	O
Studies	POTIGA.xml:S1:2345:7	O

Overall	POTIGA.xml:S1:2359:7	O
,	POTIGA.xml:S1:2366:1	O
the	POTIGA.xml:S1:2368:3	O
most	POTIGA.xml:S1:2372:4	O
frequently	POTIGA.xml:S1:2377:10	O
reported	POTIGA.xml:S1:2388:8	O
adverse	POTIGA.xml:S1:2397:7	O
reactions	POTIGA.xml:S1:2405:9	O
in	POTIGA.xml:S1:2415:2	O
patients	POTIGA.xml:S1:2418:8	O
receiving	POTIGA.xml:S1:2427:9	O
POTIGA	POTIGA.xml:S1:2437:6	O
(	POTIGA.xml:S1:2444:1	O
4%	POTIGA.xml:S1:2447:2	O
and	POTIGA.xml:S1:2450:3	O
occurring	POTIGA.xml:S1:2454:9	O
approximately	POTIGA.xml:S1:2464:13	O
twice	POTIGA.xml:S1:2478:5	O
the	POTIGA.xml:S1:2484:3	O
placebo	POTIGA.xml:S1:2488:7	O
rate	POTIGA.xml:S1:2496:4	O
)	POTIGA.xml:S1:2500:1	O
were	POTIGA.xml:S1:2502:4	O
dizziness	POTIGA.xml:S1:2507:9	B-AdverseReaction
(	POTIGA.xml:S1:2517:1	O
23%	POTIGA.xml:S1:2518:3	O
)	POTIGA.xml:S1:2521:1	O
,	POTIGA.xml:S1:2522:1	O
somnolence	POTIGA.xml:S1:2524:10	B-AdverseReaction
(	POTIGA.xml:S1:2535:1	O
22%	POTIGA.xml:S1:2536:3	O
)	POTIGA.xml:S1:2539:1	O
,	POTIGA.xml:S1:2540:1	O
fatigue	POTIGA.xml:S1:2542:7	B-AdverseReaction
(	POTIGA.xml:S1:2550:1	O
15%	POTIGA.xml:S1:2551:3	O
)	POTIGA.xml:S1:2554:1	O
,	POTIGA.xml:S1:2555:1	O
confusional	POTIGA.xml:S1:2557:11	B-AdverseReaction
state	POTIGA.xml:S1:2569:5	I-AdverseReaction
(	POTIGA.xml:S1:2575:1	O
9%	POTIGA.xml:S1:2576:2	O
)	POTIGA.xml:S1:2578:1	O
,	POTIGA.xml:S1:2579:1	O
vertigo	POTIGA.xml:S1:2581:7	B-AdverseReaction
(	POTIGA.xml:S1:2589:1	O
8%	POTIGA.xml:S1:2590:2	O
)	POTIGA.xml:S1:2592:1	O
,	POTIGA.xml:S1:2593:1	O
tremor	POTIGA.xml:S1:2595:6	B-AdverseReaction
(	POTIGA.xml:S1:2602:1	O
8%	POTIGA.xml:S1:2603:2	O
)	POTIGA.xml:S1:2605:1	O
,	POTIGA.xml:S1:2606:1	O
abnormal	POTIGA.xml:S1:2608:8	B-AdverseReaction
coordination	POTIGA.xml:S1:2617:12	I-AdverseReaction
(	POTIGA.xml:S1:2630:1	O
7%	POTIGA.xml:S1:2631:2	O
)	POTIGA.xml:S1:2633:1	O
,	POTIGA.xml:S1:2634:1	O
diplopia	POTIGA.xml:S1:2636:8	B-AdverseReaction
(	POTIGA.xml:S1:2645:1	O
7%	POTIGA.xml:S1:2646:2	O
)	POTIGA.xml:S1:2648:1	O
,	POTIGA.xml:S1:2649:1	O
disturbance	POTIGA.xml:S1:2651:11	B-AdverseReaction
in	POTIGA.xml:S1:2663:2	I-AdverseReaction
attention	POTIGA.xml:S1:2666:9	I-AdverseReaction
(	POTIGA.xml:S1:2676:1	O
6%	POTIGA.xml:S1:2677:2	O
)	POTIGA.xml:S1:2679:1	O
,	POTIGA.xml:S1:2680:1	O
memory	POTIGA.xml:S1:2682:6	B-AdverseReaction
impairment	POTIGA.xml:S1:2689:10	I-AdverseReaction
(	POTIGA.xml:S1:2700:1	O
6%	POTIGA.xml:S1:2701:2	O
)	POTIGA.xml:S1:2703:1	O
,	POTIGA.xml:S1:2704:1	O
asthenia	POTIGA.xml:S1:2706:8	B-AdverseReaction
(	POTIGA.xml:S1:2715:1	O
5%	POTIGA.xml:S1:2716:2	O
)	POTIGA.xml:S1:2718:1	O
,	POTIGA.xml:S1:2719:1	O
blurred	POTIGA.xml:S1:2721:7	B-AdverseReaction
vision	POTIGA.xml:S1:2729:6	I-AdverseReaction
(	POTIGA.xml:S1:2736:1	O
5%	POTIGA.xml:S1:2737:2	O
)	POTIGA.xml:S1:2739:1	O
,	POTIGA.xml:S1:2740:1	O
gait	POTIGA.xml:S1:2742:4	B-AdverseReaction
disturbance	POTIGA.xml:S1:2747:11	I-AdverseReaction
(	POTIGA.xml:S1:2759:1	O
4%	POTIGA.xml:S1:2760:2	O
)	POTIGA.xml:S1:2762:1	O
,	POTIGA.xml:S1:2763:1	O
aphasia	POTIGA.xml:S1:2765:7	B-AdverseReaction
(	POTIGA.xml:S1:2773:1	O
4%	POTIGA.xml:S1:2774:2	O
)	POTIGA.xml:S1:2776:1	O
,	POTIGA.xml:S1:2777:1	O
dysarthria	POTIGA.xml:S1:2779:10	B-AdverseReaction
(	POTIGA.xml:S1:2790:1	O
4%	POTIGA.xml:S1:2791:2	O
)	POTIGA.xml:S1:2793:1	O
,	POTIGA.xml:S1:2794:1	O
and	POTIGA.xml:S1:2796:3	O
balance	POTIGA.xml:S1:2800:7	B-AdverseReaction
disorder	POTIGA.xml:S1:2808:8	I-AdverseReaction
(	POTIGA.xml:S1:2817:1	O
4%	POTIGA.xml:S1:2818:2	O
)	POTIGA.xml:S1:2820:1	O
(	POTIGA.xml:S1:2822:1	O
see	POTIGA.xml:S1:2823:3	O
Table	POTIGA.xml:S1:2827:5	O
4	POTIGA.xml:S1:2833:1	O
)	POTIGA.xml:S1:2834:1	O
.	POTIGA.xml:S1:2835:1	O

In	POTIGA.xml:S1:2837:2	O
most	POTIGA.xml:S1:2840:4	O
cases	POTIGA.xml:S1:2845:5	O
the	POTIGA.xml:S1:2851:3	O
reactions	POTIGA.xml:S1:2855:9	O
were	POTIGA.xml:S1:2865:4	O
of	POTIGA.xml:S1:2870:2	O
mild	POTIGA.xml:S1:2873:4	O
or	POTIGA.xml:S1:2878:2	O
moderate	POTIGA.xml:S1:2881:8	O
intensity	POTIGA.xml:S1:2890:9	O
.	POTIGA.xml:S1:2899:1	O

Table	POTIGA.xml:S1:2907:5	O
4	POTIGA.xml:S1:2913:1	O
.	POTIGA.xml:S1:2914:1	O

Adverse	POTIGA.xml:S1:2916:7	O
Reactions	POTIGA.xml:S1:2924:9	O
Incidence	POTIGA.xml:S1:2934:9	O
in	POTIGA.xml:S1:2944:2	O
Placebo	POTIGA.xml:S1:2947:7	O
-	POTIGA.xml:S1:2954:1	O
Controlled	POTIGA.xml:S1:2955:10	O
Adjunctive	POTIGA.xml:S1:2966:10	O
Trials	POTIGA.xml:S1:2977:6	O
in	POTIGA.xml:S1:2984:2	O
Adult	POTIGA.xml:S1:2987:5	O
Patients	POTIGA.xml:S1:2993:8	O
with	POTIGA.xml:S1:3002:4	O
Partial	POTIGA.xml:S1:3007:7	O
-	POTIGA.xml:S1:3014:1	O
Onset	POTIGA.xml:S1:3015:5	O
Seizures	POTIGA.xml:S1:3021:8	O
(	POTIGA.xml:S1:3030:1	O
Adverse	POTIGA.xml:S1:3031:7	O
reactions	POTIGA.xml:S1:3039:9	O
in	POTIGA.xml:S1:3049:2	O
at	POTIGA.xml:S1:3052:2	O
least	POTIGA.xml:S1:3055:5	O
2%	POTIGA.xml:S1:3061:2	O
of	POTIGA.xml:S1:3064:2	O
patients	POTIGA.xml:S1:3067:8	O
treated	POTIGA.xml:S1:3076:7	O
with	POTIGA.xml:S1:3084:4	O
POTIGA	POTIGA.xml:S1:3089:6	O
in	POTIGA.xml:S1:3096:2	O
any	POTIGA.xml:S1:3099:3	O
treatment	POTIGA.xml:S1:3103:9	O
group	POTIGA.xml:S1:3113:5	O
and	POTIGA.xml:S1:3119:3	O
numerically	POTIGA.xml:S1:3123:11	O
more	POTIGA.xml:S1:3135:4	O
frequent	POTIGA.xml:S1:3140:8	O
than	POTIGA.xml:S1:3149:4	O
in	POTIGA.xml:S1:3154:2	O
the	POTIGA.xml:S1:3157:3	O
placebo	POTIGA.xml:S1:3161:7	O
group	POTIGA.xml:S1:3169:5	O
.	POTIGA.xml:S1:3174:1	O
)	POTIGA.xml:S1:3175:1	O

Body	POTIGA.xml:S1:3185:4	O
System	POTIGA.xml:S1:3190:6	O
Adverse	POTIGA.xml:S1:3197:7	O
Reaction	POTIGA.xml:S1:3205:8	O
Placebo	POTIGA.xml:S1:3217:7	O
POTIGA	POTIGA.xml:S1:3230:6	O

600	POTIGA.xml:S1:3249:3	O
mg	POTIGA.xml:S1:3253:2	O
day	POTIGA.xml:S1:3256:3	O
900	POTIGA.xml:S1:3278:3	O
mg	POTIGA.xml:S1:3282:2	O
day	POTIGA.xml:S1:3285:3	O
1	POTIGA.xml:S1:3292:1	O
,	POTIGA.xml:S1:3293:1	O
200	POTIGA.xml:S1:3294:3	O
mg	POTIGA.xml:S1:3298:2	O
day	POTIGA.xml:S1:3301:3	O
All	POTIGA.xml:S1:3308:3	O

(	POTIGA.xml:S1:3327:1	O
N	POTIGA.xml:S1:3328:1	O
427	POTIGA.xml:S1:3332:3	O
)	POTIGA.xml:S1:3335:1	O
(	POTIGA.xml:S1:3356:1	O
n	POTIGA.xml:S1:3357:1	O
281	POTIGA.xml:S1:3361:3	O
)	POTIGA.xml:S1:3364:1	O
(	POTIGA.xml:S1:3372:1	O
n	POTIGA.xml:S1:3373:1	O
273	POTIGA.xml:S1:3377:3	O
)	POTIGA.xml:S1:3380:1	O
(	POTIGA.xml:S1:3388:1	O
n	POTIGA.xml:S1:3389:1	O
259	POTIGA.xml:S1:3393:3	O
)	POTIGA.xml:S1:3396:1	O
(	POTIGA.xml:S1:3404:1	O
N	POTIGA.xml:S1:3405:1	O
813	POTIGA.xml:S1:3409:3	O
)	POTIGA.xml:S1:3412:1	O

Eye	POTIGA.xml:S1:3452:3	O

Diplopia	POTIGA.xml:S1:3647:8	B-AdverseReaction

2	POTIGA.xml:S1:3736:1	O

8	POTIGA.xml:S1:3749:1	O
6	POTIGA.xml:S1:3765:1	O
7	POTIGA.xml:S1:3781:1	O
7	POTIGA.xml:S1:3798:1	O

Blurred	POTIGA.xml:S1:3842:7	B-AdverseReaction
vision	POTIGA.xml:S1:3850:6	I-AdverseReaction

2	POTIGA.xml:S1:3931:1	O
2	POTIGA.xml:S1:3944:1	O
4	POTIGA.xml:S1:3960:1	O
10	POTIGA.xml:S1:3976:2	O
5	POTIGA.xml:S1:3993:1	O

Gastrointestinal	POTIGA.xml:S1:4037:16	O

Nausea	POTIGA.xml:S1:4232:6	B-AdverseReaction

5	POTIGA.xml:S1:4321:1	O

6	POTIGA.xml:S1:4334:1	O
6	POTIGA.xml:S1:4350:1	O
9	POTIGA.xml:S1:4366:1	O
7	POTIGA.xml:S1:4383:1	O

Constipation	POTIGA.xml:S1:4427:12	B-AdverseReaction

1	POTIGA.xml:S1:4516:1	O
1	POTIGA.xml:S1:4529:1	O
4	POTIGA.xml:S1:4545:1	O
5	POTIGA.xml:S1:4561:1	O
3	POTIGA.xml:S1:4578:1	O

Dyspepsia	POTIGA.xml:S1:4622:9	B-AdverseReaction

2	POTIGA.xml:S1:4711:1	O
3	POTIGA.xml:S1:4724:1	O
2	POTIGA.xml:S1:4740:1	O
3	POTIGA.xml:S1:4756:1	O
2	POTIGA.xml:S1:4773:1	O

General	POTIGA.xml:S1:4817:7	O

Fatigue	POTIGA.xml:S1:5012:7	B-AdverseReaction

6	POTIGA.xml:S1:5101:1	O

16	POTIGA.xml:S1:5114:2	O
15	POTIGA.xml:S1:5130:2	O
13	POTIGA.xml:S1:5146:2	O
15	POTIGA.xml:S1:5163:2	O

Asthenia	POTIGA.xml:S1:5207:8	B-AdverseReaction

2	POTIGA.xml:S1:5296:1	O
4	POTIGA.xml:S1:5309:1	O
6	POTIGA.xml:S1:5325:1	O
4	POTIGA.xml:S1:5341:1	O
5	POTIGA.xml:S1:5358:1	O

Infections	POTIGA.xml:S1:5402:10	O
and	POTIGA.xml:S1:5413:3	O
infestations	POTIGA.xml:S1:5417:12	O

Influenza	POTIGA.xml:S1:5597:9	B-AdverseReaction

2	POTIGA.xml:S1:5686:1	O

4	POTIGA.xml:S1:5699:1	O
1	POTIGA.xml:S1:5715:1	O
5	POTIGA.xml:S1:5731:1	O
3	POTIGA.xml:S1:5748:1	O

Investigations	POTIGA.xml:S1:5792:14	O

Weight	POTIGA.xml:S1:5987:6	B-AdverseReaction

increased	POTIGA.xml:S1:5994:9	I-AdverseReaction

1	POTIGA.xml:S1:6076:1	O
2	POTIGA.xml:S1:6089:1	O
3	POTIGA.xml:S1:6105:1	O
3	POTIGA.xml:S1:6121:1	O
3	POTIGA.xml:S1:6138:1	O

Nervous	POTIGA.xml:S1:6182:7	O
system	POTIGA.xml:S1:6190:6	O

Dizziness	POTIGA.xml:S1:6377:9	B-AdverseReaction

9	POTIGA.xml:S1:6466:1	O

15	POTIGA.xml:S1:6479:2	O
23	POTIGA.xml:S1:6495:2	O
32	POTIGA.xml:S1:6511:2	O
23	POTIGA.xml:S1:6528:2	O

Somnolence	POTIGA.xml:S1:6572:10	B-AdverseReaction

12	POTIGA.xml:S1:6661:2	O
15	POTIGA.xml:S1:6674:2	O
25	POTIGA.xml:S1:6690:2	O
27	POTIGA.xml:S1:6706:2	O
22	POTIGA.xml:S1:6723:2	O

Memory	POTIGA.xml:S1:6767:6	B-AdverseReaction
impairment	POTIGA.xml:S1:6774:10	I-AdverseReaction

3	POTIGA.xml:S1:6856:1	O
3	POTIGA.xml:S1:6869:1	O
6	POTIGA.xml:S1:6885:1	O
9	POTIGA.xml:S1:6901:1	O
6	POTIGA.xml:S1:6918:1	O

Tremor	POTIGA.xml:S1:6962:6	B-AdverseReaction

3	POTIGA.xml:S1:7051:1	O
3	POTIGA.xml:S1:7064:1	O
10	POTIGA.xml:S1:7080:2	O
12	POTIGA.xml:S1:7096:2	O
8	POTIGA.xml:S1:7113:1	O

Vertigo	POTIGA.xml:S1:7157:7	B-AdverseReaction

2	POTIGA.xml:S1:7246:1	O
8	POTIGA.xml:S1:7259:1	O
8	POTIGA.xml:S1:7275:1	O
9	POTIGA.xml:S1:7291:1	O
8	POTIGA.xml:S1:7308:1	O

Abnormal	POTIGA.xml:S1:7352:8	B-AdverseReaction
coordination	POTIGA.xml:S1:7361:12	I-AdverseReaction

3	POTIGA.xml:S1:7441:1	O
5	POTIGA.xml:S1:7454:1	O
5	POTIGA.xml:S1:7470:1	O
12	POTIGA.xml:S1:7486:2	O
7	POTIGA.xml:S1:7503:1	O

Disturbance	POTIGA.xml:S1:7547:11	B-AdverseReaction
in	POTIGA.xml:S1:7559:2	I-AdverseReaction
attention	POTIGA.xml:S1:7562:9	I-AdverseReaction

1	POTIGA.xml:S1:7637:1	O
6	POTIGA.xml:S1:7649:1	O
6	POTIGA.xml:S1:7665:1	O
7	POTIGA.xml:S1:7681:1	O
6	POTIGA.xml:S1:7698:1	O

Gait	POTIGA.xml:S1:7742:4	B-AdverseReaction
disturbance	POTIGA.xml:S1:7747:11	I-AdverseReaction

1	POTIGA.xml:S1:7831:1	O
2	POTIGA.xml:S1:7844:1	O
5	POTIGA.xml:S1:7860:1	O
6	POTIGA.xml:S1:7876:1	O
4	POTIGA.xml:S1:7893:1	O

Aphasia	POTIGA.xml:S1:7937:7	B-AdverseReaction

1	POTIGA.xml:S1:8027:1	O
1	POTIGA.xml:S1:8039:1	O
3	POTIGA.xml:S1:8055:1	O
7	POTIGA.xml:S1:8071:1	O
4	POTIGA.xml:S1:8088:1	O

Dysarthria	POTIGA.xml:S1:8132:10	B-AdverseReaction

1	POTIGA.xml:S1:8222:1	O
4	POTIGA.xml:S1:8234:1	O
2	POTIGA.xml:S1:8250:1	O
8	POTIGA.xml:S1:8266:1	O
4	POTIGA.xml:S1:8283:1	O

Balance	POTIGA.xml:S1:8327:7	B-AdverseReaction
disorder	POTIGA.xml:S1:8335:8	I-AdverseReaction

1	POTIGA.xml:S1:8417:1	O
3	POTIGA.xml:S1:8429:1	O
3	POTIGA.xml:S1:8445:1	O
5	POTIGA.xml:S1:8461:1	O
4	POTIGA.xml:S1:8478:1	O

Paresthesia	POTIGA.xml:S1:8522:11	B-AdverseReaction

2	POTIGA.xml:S1:8611:1	O
3	POTIGA.xml:S1:8624:1	O
2	POTIGA.xml:S1:8640:1	O
5	POTIGA.xml:S1:8656:1	O
3	POTIGA.xml:S1:8673:1	O

Amnesia	POTIGA.xml:S1:8717:7	B-AdverseReaction

1	POTIGA.xml:S1:8807:1	O
1	POTIGA.xml:S1:8820:1	O
3	POTIGA.xml:S1:8835:1	O
3	POTIGA.xml:S1:8851:1	O
2	POTIGA.xml:S1:8868:1	O

Dysphasia	POTIGA.xml:S1:8912:9	B-AdverseReaction

1	POTIGA.xml:S1:9002:1	O
1	POTIGA.xml:S1:9014:1	O
1	POTIGA.xml:S1:9030:1	O
3	POTIGA.xml:S1:9046:1	O
2	POTIGA.xml:S1:9063:1	O

Psychiatric	POTIGA.xml:S1:9107:11	O

Confusional	POTIGA.xml:S1:9302:11	B-AdverseReaction

state	POTIGA.xml:S1:9314:5	I-AdverseReaction

3	POTIGA.xml:S1:9391:1	O
4	POTIGA.xml:S1:9404:1	O
8	POTIGA.xml:S1:9420:1	O
16	POTIGA.xml:S1:9436:2	O
9	POTIGA.xml:S1:9453:1	O

Anxiety	POTIGA.xml:S1:9497:7	B-AdverseReaction

2	POTIGA.xml:S1:9586:1	O
3	POTIGA.xml:S1:9599:1	O
2	POTIGA.xml:S1:9615:1	O
5	POTIGA.xml:S1:9631:1	O
3	POTIGA.xml:S1:9648:1	O

Disorientation	POTIGA.xml:S1:9692:14	B-AdverseReaction

1	POTIGA.xml:S1:9782:1	O
1	POTIGA.xml:S1:9795:1	O
1	POTIGA.xml:S1:9811:1	O
5	POTIGA.xml:S1:9826:1	O
2	POTIGA.xml:S1:9843:1	O

Psychotic	POTIGA.xml:S1:9887:9	B-AdverseReaction
disorder	POTIGA.xml:S1:9897:8	I-AdverseReaction

0	POTIGA.xml:S1:9976:1	O
0	POTIGA.xml:S1:9989:1	O
1	POTIGA.xml:S1:10006:1	O
2	POTIGA.xml:S1:10021:1	O
1	POTIGA.xml:S1:10039:1	O

Renal	POTIGA.xml:S1:10082:5	O
and	POTIGA.xml:S1:10088:3	O
urinary	POTIGA.xml:S1:10092:7	O

Dysuria	POTIGA.xml:S1:10277:7	B-AdverseReaction

1	POTIGA.xml:S1:10367:1	O

1	POTIGA.xml:S1:10379:1	O
2	POTIGA.xml:S1:10395:1	O
4	POTIGA.xml:S1:10411:1	O
2	POTIGA.xml:S1:10428:1	O

Urinary	POTIGA.xml:S1:10472:7	B-AdverseReaction
hesitation	POTIGA.xml:S1:10480:10	I-AdverseReaction

1	POTIGA.xml:S1:10562:1	O
2	POTIGA.xml:S1:10574:1	O
1	POTIGA.xml:S1:10590:1	O
4	POTIGA.xml:S1:10606:1	O
2	POTIGA.xml:S1:10623:1	O

Hematuria	POTIGA.xml:S1:10667:9	B-AdverseReaction

1	POTIGA.xml:S1:10757:1	O
2	POTIGA.xml:S1:10769:1	O
1	POTIGA.xml:S1:10785:1	O
2	POTIGA.xml:S1:10801:1	O
2	POTIGA.xml:S1:10818:1	O

Chromaturia	POTIGA.xml:S1:10862:11	B-AdverseReaction

1	POTIGA.xml:S1:10952:1	O
1	POTIGA.xml:S1:10965:1	O
2	POTIGA.xml:S1:10980:1	O
3	POTIGA.xml:S1:10996:1	O
2	POTIGA.xml:S1:11013:1	O

Other	POTIGA.xml:S1:11039:5	O
adverse	POTIGA.xml:S1:11045:7	O
reactions	POTIGA.xml:S1:11053:9	O
reported	POTIGA.xml:S1:11063:8	O
in	POTIGA.xml:S1:11072:2	O
these	POTIGA.xml:S1:11075:5	O
3	POTIGA.xml:S1:11081:1	O
studies	POTIGA.xml:S1:11083:7	O
in	POTIGA.xml:S1:11091:2	O
2%	POTIGA.xml:S1:11095:2	O
of	POTIGA.xml:S1:11098:2	O
patients	POTIGA.xml:S1:11101:8	O
treated	POTIGA.xml:S1:11110:7	O
with	POTIGA.xml:S1:11118:4	O
POTIGA	POTIGA.xml:S1:11123:6	O
and	POTIGA.xml:S1:11130:3	O
numerically	POTIGA.xml:S1:11134:11	O
greater	POTIGA.xml:S1:11146:7	O
than	POTIGA.xml:S1:11154:4	O
placebo	POTIGA.xml:S1:11159:7	O
were	POTIGA.xml:S1:11167:4	O
increased	POTIGA.xml:S1:11172:9	B-AdverseReaction
appetite	POTIGA.xml:S1:11182:8	I-AdverseReaction
,	POTIGA.xml:S1:11190:1	O
hallucinations	POTIGA.xml:S1:11192:14	B-AdverseReaction
,	POTIGA.xml:S1:11206:1	O
myoclonus	POTIGA.xml:S1:11208:9	B-AdverseReaction
,	POTIGA.xml:S1:11217:1	O
peripheral	POTIGA.xml:S1:11219:10	B-AdverseReaction
edema	POTIGA.xml:S1:11230:5	I-AdverseReaction
,	POTIGA.xml:S1:11235:1	O
hypokinesia	POTIGA.xml:S1:11237:11	B-AdverseReaction
,	POTIGA.xml:S1:11248:1	O
dry	POTIGA.xml:S1:11250:3	B-AdverseReaction
mouth	POTIGA.xml:S1:11254:5	I-AdverseReaction
,	POTIGA.xml:S1:11259:1	O
dysphagia	POTIGA.xml:S1:11261:9	B-AdverseReaction
,	POTIGA.xml:S1:11270:1	O
hyperhydrosis	POTIGA.xml:S1:11272:13	B-AdverseReaction
,	POTIGA.xml:S1:11285:1	O
urinary	POTIGA.xml:S1:11287:7	B-AdverseReaction
retention	POTIGA.xml:S1:11295:9	I-AdverseReaction
,	POTIGA.xml:S1:11304:1	O
malaise	POTIGA.xml:S1:11306:7	B-AdverseReaction
,	POTIGA.xml:S1:11313:1	O
and	POTIGA.xml:S1:11315:3	O
increased	POTIGA.xml:S1:11319:9	B-AdverseReaction
liver	POTIGA.xml:S1:11329:5	I-AdverseReaction
enzymes	POTIGA.xml:S1:11335:7	I-AdverseReaction
.	POTIGA.xml:S1:11342:1	O

Most	POTIGA.xml:S1:11348:4	O

of	POTIGA.xml:S1:11353:2	O
the	POTIGA.xml:S1:11356:3	O
adverse	POTIGA.xml:S1:11360:7	O
reactions	POTIGA.xml:S1:11368:9	O
appear	POTIGA.xml:S1:11378:6	O
to	POTIGA.xml:S1:11385:2	O
be	POTIGA.xml:S1:11388:2	O
dose	POTIGA.xml:S1:11391:4	O
related	POTIGA.xml:S1:11396:7	O
(	POTIGA.xml:S1:11404:1	O
especially	POTIGA.xml:S1:11405:10	O
those	POTIGA.xml:S1:11416:5	O
classified	POTIGA.xml:S1:11422:10	O
as	POTIGA.xml:S1:11433:2	O
psychiatric	POTIGA.xml:S1:11436:11	O
and	POTIGA.xml:S1:11448:3	O
nervous	POTIGA.xml:S1:11452:7	O
system	POTIGA.xml:S1:11460:6	O
symptoms	POTIGA.xml:S1:11467:8	O
)	POTIGA.xml:S1:11475:1	O
,	POTIGA.xml:S1:11476:1	O
including	POTIGA.xml:S1:11478:9	O
dizziness	POTIGA.xml:S1:11488:9	B-AdverseReaction
,	POTIGA.xml:S1:11497:1	O
somnolence	POTIGA.xml:S1:11499:10	B-AdverseReaction
,	POTIGA.xml:S1:11509:1	O
confusional	POTIGA.xml:S1:11511:11	B-AdverseReaction
state	POTIGA.xml:S1:11523:5	I-AdverseReaction
,	POTIGA.xml:S1:11528:1	O
tremor	POTIGA.xml:S1:11530:6	B-AdverseReaction
,	POTIGA.xml:S1:11536:1	O
abnormal	POTIGA.xml:S1:11538:8	B-AdverseReaction
coordination	POTIGA.xml:S1:11547:12	I-AdverseReaction
,	POTIGA.xml:S1:11559:1	O
memory	POTIGA.xml:S1:11561:6	B-AdverseReaction
impairment	POTIGA.xml:S1:11568:10	I-AdverseReaction
,	POTIGA.xml:S1:11578:1	O
blurred	POTIGA.xml:S1:11580:7	B-AdverseReaction
vision	POTIGA.xml:S1:11588:6	I-AdverseReaction
,	POTIGA.xml:S1:11594:1	O
gait	POTIGA.xml:S1:11596:4	B-AdverseReaction
disturbance	POTIGA.xml:S1:11601:11	I-AdverseReaction
,	POTIGA.xml:S1:11612:1	O
aphasia	POTIGA.xml:S1:11614:7	B-AdverseReaction
,	POTIGA.xml:S1:11621:1	O
balance	POTIGA.xml:S1:11623:7	B-AdverseReaction
disorder	POTIGA.xml:S1:11631:8	I-AdverseReaction
,	POTIGA.xml:S1:11639:1	O
constipation	POTIGA.xml:S1:11641:12	B-AdverseReaction
,	POTIGA.xml:S1:11653:1	O
dysuria	POTIGA.xml:S1:11655:7	B-AdverseReaction
,	POTIGA.xml:S1:11662:1	O
and	POTIGA.xml:S1:11664:3	O
chromaturia	POTIGA.xml:S1:11668:11	B-AdverseReaction
.	POTIGA.xml:S1:11679:1	O

POTIGA	POTIGA.xml:S1:11685:6	O
was	POTIGA.xml:S1:11692:3	O
associated	POTIGA.xml:S1:11696:10	O
with	POTIGA.xml:S1:11707:4	O
dose	POTIGA.xml:S1:11712:4	O
-	POTIGA.xml:S1:11716:1	O
related	POTIGA.xml:S1:11717:7	O
weight	POTIGA.xml:S1:11725:6	B-AdverseReaction
gain	POTIGA.xml:S1:11732:4	I-AdverseReaction
,	POTIGA.xml:S1:11736:1	O
with	POTIGA.xml:S1:11738:4	O
mean	POTIGA.xml:S1:11743:4	O
weight	POTIGA.xml:S1:11748:6	B-AdverseReaction
increasing	POTIGA.xml:S1:11755:10	I-AdverseReaction
by	POTIGA.xml:S1:11766:2	O
0.2	POTIGA.xml:S1:11769:3	O
kg	POTIGA.xml:S1:11773:2	O
,	POTIGA.xml:S1:11775:1	O
1.2	POTIGA.xml:S1:11777:3	O
kg	POTIGA.xml:S1:11781:2	O
,	POTIGA.xml:S1:11783:1	O
1.6	POTIGA.xml:S1:11785:3	O
kg	POTIGA.xml:S1:11789:2	O
,	POTIGA.xml:S1:11791:1	O
and	POTIGA.xml:S1:11793:3	O
2.7	POTIGA.xml:S1:11797:3	O
kg	POTIGA.xml:S1:11801:2	O
in	POTIGA.xml:S1:11804:2	O
the	POTIGA.xml:S1:11807:3	O
placebo	POTIGA.xml:S1:11811:7	O
,	POTIGA.xml:S1:11818:1	O
600	POTIGA.xml:S1:11820:3	O
mg	POTIGA.xml:S1:11824:2	O
per	POTIGA.xml:S1:11827:3	O
day	POTIGA.xml:S1:11831:3	O
,	POTIGA.xml:S1:11834:1	O
900	POTIGA.xml:S1:11836:3	O
mg	POTIGA.xml:S1:11840:2	O
per	POTIGA.xml:S1:11843:3	O
day	POTIGA.xml:S1:11847:3	O
,	POTIGA.xml:S1:11850:1	O
and	POTIGA.xml:S1:11852:3	O
1	POTIGA.xml:S1:11856:1	O
,	POTIGA.xml:S1:11857:1	O
200	POTIGA.xml:S1:11858:3	O
mg	POTIGA.xml:S1:11862:2	O
per	POTIGA.xml:S1:11865:3	O
day	POTIGA.xml:S1:11869:3	O
groups	POTIGA.xml:S1:11873:6	O
,	POTIGA.xml:S1:11879:1	O
respectively	POTIGA.xml:S1:11881:12	O
.	POTIGA.xml:S1:11893:1	O

Additional	POTIGA.xml:S1:11901:10	O
Adverse	POTIGA.xml:S1:11912:7	O
Reactions	POTIGA.xml:S1:11920:9	O
Observed	POTIGA.xml:S1:11930:8	O
during	POTIGA.xml:S1:11939:6	O
All	POTIGA.xml:S1:11946:3	O
Phase	POTIGA.xml:S1:11950:5	O
2	POTIGA.xml:S1:11956:1	O
and	POTIGA.xml:S1:11958:3	O
3	POTIGA.xml:S1:11962:1	O
Clinical	POTIGA.xml:S1:11964:8	O
Trials	POTIGA.xml:S1:11973:6	O

Following	POTIGA.xml:S1:11986:9	O
is	POTIGA.xml:S1:11996:2	O
a	POTIGA.xml:S1:11999:1	O
list	POTIGA.xml:S1:12001:4	O
of	POTIGA.xml:S1:12006:2	O
adverse	POTIGA.xml:S1:12009:7	O
reactions	POTIGA.xml:S1:12017:9	O
reported	POTIGA.xml:S1:12027:8	O
by	POTIGA.xml:S1:12036:2	O
patients	POTIGA.xml:S1:12039:8	O
treated	POTIGA.xml:S1:12048:7	O
with	POTIGA.xml:S1:12056:4	O
POTIGA	POTIGA.xml:S1:12061:6	O
during	POTIGA.xml:S1:12068:6	O
all	POTIGA.xml:S1:12075:3	O
clinical	POTIGA.xml:S1:12079:8	O
trials	POTIGA.xml:S1:12088:6	O
:	POTIGA.xml:S1:12094:1	O
rash	POTIGA.xml:S1:12096:4	B-AdverseReaction
,	POTIGA.xml:S1:12100:1	O
nystagmus	POTIGA.xml:S1:12102:9	B-AdverseReaction
,	POTIGA.xml:S1:12111:1	O
dyspnea	POTIGA.xml:S1:12113:7	B-AdverseReaction
,	POTIGA.xml:S1:12120:1	O
leukopenia	POTIGA.xml:S1:12122:10	B-AdverseReaction
,	POTIGA.xml:S1:12132:1	O
muscle	POTIGA.xml:S1:12134:6	B-AdverseReaction
spasms	POTIGA.xml:S1:12141:6	I-AdverseReaction
,	POTIGA.xml:S1:12147:1	O
alopecia	POTIGA.xml:S1:12149:8	B-AdverseReaction
,	POTIGA.xml:S1:12157:1	O
nephrolithiasis	POTIGA.xml:S1:12159:15	B-AdverseReaction
,	POTIGA.xml:S1:12174:1	O
syncope	POTIGA.xml:S1:12176:7	B-AdverseReaction
,	POTIGA.xml:S1:12183:1	O
neutropenia	POTIGA.xml:S1:12185:11	B-AdverseReaction
,	POTIGA.xml:S1:12196:1	O
thrombocytopenia	POTIGA.xml:S1:12198:16	B-AdverseReaction
,	POTIGA.xml:S1:12214:1	O
euphoric	POTIGA.xml:S1:12216:8	B-AdverseReaction
mood	POTIGA.xml:S1:12225:4	I-AdverseReaction
,	POTIGA.xml:S1:12229:1	O
renal	POTIGA.xml:S1:12231:5	B-AdverseReaction
colic	POTIGA.xml:S1:12237:5	I-AdverseReaction
,	POTIGA.xml:S1:12242:1	O
coma	POTIGA.xml:S1:12244:4	B-AdverseReaction
,	POTIGA.xml:S1:12248:1	O
encephalopathy	POTIGA.xml:S1:12250:14	B-AdverseReaction
.	POTIGA.xml:S1:12264:1	O

Comparison	POTIGA.xml:S1:12272:10	O
of	POTIGA.xml:S1:12283:2	O
Gender	POTIGA.xml:S1:12286:6	O
,	POTIGA.xml:S1:12292:1	O
Age	POTIGA.xml:S1:12294:3	O
,	POTIGA.xml:S1:12297:1	O
and	POTIGA.xml:S1:12299:3	O
Race	POTIGA.xml:S1:12303:4	O

The	POTIGA.xml:S1:12314:3	O
overall	POTIGA.xml:S1:12318:7	O
adverse	POTIGA.xml:S1:12326:7	O
reaction	POTIGA.xml:S1:12334:8	O
profile	POTIGA.xml:S1:12343:7	O
of	POTIGA.xml:S1:12351:2	O
POTIGA	POTIGA.xml:S1:12354:6	O
was	POTIGA.xml:S1:12361:3	O
similar	POTIGA.xml:S1:12365:7	O
for	POTIGA.xml:S1:12373:3	O
females	POTIGA.xml:S1:12377:7	O
and	POTIGA.xml:S1:12385:3	O
males	POTIGA.xml:S1:12389:5	O
.	POTIGA.xml:S1:12394:1	O

There	POTIGA.xml:S1:12400:5	O
are	POTIGA.xml:S1:12406:3	O
insufficient	POTIGA.xml:S1:12410:12	O
data	POTIGA.xml:S1:12423:4	O
to	POTIGA.xml:S1:12428:2	O
support	POTIGA.xml:S1:12431:7	O
meaningful	POTIGA.xml:S1:12439:10	O
analyses	POTIGA.xml:S1:12450:8	O
of	POTIGA.xml:S1:12459:2	O
adverse	POTIGA.xml:S1:12462:7	O
reactions	POTIGA.xml:S1:12470:9	O
by	POTIGA.xml:S1:12480:2	O
age	POTIGA.xml:S1:12483:3	O
or	POTIGA.xml:S1:12487:2	O
race	POTIGA.xml:S1:12490:4	O
.	POTIGA.xml:S1:12494:1	O

Approximately	POTIGA.xml:S1:12496:13	O
86%	POTIGA.xml:S1:12510:3	O
of	POTIGA.xml:S1:12514:2	O
the	POTIGA.xml:S1:12517:3	O
population	POTIGA.xml:S1:12521:10	O
studied	POTIGA.xml:S1:12532:7	O
was	POTIGA.xml:S1:12540:3	O
Caucasian	POTIGA.xml:S1:12544:9	O
,	POTIGA.xml:S1:12553:1	O
and	POTIGA.xml:S1:12555:3	O
0.8%	POTIGA.xml:S1:12559:4	O
of	POTIGA.xml:S1:12564:2	O
the	POTIGA.xml:S1:12567:3	O
population	POTIGA.xml:S1:12571:10	O
was	POTIGA.xml:S1:12582:3	O
aged	POTIGA.xml:S1:12586:4	O
65	POTIGA.xml:S1:12591:2	O
years	POTIGA.xml:S1:12594:5	O
or	POTIGA.xml:S1:12600:2	O
older	POTIGA.xml:S1:12603:5	O
.	POTIGA.xml:S1:12608:1	O
\n\n	POTIGA.xml:S2:0:2	O
BOXED	POTIGA.xml:S2:6:5	O
WARNING	POTIGA.xml:S2:12:7	O
:	POTIGA.xml:S2:19:1	O
WARNING	POTIGA.xml:S2:21:7	O
:	POTIGA.xml:S2:28:1	O
RETINAL	POTIGA.xml:S2:30:7	B-AdverseReaction
ABNORMALITIES	POTIGA.xml:S2:38:13	I-AdverseReaction
AND	POTIGA.xml:S2:52:3	O
POTENTIAL	POTIGA.xml:S2:56:9	B-Factor
VISION	POTIGA.xml:S2:66:6	B-AdverseReaction
LOSS	POTIGA.xml:S2:73:4	I-AdverseReaction
\n\n	POTIGA.xml:S2:77:2	O
WARNING	POTIGA.xml:S2:81:7	O
:	POTIGA.xml:S2:88:1	O
RETINAL	POTIGA.xml:S2:90:7	B-AdverseReaction
ABNORMALITIES	POTIGA.xml:S2:98:13	I-AdverseReaction
AND	POTIGA.xml:S2:112:3	O
POTENTIAL	POTIGA.xml:S2:116:9	B-Factor
VISION	POTIGA.xml:S2:126:6	B-AdverseReaction
LOSS	POTIGA.xml:S2:133:4	I-AdverseReaction
\n\n	POTIGA.xml:S2:137:2	O
POTIGA	POTIGA.xml:S2:143:6	O
can	POTIGA.xml:S2:150:3	B-Factor
cause	POTIGA.xml:S2:154:5	O
retinal	POTIGA.xml:S2:160:7	B-AdverseReaction
abnormalities	POTIGA.xml:S2:168:13	I-AdverseReaction
with	POTIGA.xml:S2:182:4	O
funduscopic	POTIGA.xml:S2:187:11	O
features	POTIGA.xml:S2:199:8	O
similar	POTIGA.xml:S2:208:7	I-AdverseReaction
to	POTIGA.xml:S2:216:2	I-AdverseReaction
those	POTIGA.xml:S2:219:5	O
seen	POTIGA.xml:S2:225:4	O
in	POTIGA.xml:S2:230:2	O
retinal	POTIGA.xml:S2:233:7	I-AdverseReaction
pigment	POTIGA.xml:S2:241:7	I-AdverseReaction
dystrophies	POTIGA.xml:S2:249:11	I-AdverseReaction
,	POTIGA.xml:S2:260:1	O
which	POTIGA.xml:S2:262:5	O
are	POTIGA.xml:S2:268:3	O
known	POTIGA.xml:S2:272:5	O
to	POTIGA.xml:S2:278:2	O
result	POTIGA.xml:S2:281:6	O
in	POTIGA.xml:S2:288:2	O
damage	POTIGA.xml:S2:291:6	B-AdverseReaction
to	POTIGA.xml:S2:298:2	I-AdverseReaction
the	POTIGA.xml:S2:301:3	I-AdverseReaction
photoreceptors	POTIGA.xml:S2:305:14	I-AdverseReaction
and	POTIGA.xml:S2:320:3	O
vision	POTIGA.xml:S2:324:6	B-AdverseReaction
loss	POTIGA.xml:S2:331:4	I-AdverseReaction
.	POTIGA.xml:S2:335:1	O

Some	POTIGA.xml:S2:345:4	O
patients	POTIGA.xml:S2:350:8	O
with	POTIGA.xml:S2:359:4	O
retinal	POTIGA.xml:S2:364:7	B-AdverseReaction
abnormalities	POTIGA.xml:S2:372:13	I-AdverseReaction
have	POTIGA.xml:S2:386:4	O
been	POTIGA.xml:S2:391:4	O
found	POTIGA.xml:S2:396:5	O
to	POTIGA.xml:S2:402:2	O
have	POTIGA.xml:S2:405:4	O
abnormal	POTIGA.xml:S2:410:8	B-AdverseReaction
visual	POTIGA.xml:S2:419:6	I-AdverseReaction
acuity	POTIGA.xml:S2:426:6	I-AdverseReaction
.	POTIGA.xml:S2:432:1	O

It	POTIGA.xml:S2:434:2	O
is	POTIGA.xml:S2:437:2	O
not	POTIGA.xml:S2:440:3	B-Factor
possible	POTIGA.xml:S2:444:8	I-Factor
to	POTIGA.xml:S2:453:2	I-Factor
determine	POTIGA.xml:S2:456:9	I-Factor
whether	POTIGA.xml:S2:466:7	O
POTIGA	POTIGA.xml:S2:474:6	O
caused	POTIGA.xml:S2:481:6	O
this	POTIGA.xml:S2:488:4	O
decreased	POTIGA.xml:S2:493:9	B-AdverseReaction
visual	POTIGA.xml:S2:503:6	I-AdverseReaction
acuity	POTIGA.xml:S2:510:6	I-AdverseReaction
,	POTIGA.xml:S2:516:1	O
as	POTIGA.xml:S2:518:2	O
baseline	POTIGA.xml:S2:521:8	O
assessments	POTIGA.xml:S2:530:11	O
are	POTIGA.xml:S2:542:3	O
not	POTIGA.xml:S2:546:3	O
available	POTIGA.xml:S2:550:9	O
for	POTIGA.xml:S2:560:3	O
these	POTIGA.xml:S2:564:5	O
patients	POTIGA.xml:S2:570:8	O
.	POTIGA.xml:S2:578:1	O

Approximately	POTIGA.xml:S2:588:13	O
one	POTIGA.xml:S2:602:3	O
third	POTIGA.xml:S2:606:5	O
of	POTIGA.xml:S2:612:2	O
the	POTIGA.xml:S2:615:3	O
patients	POTIGA.xml:S2:619:8	O
who	POTIGA.xml:S2:628:3	O
had	POTIGA.xml:S2:632:3	O
eye	POTIGA.xml:S2:636:3	O
examinations	POTIGA.xml:S2:640:12	O
performed	POTIGA.xml:S2:653:9	O
after	POTIGA.xml:S2:663:5	O
approximately	POTIGA.xml:S2:669:13	O
4	POTIGA.xml:S2:683:1	O
years	POTIGA.xml:S2:685:5	O
of	POTIGA.xml:S2:691:2	O
treatment	POTIGA.xml:S2:694:9	O
were	POTIGA.xml:S2:704:4	O
found	POTIGA.xml:S2:709:5	O
to	POTIGA.xml:S2:715:2	O
have	POTIGA.xml:S2:718:4	O
retinal	POTIGA.xml:S2:723:7	B-AdverseReaction
pigmentary	POTIGA.xml:S2:731:10	I-AdverseReaction
abnormalities	POTIGA.xml:S2:742:13	I-AdverseReaction
.	POTIGA.xml:S2:755:1	O

An	POTIGA.xml:S2:757:2	O
earlier	POTIGA.xml:S2:760:7	O
onset	POTIGA.xml:S2:768:5	O
cannot	POTIGA.xml:S2:774:6	O
be	POTIGA.xml:S2:781:2	O
ruled	POTIGA.xml:S2:784:5	O
out	POTIGA.xml:S2:790:3	O
,	POTIGA.xml:S2:793:1	O
and	POTIGA.xml:S2:795:3	O
it	POTIGA.xml:S2:799:2	O
is	POTIGA.xml:S2:802:2	O
possible	POTIGA.xml:S2:805:8	O
that	POTIGA.xml:S2:814:4	O
retinal	POTIGA.xml:S2:819:7	B-AdverseReaction
abnormalities	POTIGA.xml:S2:827:13	I-AdverseReaction
were	POTIGA.xml:S2:841:4	O
present	POTIGA.xml:S2:846:7	O
earlier	POTIGA.xml:S2:854:7	O
in	POTIGA.xml:S2:862:2	O
the	POTIGA.xml:S2:865:3	O
course	POTIGA.xml:S2:869:6	O
of	POTIGA.xml:S2:876:2	O
exposure	POTIGA.xml:S2:879:8	O
to	POTIGA.xml:S2:888:2	O
POTIGA	POTIGA.xml:S2:891:6	O
.	POTIGA.xml:S2:897:1	O

The	POTIGA.xml:S2:899:3	O
rate	POTIGA.xml:S2:903:4	O
of	POTIGA.xml:S2:908:2	O
progression	POTIGA.xml:S2:911:11	O
of	POTIGA.xml:S2:923:2	O
retinal	POTIGA.xml:S2:926:7	B-AdverseReaction
abnormalities	POTIGA.xml:S2:934:13	I-AdverseReaction
and	POTIGA.xml:S2:948:3	O
their	POTIGA.xml:S2:952:5	O
reversibility	POTIGA.xml:S2:958:13	O
are	POTIGA.xml:S2:972:3	O
unknown	POTIGA.xml:S2:976:7	O
.	POTIGA.xml:S2:983:1	O

POTIGA	POTIGA.xml:S2:993:6	O
should	POTIGA.xml:S2:1000:6	O
only	POTIGA.xml:S2:1007:4	O
be	POTIGA.xml:S2:1012:2	O
used	POTIGA.xml:S2:1015:4	O
in	POTIGA.xml:S2:1020:2	O
patients	POTIGA.xml:S2:1023:8	O
who	POTIGA.xml:S2:1032:3	O
have	POTIGA.xml:S2:1036:4	O
responded	POTIGA.xml:S2:1041:9	O
inadequately	POTIGA.xml:S2:1051:12	O
to	POTIGA.xml:S2:1064:2	O
several	POTIGA.xml:S2:1067:7	O
alternative	POTIGA.xml:S2:1075:11	O
treatments	POTIGA.xml:S2:1087:10	O
and	POTIGA.xml:S2:1098:3	O
for	POTIGA.xml:S2:1102:3	O
whom	POTIGA.xml:S2:1106:4	O
the	POTIGA.xml:S2:1111:3	O
benefits	POTIGA.xml:S2:1115:8	O
outweigh	POTIGA.xml:S2:1124:8	O
the	POTIGA.xml:S2:1133:3	O
potential	POTIGA.xml:S2:1137:9	O
risk	POTIGA.xml:S2:1147:4	O
of	POTIGA.xml:S2:1152:2	O
vision	POTIGA.xml:S2:1155:6	O
loss	POTIGA.xml:S2:1162:4	O
.	POTIGA.xml:S2:1166:1	O

Patients	POTIGA.xml:S2:1168:8	O
who	POTIGA.xml:S2:1177:3	O
fail	POTIGA.xml:S2:1181:4	O
to	POTIGA.xml:S2:1186:2	O
show	POTIGA.xml:S2:1189:4	O
substantial	POTIGA.xml:S2:1194:11	O
clinical	POTIGA.xml:S2:1206:8	O
benefit	POTIGA.xml:S2:1215:7	O
after	POTIGA.xml:S2:1223:5	O
adequate	POTIGA.xml:S2:1229:8	O
titration	POTIGA.xml:S2:1238:9	O
should	POTIGA.xml:S2:1248:6	O
be	POTIGA.xml:S2:1255:2	O
discontinued	POTIGA.xml:S2:1258:12	O
from	POTIGA.xml:S2:1271:4	O
POTIGA	POTIGA.xml:S2:1276:6	O
.	POTIGA.xml:S2:1282:1	O

All	POTIGA.xml:S2:1292:3	O
patients	POTIGA.xml:S2:1296:8	O
taking	POTIGA.xml:S2:1305:6	O
POTIGA	POTIGA.xml:S2:1312:6	O
should	POTIGA.xml:S2:1319:6	O
have	POTIGA.xml:S2:1326:4	O
baseline	POTIGA.xml:S2:1331:8	O
and	POTIGA.xml:S2:1340:3	O
periodic	POTIGA.xml:S2:1344:8	O
(	POTIGA.xml:S2:1353:1	O
every	POTIGA.xml:S2:1354:5	O
6	POTIGA.xml:S2:1360:1	O
months	POTIGA.xml:S2:1362:6	O
)	POTIGA.xml:S2:1368:1	O
systematic	POTIGA.xml:S2:1370:10	O
visual	POTIGA.xml:S2:1381:6	O
monitoring	POTIGA.xml:S2:1388:10	O
by	POTIGA.xml:S2:1399:2	O
an	POTIGA.xml:S2:1402:2	O
ophthalmic	POTIGA.xml:S2:1405:10	O
professional	POTIGA.xml:S2:1416:12	O
.	POTIGA.xml:S2:1428:1	O

Testing	POTIGA.xml:S2:1430:7	O
should	POTIGA.xml:S2:1438:6	O
include	POTIGA.xml:S2:1445:7	O
visual	POTIGA.xml:S2:1453:6	O
acuity	POTIGA.xml:S2:1460:6	O
and	POTIGA.xml:S2:1467:3	O
dilated	POTIGA.xml:S2:1471:7	O
fundus	POTIGA.xml:S2:1479:6	O
photography	POTIGA.xml:S2:1486:11	O
.	POTIGA.xml:S2:1497:1	O

Additional	POTIGA.xml:S2:1499:10	O
testing	POTIGA.xml:S2:1510:7	O
may	POTIGA.xml:S2:1518:3	O
include	POTIGA.xml:S2:1522:7	O
fluorescein	POTIGA.xml:S2:1530:11	O
angiograms	POTIGA.xml:S2:1542:10	O
(	POTIGA.xml:S2:1553:1	O
FA	POTIGA.xml:S2:1554:2	O
)	POTIGA.xml:S2:1556:1	O
,	POTIGA.xml:S2:1557:1	O
optical	POTIGA.xml:S2:1559:7	O
coherence	POTIGA.xml:S2:1567:9	O
tomography	POTIGA.xml:S2:1577:10	O
(	POTIGA.xml:S2:1588:1	O
OCT	POTIGA.xml:S2:1589:3	O
)	POTIGA.xml:S2:1592:1	O
,	POTIGA.xml:S2:1593:1	O
perimetry	POTIGA.xml:S2:1595:9	O
,	POTIGA.xml:S2:1604:1	O
and	POTIGA.xml:S2:1606:3	O
electroretinograms	POTIGA.xml:S2:1610:18	O
(	POTIGA.xml:S2:1629:1	O
ERG	POTIGA.xml:S2:1630:3	O
)	POTIGA.xml:S2:1633:1	O
.	POTIGA.xml:S2:1634:1	O

If	POTIGA.xml:S2:1644:2	O
retinal	POTIGA.xml:S2:1647:7	O
pigmentary	POTIGA.xml:S2:1655:10	O
abnormalities	POTIGA.xml:S2:1666:13	O
or	POTIGA.xml:S2:1680:2	O
vision	POTIGA.xml:S2:1683:6	O
changes	POTIGA.xml:S2:1690:7	O
are	POTIGA.xml:S2:1698:3	O
detected	POTIGA.xml:S2:1702:8	O
,	POTIGA.xml:S2:1710:1	O
POTIGA	POTIGA.xml:S2:1712:6	O
should	POTIGA.xml:S2:1719:6	O
be	POTIGA.xml:S2:1726:2	O
discontinued	POTIGA.xml:S2:1729:12	O
unless	POTIGA.xml:S2:1742:6	O
no	POTIGA.xml:S2:1749:2	O
other	POTIGA.xml:S2:1752:5	O
suitable	POTIGA.xml:S2:1758:8	O
treatment	POTIGA.xml:S2:1767:9	O
options	POTIGA.xml:S2:1777:7	O
are	POTIGA.xml:S2:1785:3	O
available	POTIGA.xml:S2:1789:9	O
and	POTIGA.xml:S2:1799:3	O
the	POTIGA.xml:S2:1803:3	O
benefits	POTIGA.xml:S2:1807:8	O
of	POTIGA.xml:S2:1816:2	O
treatment	POTIGA.xml:S2:1819:9	O
outweigh	POTIGA.xml:S2:1829:8	O
the	POTIGA.xml:S2:1838:3	O
potential	POTIGA.xml:S2:1842:9	O
risk	POTIGA.xml:S2:1852:4	O
of	POTIGA.xml:S2:1857:2	O
vision	POTIGA.xml:S2:1860:6	O
loss	POTIGA.xml:S2:1867:4	O
.	POTIGA.xml:S2:1871:1	O

EXCERPT	POTIGA.xml:S2:1881:7	O
:	POTIGA.xml:S2:1888:1	O
WARNING	POTIGA.xml:S2:1892:7	O
:	POTIGA.xml:S2:1899:1	O
RETINAL	POTIGA.xml:S2:1901:7	B-AdverseReaction
ABNORMALITIES	POTIGA.xml:S2:1909:13	I-AdverseReaction
AND	POTIGA.xml:S2:1923:3	O
POTENTIAL	POTIGA.xml:S2:1927:9	B-Factor
VISION	POTIGA.xml:S2:1937:6	B-AdverseReaction
LOSS	POTIGA.xml:S2:1944:4	I-AdverseReaction
\n\n\n\n	POTIGA.xml:S2:1948:4	O
See	POTIGA.xml:S2:1955:3	O
full	POTIGA.xml:S2:1959:4	O
prescribing	POTIGA.xml:S2:1964:11	O
information	POTIGA.xml:S2:1976:11	O
for	POTIGA.xml:S2:1988:3	O
complete	POTIGA.xml:S2:1992:8	O
boxed	POTIGA.xml:S2:2001:5	O
warning	POTIGA.xml:S2:2007:7	O
.	POTIGA.xml:S2:2014:1	O

POTIGA	POTIGA.xml:S2:2025:6	O
can	POTIGA.xml:S2:2032:3	O
cause	POTIGA.xml:S2:2036:5	O
retinal	POTIGA.xml:S2:2042:7	B-AdverseReaction
abnormalities	POTIGA.xml:S2:2050:13	I-AdverseReaction
with	POTIGA.xml:S2:2064:4	O
funduscopic	POTIGA.xml:S2:2069:11	O
features	POTIGA.xml:S2:2081:8	O
similar	POTIGA.xml:S2:2090:7	I-AdverseReaction
to	POTIGA.xml:S2:2098:2	I-AdverseReaction
those	POTIGA.xml:S2:2101:5	O
seen	POTIGA.xml:S2:2107:4	O
in	POTIGA.xml:S2:2112:2	O
retinal	POTIGA.xml:S2:2115:7	O
pigment	POTIGA.xml:S2:2123:7	I-AdverseReaction
dystrophies	POTIGA.xml:S2:2131:11	I-AdverseReaction
,	POTIGA.xml:S2:2142:1	O
which	POTIGA.xml:S2:2144:5	O
are	POTIGA.xml:S2:2150:3	O
known	POTIGA.xml:S2:2154:5	O
to	POTIGA.xml:S2:2160:2	O
result	POTIGA.xml:S2:2163:6	O
in	POTIGA.xml:S2:2170:2	O
damage	POTIGA.xml:S2:2173:6	B-AdverseReaction
to	POTIGA.xml:S2:2180:2	I-AdverseReaction
the	POTIGA.xml:S2:2183:3	I-AdverseReaction
photoreceptors	POTIGA.xml:S2:2187:14	I-AdverseReaction
and	POTIGA.xml:S2:2202:3	O
vision	POTIGA.xml:S2:2206:6	B-AdverseReaction
loss	POTIGA.xml:S2:2213:4	I-AdverseReaction
.	POTIGA.xml:S2:2217:1	O

(	POTIGA.xml:S2:2219:1	O
5.1	POTIGA.xml:S2:2220:3	O
)	POTIGA.xml:S2:2223:1	O
\n	POTIGA.xml:S2:2225:1	O
Some	POTIGA.xml:S2:2230:4	O
patients	POTIGA.xml:S2:2235:8	O
with	POTIGA.xml:S2:2244:4	O
retinal	POTIGA.xml:S2:2249:7	O
abnormalities	POTIGA.xml:S2:2257:13	O
have	POTIGA.xml:S2:2271:4	O
been	POTIGA.xml:S2:2276:4	O
found	POTIGA.xml:S2:2281:5	O
to	POTIGA.xml:S2:2287:2	O
have	POTIGA.xml:S2:2290:4	O
abnormal	POTIGA.xml:S2:2295:8	O
visual	POTIGA.xml:S2:2304:6	O
acuity	POTIGA.xml:S2:2311:6	O
.	POTIGA.xml:S2:2317:1	O

It	POTIGA.xml:S2:2319:2	O
is	POTIGA.xml:S2:2322:2	O
not	POTIGA.xml:S2:2325:3	B-Factor
possible	POTIGA.xml:S2:2329:8	I-Factor
to	POTIGA.xml:S2:2338:2	I-Factor
determine	POTIGA.xml:S2:2341:9	I-Factor
whether	POTIGA.xml:S2:2351:7	O
POTIGA	POTIGA.xml:S2:2359:6	O
caused	POTIGA.xml:S2:2366:6	O
this	POTIGA.xml:S2:2373:4	O
decreased	POTIGA.xml:S2:2378:9	B-AdverseReaction
visual	POTIGA.xml:S2:2388:6	I-AdverseReaction
acuity	POTIGA.xml:S2:2395:6	I-AdverseReaction
.	POTIGA.xml:S2:2401:1	O

(	POTIGA.xml:S2:2403:1	O
5.1	POTIGA.xml:S2:2404:3	O
)	POTIGA.xml:S2:2407:1	O
\n	POTIGA.xml:S2:2409:1	O
The	POTIGA.xml:S2:2414:3	O
rate	POTIGA.xml:S2:2418:4	O
of	POTIGA.xml:S2:2423:2	O
progression	POTIGA.xml:S2:2426:11	O
of	POTIGA.xml:S2:2438:2	O
retinal	POTIGA.xml:S2:2441:7	O
abnormalities	POTIGA.xml:S2:2449:13	O
and	POTIGA.xml:S2:2463:3	O
their	POTIGA.xml:S2:2467:5	O
reversibility	POTIGA.xml:S2:2473:13	O
are	POTIGA.xml:S2:2487:3	O
unknown	POTIGA.xml:S2:2491:7	O
.	POTIGA.xml:S2:2498:1	O

(	POTIGA.xml:S2:2500:1	O
5.1	POTIGA.xml:S2:2501:3	O
)	POTIGA.xml:S2:2504:1	O
\n	POTIGA.xml:S2:2506:1	O
Patients	POTIGA.xml:S2:2511:8	O
who	POTIGA.xml:S2:2520:3	O
fail	POTIGA.xml:S2:2524:4	O
to	POTIGA.xml:S2:2529:2	O
show	POTIGA.xml:S2:2532:4	O
substantial	POTIGA.xml:S2:2537:11	O
clinical	POTIGA.xml:S2:2549:8	O
benefit	POTIGA.xml:S2:2558:7	O
after	POTIGA.xml:S2:2566:5	O
adequate	POTIGA.xml:S2:2572:8	O
titration	POTIGA.xml:S2:2581:9	O
should	POTIGA.xml:S2:2591:6	O
be	POTIGA.xml:S2:2598:2	O
discontinued	POTIGA.xml:S2:2601:12	O
from	POTIGA.xml:S2:2614:4	O
POTIGA	POTIGA.xml:S2:2619:6	O
.	POTIGA.xml:S2:2625:1	O

(	POTIGA.xml:S2:2627:1	O
5.1	POTIGA.xml:S2:2628:3	O
)	POTIGA.xml:S2:2631:1	O
\n	POTIGA.xml:S2:2633:1	O
All	POTIGA.xml:S2:2638:3	O
patients	POTIGA.xml:S2:2642:8	O
taking	POTIGA.xml:S2:2651:6	O
POTIGA	POTIGA.xml:S2:2658:6	O
should	POTIGA.xml:S2:2665:6	O
have	POTIGA.xml:S2:2672:4	O
baseline	POTIGA.xml:S2:2677:8	O
and	POTIGA.xml:S2:2686:3	O
periodic	POTIGA.xml:S2:2690:8	O
(	POTIGA.xml:S2:2699:1	O
every	POTIGA.xml:S2:2700:5	O
6	POTIGA.xml:S2:2706:1	O
months	POTIGA.xml:S2:2708:6	O
)	POTIGA.xml:S2:2714:1	O
systematic	POTIGA.xml:S2:2716:10	O
visual	POTIGA.xml:S2:2727:6	O
monitoring	POTIGA.xml:S2:2734:10	O
by	POTIGA.xml:S2:2745:2	O
an	POTIGA.xml:S2:2748:2	O
ophthalmic	POTIGA.xml:S2:2751:10	O
professional	POTIGA.xml:S2:2762:12	O
.	POTIGA.xml:S2:2774:1	O

Testing	POTIGA.xml:S2:2776:7	O
should	POTIGA.xml:S2:2784:6	O
include	POTIGA.xml:S2:2791:7	O
visual	POTIGA.xml:S2:2799:6	O
acuity	POTIGA.xml:S2:2806:6	O
and	POTIGA.xml:S2:2813:3	O
dilated	POTIGA.xml:S2:2817:7	O
fundus	POTIGA.xml:S2:2825:6	O
photography	POTIGA.xml:S2:2832:11	O
.	POTIGA.xml:S2:2843:1	O

(	POTIGA.xml:S2:2845:1	O
5.1	POTIGA.xml:S2:2846:3	O
)	POTIGA.xml:S2:2849:1	O
\n	POTIGA.xml:S2:2851:1	O
If	POTIGA.xml:S2:2856:2	O
retinal	POTIGA.xml:S2:2859:7	O
pigmentary	POTIGA.xml:S2:2867:10	O
abnormalities	POTIGA.xml:S2:2878:13	O
or	POTIGA.xml:S2:2892:2	O
vision	POTIGA.xml:S2:2895:6	O
changes	POTIGA.xml:S2:2902:7	O
are	POTIGA.xml:S2:2910:3	O
detected	POTIGA.xml:S2:2914:8	O
,	POTIGA.xml:S2:2922:1	O
POTIGA	POTIGA.xml:S2:2924:6	O
should	POTIGA.xml:S2:2931:6	O
be	POTIGA.xml:S2:2938:2	O
discontinued	POTIGA.xml:S2:2941:12	O
unless	POTIGA.xml:S2:2954:6	O
no	POTIGA.xml:S2:2961:2	O
other	POTIGA.xml:S2:2964:5	O
suitable	POTIGA.xml:S2:2970:8	O
treatment	POTIGA.xml:S2:2979:9	O
options	POTIGA.xml:S2:2989:7	O
are	POTIGA.xml:S2:2997:3	O
available	POTIGA.xml:S2:3001:9	O
and	POTIGA.xml:S2:3011:3	O
the	POTIGA.xml:S2:3015:3	O
benefits	POTIGA.xml:S2:3019:8	O
of	POTIGA.xml:S2:3028:2	O
treatment	POTIGA.xml:S2:3031:9	O
outweigh	POTIGA.xml:S2:3041:8	O
the	POTIGA.xml:S2:3050:3	O
potential	POTIGA.xml:S2:3054:9	O
risk	POTIGA.xml:S2:3064:4	O
of	POTIGA.xml:S2:3069:2	O
vision	POTIGA.xml:S2:3072:6	O
loss	POTIGA.xml:S2:3079:4	O
.	POTIGA.xml:S2:3083:1	O

(	POTIGA.xml:S2:3085:1	O
5.1	POTIGA.xml:S2:3086:3	O
)	POTIGA.xml:S2:3089:1	O
\n	POTIGA.xml:S2:3091:1	O
5	POTIGA.xml:S3:4:1	O
WARNINGS	POTIGA.xml:S3:6:8	O
AND	POTIGA.xml:S3:15:3	O
PRECAUTIONS	POTIGA.xml:S3:19:11	O

EXCERPT	POTIGA.xml:S3:37:7	O
:	POTIGA.xml:S3:44:1	O
Urinary	POTIGA.xml:S3:54:7	B-AdverseReaction
retention	POTIGA.xml:S3:62:9	I-AdverseReaction
:	POTIGA.xml:S3:71:1	O
Patients	POTIGA.xml:S3:73:8	O
should	POTIGA.xml:S3:82:6	O
be	POTIGA.xml:S3:89:2	O
carefully	POTIGA.xml:S3:92:9	O
monitored	POTIGA.xml:S3:102:9	O
for	POTIGA.xml:S3:112:3	O
urologic	POTIGA.xml:S3:116:8	O
symptoms	POTIGA.xml:S3:125:8	O
.	POTIGA.xml:S3:133:1	O

(	POTIGA.xml:S3:135:1	O
5.2	POTIGA.xml:S3:138:3	O
)	POTIGA.xml:S3:143:1	O

POTIGA	POTIGA.xml:S3:152:6	O
can	POTIGA.xml:S3:159:3	B-Factor
cause	POTIGA.xml:S3:163:5	O
skin	POTIGA.xml:S3:169:4	B-AdverseReaction
discoloration	POTIGA.xml:S3:174:13	I-AdverseReaction
.	POTIGA.xml:S3:187:1	O

If	POTIGA.xml:S3:189:2	O
a	POTIGA.xml:S3:192:1	O
patient	POTIGA.xml:S3:194:7	O
develops	POTIGA.xml:S3:202:8	O
skin	POTIGA.xml:S3:211:4	O
discoloration	POTIGA.xml:S3:216:13	O
,	POTIGA.xml:S3:229:1	O
serious	POTIGA.xml:S3:231:7	O
consideration	POTIGA.xml:S3:239:13	O
should	POTIGA.xml:S3:253:6	O
be	POTIGA.xml:S3:260:2	O
given	POTIGA.xml:S3:263:5	O
to	POTIGA.xml:S3:269:2	O
an	POTIGA.xml:S3:272:2	O
alternative	POTIGA.xml:S3:275:11	O
treatment	POTIGA.xml:S3:287:9	O
.	POTIGA.xml:S3:296:1	O

(	POTIGA.xml:S3:298:1	O
5.3	POTIGA.xml:S3:301:3	O
)	POTIGA.xml:S3:306:1	O

Neuropsychiatric	POTIGA.xml:S3:315:16	B-AdverseReaction
symptoms	POTIGA.xml:S3:332:8	I-AdverseReaction
:	POTIGA.xml:S3:340:1	O
Monitor	POTIGA.xml:S3:342:7	O
for	POTIGA.xml:S3:350:3	O
confusional	POTIGA.xml:S3:354:11	O
state	POTIGA.xml:S3:366:5	O
,	POTIGA.xml:S3:371:1	O
psychotic	POTIGA.xml:S3:373:9	O
symptoms	POTIGA.xml:S3:383:8	O
,	POTIGA.xml:S3:391:1	O
and	POTIGA.xml:S3:393:3	O
hallucinations	POTIGA.xml:S3:397:14	O
.	POTIGA.xml:S3:411:1	O

(	POTIGA.xml:S3:413:1	O
5.4	POTIGA.xml:S3:416:3	O
)	POTIGA.xml:S3:421:1	O

Monitor	POTIGA.xml:S3:430:7	O
for	POTIGA.xml:S3:438:3	O
dizziness	POTIGA.xml:S3:442:9	O
and	POTIGA.xml:S3:452:3	O
somnolence	POTIGA.xml:S3:456:10	O
.	POTIGA.xml:S3:466:1	O

(	POTIGA.xml:S3:468:1	O
5.5	POTIGA.xml:S3:471:3	O
)	POTIGA.xml:S3:476:1	O

QT	POTIGA.xml:S3:485:2	B-AdverseReaction
prolongation	POTIGA.xml:S3:488:12	I-AdverseReaction
:	POTIGA.xml:S3:500:1	O
QT	POTIGA.xml:S3:502:2	O
interval	POTIGA.xml:S3:505:8	O
should	POTIGA.xml:S3:514:6	O
be	POTIGA.xml:S3:521:2	O
monitored	POTIGA.xml:S3:524:9	O
in	POTIGA.xml:S3:534:2	O
patients	POTIGA.xml:S3:537:8	O
taking	POTIGA.xml:S3:546:6	O
concomitant	POTIGA.xml:S3:553:11	O
medications	POTIGA.xml:S3:565:11	O
known	POTIGA.xml:S3:577:5	O
to	POTIGA.xml:S3:583:2	O
increase	POTIGA.xml:S3:586:8	O
the	POTIGA.xml:S3:595:3	O
QT	POTIGA.xml:S3:599:2	O
interval	POTIGA.xml:S3:602:8	O
or	POTIGA.xml:S3:611:2	O
with	POTIGA.xml:S3:614:4	O
certain	POTIGA.xml:S3:619:7	O
heart	POTIGA.xml:S3:627:5	O
conditions	POTIGA.xml:S3:633:10	O
.	POTIGA.xml:S3:643:1	O

(	POTIGA.xml:S3:645:1	O
5.6	POTIGA.xml:S3:648:3	O
)	POTIGA.xml:S3:653:1	O

Monitor	POTIGA.xml:S3:662:7	O
for	POTIGA.xml:S3:670:3	O
suicidal	POTIGA.xml:S3:674:8	O
thoughts	POTIGA.xml:S3:683:8	O
or	POTIGA.xml:S3:692:2	O
behaviors	POTIGA.xml:S3:695:9	O
.	POTIGA.xml:S3:704:1	O

(	POTIGA.xml:S3:706:1	O
5.7	POTIGA.xml:S3:709:3	O
)	POTIGA.xml:S3:714:1	O

5.1	POTIGA.xml:S3:728:3	O

Retinal	POTIGA.xml:S3:732:7	O

Abnormalities	POTIGA.xml:S3:740:13	O
and	POTIGA.xml:S3:754:3	O
Potential	POTIGA.xml:S3:758:9	O
Vision	POTIGA.xml:S3:768:6	O
Loss	POTIGA.xml:S3:775:4	O

POTIGA	POTIGA.xml:S3:785:6	O
can	POTIGA.xml:S3:792:3	B-Factor
cause	POTIGA.xml:S3:796:5	O
abnormalities	POTIGA.xml:S3:802:13	B-AdverseReaction
of	POTIGA.xml:S3:816:2	I-AdverseReaction
the	POTIGA.xml:S3:819:3	I-AdverseReaction
retina	POTIGA.xml:S3:823:6	I-AdverseReaction
.	POTIGA.xml:S3:829:1	O

The	POTIGA.xml:S3:831:3	O
abnormalities	POTIGA.xml:S3:835:13	O
seen	POTIGA.xml:S3:849:4	O
in	POTIGA.xml:S3:854:2	O
patients	POTIGA.xml:S3:857:8	O
treated	POTIGA.xml:S3:866:7	O
with	POTIGA.xml:S3:874:4	O
POTIGA	POTIGA.xml:S3:879:6	O
have	POTIGA.xml:S3:886:4	O
funduscopic	POTIGA.xml:S3:891:11	B-AdverseReaction
features	POTIGA.xml:S3:903:8	I-AdverseReaction
similar	POTIGA.xml:S3:912:7	I-AdverseReaction
to	POTIGA.xml:S3:920:2	I-AdverseReaction
those	POTIGA.xml:S3:923:5	O
seen	POTIGA.xml:S3:929:4	O
in	POTIGA.xml:S3:934:2	O
retinal	POTIGA.xml:S3:937:7	I-AdverseReaction
pigment	POTIGA.xml:S3:945:7	I-AdverseReaction
dystrophies	POTIGA.xml:S3:953:11	I-AdverseReaction
that	POTIGA.xml:S3:965:4	O
are	POTIGA.xml:S3:970:3	O
known	POTIGA.xml:S3:974:5	O
to	POTIGA.xml:S3:980:2	O
result	POTIGA.xml:S3:983:6	O
in	POTIGA.xml:S3:990:2	O
damage	POTIGA.xml:S3:993:6	B-AdverseReaction
to	POTIGA.xml:S3:1000:2	I-AdverseReaction
photoreceptors	POTIGA.xml:S3:1003:14	I-AdverseReaction
and	POTIGA.xml:S3:1018:3	O
vision	POTIGA.xml:S3:1022:6	B-AdverseReaction
loss	POTIGA.xml:S3:1029:4	I-AdverseReaction
.	POTIGA.xml:S3:1033:1	O

The	POTIGA.xml:S3:1039:3	O
retinal	POTIGA.xml:S3:1043:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:1051:13	I-AdverseReaction
observed	POTIGA.xml:S3:1065:8	O
with	POTIGA.xml:S3:1074:4	O
POTIGA	POTIGA.xml:S3:1079:6	O
have	POTIGA.xml:S3:1086:4	O
been	POTIGA.xml:S3:1091:4	O
reported	POTIGA.xml:S3:1096:8	O
in	POTIGA.xml:S3:1105:2	O
patients	POTIGA.xml:S3:1108:8	O
who	POTIGA.xml:S3:1117:3	O
were	POTIGA.xml:S3:1121:4	O
originally	POTIGA.xml:S3:1126:10	O
enrolled	POTIGA.xml:S3:1137:8	O
in	POTIGA.xml:S3:1146:2	O
clinical	POTIGA.xml:S3:1149:8	O
trials	POTIGA.xml:S3:1158:6	O
with	POTIGA.xml:S3:1165:4	O
POTIGA	POTIGA.xml:S3:1170:6	O
and	POTIGA.xml:S3:1177:3	O
who	POTIGA.xml:S3:1181:3	O
have	POTIGA.xml:S3:1185:4	O
generally	POTIGA.xml:S3:1190:9	O
taken	POTIGA.xml:S3:1200:5	O
the	POTIGA.xml:S3:1206:3	O
drug	POTIGA.xml:S3:1210:4	O
for	POTIGA.xml:S3:1215:3	O
a	POTIGA.xml:S3:1219:1	O
long	POTIGA.xml:S3:1221:4	O
period	POTIGA.xml:S3:1226:6	O
of	POTIGA.xml:S3:1233:2	O
time	POTIGA.xml:S3:1236:4	O
in	POTIGA.xml:S3:1241:2	O
2	POTIGA.xml:S3:1244:1	O
ongoing	POTIGA.xml:S3:1246:7	O
extension	POTIGA.xml:S3:1254:9	O
trials	POTIGA.xml:S3:1264:6	O
.	POTIGA.xml:S3:1270:1	O

Approximately	POTIGA.xml:S3:1272:13	O
one	POTIGA.xml:S3:1286:3	O
third	POTIGA.xml:S3:1290:5	O
of	POTIGA.xml:S3:1296:2	O
the	POTIGA.xml:S3:1299:3	O
patients	POTIGA.xml:S3:1303:8	O
who	POTIGA.xml:S3:1312:3	O
had	POTIGA.xml:S3:1316:3	O
eye	POTIGA.xml:S3:1320:3	O
examinations	POTIGA.xml:S3:1324:12	O
performed	POTIGA.xml:S3:1337:9	O
after	POTIGA.xml:S3:1347:5	O
approximately	POTIGA.xml:S3:1353:13	O
4	POTIGA.xml:S3:1367:1	O
years	POTIGA.xml:S3:1369:5	O
of	POTIGA.xml:S3:1375:2	O
treatment	POTIGA.xml:S3:1378:9	O
were	POTIGA.xml:S3:1388:4	O
found	POTIGA.xml:S3:1393:5	O
to	POTIGA.xml:S3:1399:2	O
have	POTIGA.xml:S3:1402:4	O
retinal	POTIGA.xml:S3:1407:7	B-AdverseReaction
pigmentary	POTIGA.xml:S3:1415:10	I-AdverseReaction
abnormalities	POTIGA.xml:S3:1426:13	I-AdverseReaction
.	POTIGA.xml:S3:1439:1	O

However	POTIGA.xml:S3:1441:7	O
,	POTIGA.xml:S3:1448:1	O
an	POTIGA.xml:S3:1450:2	O
earlier	POTIGA.xml:S3:1453:7	O
onset	POTIGA.xml:S3:1461:5	O
cannot	POTIGA.xml:S3:1467:6	O
be	POTIGA.xml:S3:1474:2	O
ruled	POTIGA.xml:S3:1477:5	O
out	POTIGA.xml:S3:1483:3	O
,	POTIGA.xml:S3:1486:1	O
and	POTIGA.xml:S3:1488:3	O
it	POTIGA.xml:S3:1492:2	O
is	POTIGA.xml:S3:1495:2	O
possible	POTIGA.xml:S3:1498:8	O
that	POTIGA.xml:S3:1507:4	O
retinal	POTIGA.xml:S3:1512:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:1520:13	I-AdverseReaction
were	POTIGA.xml:S3:1534:4	O
present	POTIGA.xml:S3:1539:7	O
earlier	POTIGA.xml:S3:1547:7	O
in	POTIGA.xml:S3:1555:2	O
the	POTIGA.xml:S3:1558:3	O
course	POTIGA.xml:S3:1562:6	O
of	POTIGA.xml:S3:1569:2	O
exposure	POTIGA.xml:S3:1572:8	O
to	POTIGA.xml:S3:1581:2	O
POTIGA	POTIGA.xml:S3:1584:6	O
.	POTIGA.xml:S3:1590:1	O

POTIGA	POTIGA.xml:S3:1592:6	O
causes	POTIGA.xml:S3:1599:6	O
skin	POTIGA.xml:S3:1606:4	B-AdverseReaction
,	POTIGA.xml:S3:1610:1	O
scleral	POTIGA.xml:S3:1612:7	B-AdverseReaction
,	POTIGA.xml:S3:1619:1	O
nail	POTIGA.xml:S3:1621:4	B-AdverseReaction
,	POTIGA.xml:S3:1625:1	O
and	POTIGA.xml:S3:1627:3	O
mucous	POTIGA.xml:S3:1631:6	B-AdverseReaction
membrane	POTIGA.xml:S3:1638:8	I-AdverseReaction
discoloration	POTIGA.xml:S3:1647:13	I-AdverseReaction
and	POTIGA.xml:S3:1661:3	O
it	POTIGA.xml:S3:1665:2	O
is	POTIGA.xml:S3:1668:2	O
not	POTIGA.xml:S3:1671:3	O
clear	POTIGA.xml:S3:1675:5	O
whether	POTIGA.xml:S3:1681:7	O
this	POTIGA.xml:S3:1689:4	O
discoloration	POTIGA.xml:S3:1694:13	B-AdverseReaction
is	POTIGA.xml:S3:1708:2	O
related	POTIGA.xml:S3:1711:7	O
to	POTIGA.xml:S3:1719:2	O
retinal	POTIGA.xml:S3:1722:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:1730:13	I-AdverseReaction
[	POTIGA.xml:S3:1744:1	O
see	POTIGA.xml:S3:1745:3	O
Warnings	POTIGA.xml:S3:1749:8	O
and	POTIGA.xml:S3:1758:3	O
Precautions	POTIGA.xml:S3:1762:11	O
(	POTIGA.xml:S3:1774:1	O
5.3	POTIGA.xml:S3:1775:3	O
)]	POTIGA.xml:S3:1778:2	O
.	POTIGA.xml:S3:1782:1	O

Approximately	POTIGA.xml:S3:1784:13	O
15%	POTIGA.xml:S3:1798:3	O
of	POTIGA.xml:S3:1802:2	O
patients	POTIGA.xml:S3:1805:8	O
with	POTIGA.xml:S3:1814:4	O
retinal	POTIGA.xml:S3:1819:7	B-AdverseReaction
pigmentary	POTIGA.xml:S3:1827:10	I-AdverseReaction
abnormalities	POTIGA.xml:S3:1838:13	I-AdverseReaction
had	POTIGA.xml:S3:1852:3	O
no	POTIGA.xml:S3:1856:2	B-Negation
such	POTIGA.xml:S3:1859:4	O
discoloration	POTIGA.xml:S3:1864:13	B-AdverseReaction
.	POTIGA.xml:S3:1877:1	O

Funduscopic	POTIGA.xml:S3:1883:11	B-AdverseReaction
abnormalities	POTIGA.xml:S3:1895:13	I-AdverseReaction
have	POTIGA.xml:S3:1909:4	O
most	POTIGA.xml:S3:1914:4	O
commonly	POTIGA.xml:S3:1919:8	O
been	POTIGA.xml:S3:1928:4	O
described	POTIGA.xml:S3:1933:9	O
as	POTIGA.xml:S3:1943:2	O
perivascular	POTIGA.xml:S3:1946:12	B-AdverseReaction
pigmentation	POTIGA.xml:S3:1959:12	I-AdverseReaction
(	POTIGA.xml:S3:1972:1	O
bone	POTIGA.xml:S3:1973:4	I-AdverseReaction
spicule	POTIGA.xml:S3:1978:7	I-AdverseReaction
pattern	POTIGA.xml:S3:1986:7	I-AdverseReaction
)	POTIGA.xml:S3:1993:1	O
in	POTIGA.xml:S3:1995:2	I-AdverseReaction
the	POTIGA.xml:S3:1998:3	I-AdverseReaction
retinal	POTIGA.xml:S3:2002:7	I-AdverseReaction
periphery	POTIGA.xml:S3:2010:9	I-AdverseReaction
and	POTIGA.xml:S3:2020:3	O
or	POTIGA.xml:S3:2024:2	O
as	POTIGA.xml:S3:2027:2	O
areas	POTIGA.xml:S3:2030:5	O
of	POTIGA.xml:S3:2036:2	O
focal	POTIGA.xml:S3:2039:5	B-AdverseReaction
retinal	POTIGA.xml:S3:2045:7	I-AdverseReaction
pigment	POTIGA.xml:S3:2053:7	I-AdverseReaction
epithelium	POTIGA.xml:S3:2061:10	I-AdverseReaction
clumping	POTIGA.xml:S3:2072:8	I-AdverseReaction
.	POTIGA.xml:S3:2080:1	O

Although	POTIGA.xml:S3:2082:8	O
some	POTIGA.xml:S3:2091:4	O
of	POTIGA.xml:S3:2096:2	O
the	POTIGA.xml:S3:2099:3	O
patients	POTIGA.xml:S3:2103:8	O
with	POTIGA.xml:S3:2112:4	O
retinal	POTIGA.xml:S3:2117:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:2125:13	I-AdverseReaction
have	POTIGA.xml:S3:2139:4	O
been	POTIGA.xml:S3:2144:4	O
found	POTIGA.xml:S3:2149:5	O
to	POTIGA.xml:S3:2155:2	O
have	POTIGA.xml:S3:2158:4	O
abnormal	POTIGA.xml:S3:2163:8	B-AdverseReaction
visual	POTIGA.xml:S3:2172:6	I-AdverseReaction
acuity	POTIGA.xml:S3:2179:6	I-AdverseReaction
,	POTIGA.xml:S3:2185:1	O
it	POTIGA.xml:S3:2187:2	O
is	POTIGA.xml:S3:2190:2	O
not	POTIGA.xml:S3:2193:3	O
possible	POTIGA.xml:S3:2197:8	O
to	POTIGA.xml:S3:2206:2	O
assess	POTIGA.xml:S3:2209:6	O
whether	POTIGA.xml:S3:2216:7	B-Factor
POTIGA	POTIGA.xml:S3:2224:6	O
caused	POTIGA.xml:S3:2231:6	O
their	POTIGA.xml:S3:2238:5	O
decreased	POTIGA.xml:S3:2244:9	B-AdverseReaction
visual	POTIGA.xml:S3:2254:6	I-AdverseReaction
acuity	POTIGA.xml:S3:2261:6	I-AdverseReaction
,	POTIGA.xml:S3:2267:1	O
as	POTIGA.xml:S3:2269:2	O
baseline	POTIGA.xml:S3:2272:8	O
assessments	POTIGA.xml:S3:2281:11	O
are	POTIGA.xml:S3:2293:3	O
not	POTIGA.xml:S3:2297:3	O
available	POTIGA.xml:S3:2301:9	O
for	POTIGA.xml:S3:2311:3	O
these	POTIGA.xml:S3:2315:5	O
patients	POTIGA.xml:S3:2321:8	O
.	POTIGA.xml:S3:2329:1	O

Two	POTIGA.xml:S3:2331:3	O
patients	POTIGA.xml:S3:2335:8	O
with	POTIGA.xml:S3:2344:4	O
retinal	POTIGA.xml:S3:2349:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:2357:13	I-AdverseReaction
have	POTIGA.xml:S3:2371:4	O
had	POTIGA.xml:S3:2376:3	O
more	POTIGA.xml:S3:2380:4	O
extensive	POTIGA.xml:S3:2385:9	O
diagnostic	POTIGA.xml:S3:2395:10	O
retinal	POTIGA.xml:S3:2406:7	O
evaluations	POTIGA.xml:S3:2414:11	O
.	POTIGA.xml:S3:2425:1	O

The	POTIGA.xml:S3:2427:3	O
results	POTIGA.xml:S3:2431:7	O
of	POTIGA.xml:S3:2439:2	O
these	POTIGA.xml:S3:2442:5	O
evaluations	POTIGA.xml:S3:2448:11	O
were	POTIGA.xml:S3:2460:4	O
consistent	POTIGA.xml:S3:2465:10	O
with	POTIGA.xml:S3:2476:4	O
a	POTIGA.xml:S3:2481:1	O
retinal	POTIGA.xml:S3:2483:7	B-AdverseReaction
dystrophy	POTIGA.xml:S3:2491:9	I-AdverseReaction
,	POTIGA.xml:S3:2500:1	O
including	POTIGA.xml:S3:2502:9	O
abnormalities	POTIGA.xml:S3:2512:13	B-AdverseReaction
in	POTIGA.xml:S3:2526:2	I-AdverseReaction
the	POTIGA.xml:S3:2529:3	I-AdverseReaction
electroretinogram	POTIGA.xml:S3:2533:17	I-AdverseReaction
and	POTIGA.xml:S3:2551:3	O
electrooculogram	POTIGA.xml:S3:2555:16	I-AdverseReaction
of	POTIGA.xml:S3:2572:2	O
both	POTIGA.xml:S3:2575:4	O
patients	POTIGA.xml:S3:2580:8	O
,	POTIGA.xml:S3:2588:1	O
with	POTIGA.xml:S3:2590:4	O
abnormal	POTIGA.xml:S3:2595:8	B-AdverseReaction
fluorescein	POTIGA.xml:S3:2604:11	I-AdverseReaction
angiography	POTIGA.xml:S3:2616:11	I-AdverseReaction
and	POTIGA.xml:S3:2628:3	O
diminished	POTIGA.xml:S3:2632:10	B-AdverseReaction
sensitivity	POTIGA.xml:S3:2643:11	I-AdverseReaction
on	POTIGA.xml:S3:2655:2	I-AdverseReaction
visual	POTIGA.xml:S3:2658:6	I-AdverseReaction
field	POTIGA.xml:S3:2665:5	I-AdverseReaction
testing	POTIGA.xml:S3:2671:7	O
in	POTIGA.xml:S3:2679:2	O
one	POTIGA.xml:S3:2682:3	O
patient	POTIGA.xml:S3:2686:7	O
.	POTIGA.xml:S3:2693:1	O

The	POTIGA.xml:S3:2699:3	O
rate	POTIGA.xml:S3:2703:4	O
of	POTIGA.xml:S3:2708:2	O
progression	POTIGA.xml:S3:2711:11	O
of	POTIGA.xml:S3:2723:2	O
retinal	POTIGA.xml:S3:2726:7	B-AdverseReaction
abnormalities	POTIGA.xml:S3:2734:13	I-AdverseReaction
and	POTIGA.xml:S3:2748:3	O
the	POTIGA.xml:S3:2752:3	O
reversibility	POTIGA.xml:S3:2756:13	O
after	POTIGA.xml:S3:2770:5	O
drug	POTIGA.xml:S3:2776:4	O
discontinuation	POTIGA.xml:S3:2781:15	O
are	POTIGA.xml:S3:2797:3	O
unknown	POTIGA.xml:S3:2801:7	O
.	POTIGA.xml:S3:2808:1	O

Because	POTIGA.xml:S3:2814:7	B-Factor
of	POTIGA.xml:S3:2822:2	O
the	POTIGA.xml:S3:2825:3	O
observed	POTIGA.xml:S3:2829:8	O
ophthalmologic	POTIGA.xml:S3:2838:14	O
adverse	POTIGA.xml:S3:2853:7	O
reactions	POTIGA.xml:S3:2861:9	O
,	POTIGA.xml:S3:2870:1	O
POTIGA	POTIGA.xml:S3:2872:6	O
should	POTIGA.xml:S3:2879:6	O
only	POTIGA.xml:S3:2886:4	O
be	POTIGA.xml:S3:2891:2	O
used	POTIGA.xml:S3:2894:4	O
in	POTIGA.xml:S3:2899:2	O
patients	POTIGA.xml:S3:2902:8	O
who	POTIGA.xml:S3:2911:3	O
have	POTIGA.xml:S3:2915:4	O
responded	POTIGA.xml:S3:2920:9	O
inadequately	POTIGA.xml:S3:2930:12	O
to	POTIGA.xml:S3:2943:2	O
several	POTIGA.xml:S3:2946:7	O
alternative	POTIGA.xml:S3:2954:11	O
treatments	POTIGA.xml:S3:2966:10	O
and	POTIGA.xml:S3:2977:3	O
for	POTIGA.xml:S3:2981:3	O
whom	POTIGA.xml:S3:2985:4	O
the	POTIGA.xml:S3:2990:3	O
benefits	POTIGA.xml:S3:2994:8	O
outweigh	POTIGA.xml:S3:3003:8	O
the	POTIGA.xml:S3:3012:3	O
risk	POTIGA.xml:S3:3016:4	O
of	POTIGA.xml:S3:3021:2	O
retinal	POTIGA.xml:S3:3024:7	O
abnormalities	POTIGA.xml:S3:3032:13	O
and	POTIGA.xml:S3:3046:3	O
potential	POTIGA.xml:S3:3050:9	O
vision	POTIGA.xml:S3:3060:6	O
loss	POTIGA.xml:S3:3067:4	O
.	POTIGA.xml:S3:3071:1	O

Patients	POTIGA.xml:S3:3073:8	O
who	POTIGA.xml:S3:3082:3	O
fail	POTIGA.xml:S3:3086:4	O
to	POTIGA.xml:S3:3091:2	O
show	POTIGA.xml:S3:3094:4	O
substantial	POTIGA.xml:S3:3099:11	O
clinical	POTIGA.xml:S3:3111:8	O
benefit	POTIGA.xml:S3:3120:7	O
after	POTIGA.xml:S3:3128:5	O
adequate	POTIGA.xml:S3:3134:8	O
titration	POTIGA.xml:S3:3143:9	O
should	POTIGA.xml:S3:3153:6	O
be	POTIGA.xml:S3:3160:2	O
discontinued	POTIGA.xml:S3:3163:12	O
from	POTIGA.xml:S3:3176:4	O
POTIGA	POTIGA.xml:S3:3181:6	O
.	POTIGA.xml:S3:3187:1	O

Patients	POTIGA.xml:S3:3193:8	O
should	POTIGA.xml:S3:3202:6	O
have	POTIGA.xml:S3:3209:4	O
baseline	POTIGA.xml:S3:3214:8	O
ophthalmologic	POTIGA.xml:S3:3223:14	O
testing	POTIGA.xml:S3:3238:7	O
by	POTIGA.xml:S3:3246:2	O
an	POTIGA.xml:S3:3249:2	O
ophthalmic	POTIGA.xml:S3:3252:10	O
professional	POTIGA.xml:S3:3263:12	O
and	POTIGA.xml:S3:3276:3	O
follow	POTIGA.xml:S3:3280:6	O
-	POTIGA.xml:S3:3286:1	O
up	POTIGA.xml:S3:3287:2	O
testing	POTIGA.xml:S3:3290:7	O
every	POTIGA.xml:S3:3298:5	O
6	POTIGA.xml:S3:3304:1	O
months	POTIGA.xml:S3:3306:6	O
.	POTIGA.xml:S3:3312:1	O

The	POTIGA.xml:S3:3314:3	O
best	POTIGA.xml:S3:3318:4	O
method	POTIGA.xml:S3:3323:6	O
of	POTIGA.xml:S3:3330:2	O
detection	POTIGA.xml:S3:3333:9	O
of	POTIGA.xml:S3:3343:2	O
these	POTIGA.xml:S3:3346:5	O
abnormalities	POTIGA.xml:S3:3352:13	O
and	POTIGA.xml:S3:3366:3	O
the	POTIGA.xml:S3:3370:3	O
optimal	POTIGA.xml:S3:3374:7	O
frequency	POTIGA.xml:S3:3382:9	O
of	POTIGA.xml:S3:3392:2	O
periodic	POTIGA.xml:S3:3395:8	O
ophthalmologic	POTIGA.xml:S3:3404:14	O
monitoring	POTIGA.xml:S3:3419:10	O
are	POTIGA.xml:S3:3430:3	O
unknown	POTIGA.xml:S3:3434:7	O
.	POTIGA.xml:S3:3441:1	O

Patients	POTIGA.xml:S3:3443:8	O
who	POTIGA.xml:S3:3452:3	O
cannot	POTIGA.xml:S3:3456:6	O
be	POTIGA.xml:S3:3463:2	O
monitored	POTIGA.xml:S3:3466:9	O
should	POTIGA.xml:S3:3476:6	O
usually	POTIGA.xml:S3:3483:7	O
not	POTIGA.xml:S3:3491:3	O
be	POTIGA.xml:S3:3495:2	O
treated	POTIGA.xml:S3:3498:7	O
with	POTIGA.xml:S3:3506:4	O
POTIGA	POTIGA.xml:S3:3511:6	O
.	POTIGA.xml:S3:3517:1	O

The	POTIGA.xml:S3:3519:3	O
ophthalmologic	POTIGA.xml:S3:3523:14	O
monitoring	POTIGA.xml:S3:3538:10	O
program	POTIGA.xml:S3:3549:7	O
should	POTIGA.xml:S3:3557:6	O
include	POTIGA.xml:S3:3564:7	O
visual	POTIGA.xml:S3:3572:6	O
acuity	POTIGA.xml:S3:3579:6	O
testing	POTIGA.xml:S3:3586:7	O
and	POTIGA.xml:S3:3594:3	O
dilated	POTIGA.xml:S3:3598:7	O
fundus	POTIGA.xml:S3:3606:6	O
photography	POTIGA.xml:S3:3613:11	O
.	POTIGA.xml:S3:3624:1	O

Additional	POTIGA.xml:S3:3626:10	O
testing	POTIGA.xml:S3:3637:7	O
may	POTIGA.xml:S3:3645:3	O
include	POTIGA.xml:S3:3649:7	O
fluorescein	POTIGA.xml:S3:3657:11	O
angiograms	POTIGA.xml:S3:3669:10	O
(	POTIGA.xml:S3:3680:1	O
FA	POTIGA.xml:S3:3681:2	O
)	POTIGA.xml:S3:3683:1	O
,	POTIGA.xml:S3:3684:1	O
optical	POTIGA.xml:S3:3686:7	O
coherence	POTIGA.xml:S3:3694:9	O
tomography	POTIGA.xml:S3:3704:10	O
(	POTIGA.xml:S3:3715:1	O
OCT	POTIGA.xml:S3:3716:3	O
)	POTIGA.xml:S3:3719:1	O
,	POTIGA.xml:S3:3720:1	O
perimetry	POTIGA.xml:S3:3722:9	O
,	POTIGA.xml:S3:3731:1	O
and	POTIGA.xml:S3:3733:3	O
electroretinograms	POTIGA.xml:S3:3737:18	O
(	POTIGA.xml:S3:3756:1	O
ERG	POTIGA.xml:S3:3757:3	O
)	POTIGA.xml:S3:3760:1	O
.	POTIGA.xml:S3:3761:1	O

If	POTIGA.xml:S3:3763:2	O
retinal	POTIGA.xml:S3:3766:7	O
pigmentary	POTIGA.xml:S3:3774:10	O
abnormalities	POTIGA.xml:S3:3785:13	O
or	POTIGA.xml:S3:3799:2	O
vision	POTIGA.xml:S3:3802:6	O
changes	POTIGA.xml:S3:3809:7	O
are	POTIGA.xml:S3:3817:3	O
detected	POTIGA.xml:S3:3821:8	O
,	POTIGA.xml:S3:3829:1	O
POTIGA	POTIGA.xml:S3:3831:6	O
should	POTIGA.xml:S3:3838:6	O
be	POTIGA.xml:S3:3845:2	O
discontinued	POTIGA.xml:S3:3848:12	O
unless	POTIGA.xml:S3:3861:6	O
no	POTIGA.xml:S3:3868:2	O
other	POTIGA.xml:S3:3871:5	O
suitable	POTIGA.xml:S3:3877:8	O
treatment	POTIGA.xml:S3:3886:9	O
options	POTIGA.xml:S3:3896:7	O
are	POTIGA.xml:S3:3904:3	O
available	POTIGA.xml:S3:3908:9	O
and	POTIGA.xml:S3:3918:3	O
the	POTIGA.xml:S3:3922:3	O
benefits	POTIGA.xml:S3:3926:8	O
of	POTIGA.xml:S3:3935:2	O
treatment	POTIGA.xml:S3:3938:9	O
outweigh	POTIGA.xml:S3:3948:8	O
the	POTIGA.xml:S3:3957:3	O
potential	POTIGA.xml:S3:3961:9	O
risk	POTIGA.xml:S3:3971:4	O
of	POTIGA.xml:S3:3976:2	O
vision	POTIGA.xml:S3:3979:6	O
loss	POTIGA.xml:S3:3986:4	B-Factor
.	POTIGA.xml:S3:3990:1	O

5.2	POTIGA.xml:S3:3999:3	O
Urinary	POTIGA.xml:S3:4003:7	O
Retention	POTIGA.xml:S3:4011:9	O

POTIGA	POTIGA.xml:S3:4026:6	O
caused	POTIGA.xml:S3:4033:6	O
urinary	POTIGA.xml:S3:4040:7	B-AdverseReaction
retention	POTIGA.xml:S3:4048:9	I-AdverseReaction
in	POTIGA.xml:S3:4058:2	O
clinical	POTIGA.xml:S3:4061:8	O
trials	POTIGA.xml:S3:4070:6	O
.	POTIGA.xml:S3:4076:1	O

Urinary	POTIGA.xml:S3:4078:7	B-AdverseReaction
retention	POTIGA.xml:S3:4086:9	I-AdverseReaction
was	POTIGA.xml:S3:4096:3	O
generally	POTIGA.xml:S3:4100:9	O
reported	POTIGA.xml:S3:4110:8	O
within	POTIGA.xml:S3:4119:6	O
the	POTIGA.xml:S3:4126:3	O
first	POTIGA.xml:S3:4130:5	O
6	POTIGA.xml:S3:4136:1	O
months	POTIGA.xml:S3:4138:6	O
of	POTIGA.xml:S3:4145:2	O
treatment	POTIGA.xml:S3:4148:9	O
,	POTIGA.xml:S3:4157:1	O
but	POTIGA.xml:S3:4159:3	O
was	POTIGA.xml:S3:4163:3	O
also	POTIGA.xml:S3:4167:4	O
observed	POTIGA.xml:S3:4172:8	O
later	POTIGA.xml:S3:4181:5	O
.	POTIGA.xml:S3:4186:1	O

Urinary	POTIGA.xml:S3:4188:7	B-AdverseReaction
retention	POTIGA.xml:S3:4196:9	I-AdverseReaction
was	POTIGA.xml:S3:4206:3	O
reported	POTIGA.xml:S3:4210:8	O
as	POTIGA.xml:S3:4219:2	O
an	POTIGA.xml:S3:4222:2	O
adverse	POTIGA.xml:S3:4225:7	O
event	POTIGA.xml:S3:4233:5	O
in	POTIGA.xml:S3:4239:2	O
29	POTIGA.xml:S3:4242:2	O
of	POTIGA.xml:S3:4245:2	O
1	POTIGA.xml:S3:4248:1	O
,	POTIGA.xml:S3:4249:1	O
365	POTIGA.xml:S3:4250:3	O
(	POTIGA.xml:S3:4254:1	O
approximately	POTIGA.xml:S3:4255:13	O
2%	POTIGA.xml:S3:4269:2	O
)	POTIGA.xml:S3:4271:1	O
patients	POTIGA.xml:S3:4273:8	O
treated	POTIGA.xml:S3:4282:7	O
with	POTIGA.xml:S3:4290:4	O
POTIGA	POTIGA.xml:S3:4295:6	O
in	POTIGA.xml:S3:4302:2	O
the	POTIGA.xml:S3:4305:3	O
open	POTIGA.xml:S3:4309:4	O
-	POTIGA.xml:S3:4313:1	O
label	POTIGA.xml:S3:4314:5	O
and	POTIGA.xml:S3:4320:3	O
placebo	POTIGA.xml:S3:4324:7	O
-	POTIGA.xml:S3:4331:1	O
controlled	POTIGA.xml:S3:4332:10	O
epilepsy	POTIGA.xml:S3:4343:8	O
database	POTIGA.xml:S3:4352:8	O
[	POTIGA.xml:S3:4361:1	O
see	POTIGA.xml:S3:4362:3	O
Clinical	POTIGA.xml:S3:4366:8	O
Studies	POTIGA.xml:S3:4375:7	O
(	POTIGA.xml:S3:4383:1	O
14	POTIGA.xml:S3:4384:2	O
)]	POTIGA.xml:S3:4386:2	O
.	POTIGA.xml:S3:4390:1	O

Of	POTIGA.xml:S3:4392:2	O
these	POTIGA.xml:S3:4395:5	O
29	POTIGA.xml:S3:4401:2	O
patients	POTIGA.xml:S3:4404:8	O
,	POTIGA.xml:S3:4412:1	O
5	POTIGA.xml:S3:4414:1	O
(	POTIGA.xml:S3:4416:1	O
17%	POTIGA.xml:S3:4417:3	O
)	POTIGA.xml:S3:4420:1	O
required	POTIGA.xml:S3:4422:8	O
catheterization	POTIGA.xml:S3:4431:15	O
,	POTIGA.xml:S3:4446:1	O
with	POTIGA.xml:S3:4448:4	O
post	POTIGA.xml:S3:4453:4	O
-	POTIGA.xml:S3:4457:1	O
voiding	POTIGA.xml:S3:4458:7	O
residuals	POTIGA.xml:S3:4466:9	O
of	POTIGA.xml:S3:4476:2	O
up	POTIGA.xml:S3:4479:2	O
to	POTIGA.xml:S3:4482:2	O
1	POTIGA.xml:S3:4485:1	O
,	POTIGA.xml:S3:4486:1	O
500	POTIGA.xml:S3:4487:3	O
mL	POTIGA.xml:S3:4491:2	O
.	POTIGA.xml:S3:4493:1	O

POTIGA	POTIGA.xml:S3:4495:6	O
was	POTIGA.xml:S3:4502:3	O
discontinued	POTIGA.xml:S3:4506:12	O
in	POTIGA.xml:S3:4519:2	O
3	POTIGA.xml:S3:4522:1	O
of	POTIGA.xml:S3:4524:2	O
the	POTIGA.xml:S3:4527:3	O
5	POTIGA.xml:S3:4531:1	O
patients	POTIGA.xml:S3:4533:8	O
who	POTIGA.xml:S3:4542:3	O
required	POTIGA.xml:S3:4546:8	O
catheterization	POTIGA.xml:S3:4555:15	O
,	POTIGA.xml:S3:4570:1	O
and	POTIGA.xml:S3:4572:3	O
all	POTIGA.xml:S3:4576:3	O
were	POTIGA.xml:S3:4580:4	O
able	POTIGA.xml:S3:4585:4	O
to	POTIGA.xml:S3:4590:2	O
void	POTIGA.xml:S3:4593:4	O
spontaneously	POTIGA.xml:S3:4598:13	O
;	POTIGA.xml:S3:4611:1	O
however	POTIGA.xml:S3:4613:7	O
,	POTIGA.xml:S3:4620:1	O
1	POTIGA.xml:S3:4622:1	O
of	POTIGA.xml:S3:4624:2	O
the	POTIGA.xml:S3:4627:3	O
3	POTIGA.xml:S3:4631:1	O
patients	POTIGA.xml:S3:4633:8	O
continued	POTIGA.xml:S3:4642:9	O
intermittent	POTIGA.xml:S3:4652:12	O
self	POTIGA.xml:S3:4665:4	O
-	POTIGA.xml:S3:4669:1	O
catheterization	POTIGA.xml:S3:4670:15	O
.	POTIGA.xml:S3:4685:1	O

Two	POTIGA.xml:S3:4687:3	O
patients	POTIGA.xml:S3:4691:8	O
continued	POTIGA.xml:S3:4700:9	O
treatment	POTIGA.xml:S3:4710:9	O
with	POTIGA.xml:S3:4720:4	O
POTIGA	POTIGA.xml:S3:4725:6	O
and	POTIGA.xml:S3:4732:3	O
were	POTIGA.xml:S3:4736:4	O
able	POTIGA.xml:S3:4741:4	O
to	POTIGA.xml:S3:4746:2	O
void	POTIGA.xml:S3:4749:4	O
spontaneously	POTIGA.xml:S3:4754:13	O
after	POTIGA.xml:S3:4768:5	O
catheter	POTIGA.xml:S3:4774:8	O
removal	POTIGA.xml:S3:4783:7	O
.	POTIGA.xml:S3:4790:1	O

Hydronephrosis	POTIGA.xml:S3:4792:14	B-AdverseReaction
occurred	POTIGA.xml:S3:4807:8	O
in	POTIGA.xml:S3:4816:2	O
2	POTIGA.xml:S3:4819:1	O
patients	POTIGA.xml:S3:4821:8	O
,	POTIGA.xml:S3:4829:1	O
one	POTIGA.xml:S3:4831:3	O
of	POTIGA.xml:S3:4835:2	O
whom	POTIGA.xml:S3:4838:4	O
had	POTIGA.xml:S3:4843:3	O
associated	POTIGA.xml:S3:4847:10	O
renal	POTIGA.xml:S3:4858:5	B-AdverseReaction
function	POTIGA.xml:S3:4864:8	I-AdverseReaction
impairment	POTIGA.xml:S3:4873:10	I-AdverseReaction
that	POTIGA.xml:S3:4884:4	O
resolved	POTIGA.xml:S3:4889:8	O
upon	POTIGA.xml:S3:4898:4	O
discontinuation	POTIGA.xml:S3:4903:15	O
of	POTIGA.xml:S3:4919:2	O
POTIGA	POTIGA.xml:S3:4922:6	O
.	POTIGA.xml:S3:4928:1	O

Hydronephrosis	POTIGA.xml:S3:4930:14	B-AdverseReaction
was	POTIGA.xml:S3:4945:3	O
not	POTIGA.xml:S3:4949:3	B-Negation
reported	POTIGA.xml:S3:4953:8	O
in	POTIGA.xml:S3:4962:2	O
placebo	POTIGA.xml:S3:4965:7	B-Factor
patients	POTIGA.xml:S3:4973:8	O
.	POTIGA.xml:S3:4981:1	O

In	POTIGA.xml:S3:4987:2	O
the	POTIGA.xml:S3:4990:3	O
placebo	POTIGA.xml:S3:4994:7	O
-	POTIGA.xml:S3:5001:1	O
controlled	POTIGA.xml:S3:5002:10	O
epilepsy	POTIGA.xml:S3:5013:8	O
trials	POTIGA.xml:S3:5022:6	O
,	POTIGA.xml:S3:5028:1	O
"	POTIGA.xml:S3:5030:1	O
urinary	POTIGA.xml:S3:5031:7	B-AdverseReaction
retention	POTIGA.xml:S3:5039:9	I-AdverseReaction
,	POTIGA.xml:S3:5048:1	O
"	POTIGA.xml:S3:5049:1	O
"	POTIGA.xml:S3:5051:1	O
urinary	POTIGA.xml:S3:5052:7	B-AdverseReaction
hesitation	POTIGA.xml:S3:5060:10	I-AdverseReaction
,	POTIGA.xml:S3:5070:1	O
"	POTIGA.xml:S3:5071:1	O
and	POTIGA.xml:S3:5073:3	O
"	POTIGA.xml:S3:5077:1	O
dysuria	POTIGA.xml:S3:5078:7	B-AdverseReaction
"	POTIGA.xml:S3:5085:1	O
were	POTIGA.xml:S3:5087:4	O
reported	POTIGA.xml:S3:5092:8	O
in	POTIGA.xml:S3:5101:2	O
0.9%	POTIGA.xml:S3:5104:4	O
,	POTIGA.xml:S3:5108:1	O
2.2%	POTIGA.xml:S3:5110:4	O
,	POTIGA.xml:S3:5114:1	O
and	POTIGA.xml:S3:5116:3	O
2.3%	POTIGA.xml:S3:5120:4	O
of	POTIGA.xml:S3:5125:2	O
patients	POTIGA.xml:S3:5128:8	O
on	POTIGA.xml:S3:5137:2	O
POTIGA	POTIGA.xml:S3:5140:6	O
,	POTIGA.xml:S3:5146:1	O
respectively	POTIGA.xml:S3:5148:12	O
,	POTIGA.xml:S3:5160:1	O
and	POTIGA.xml:S3:5162:3	O
in	POTIGA.xml:S3:5166:2	O
0.5%	POTIGA.xml:S3:5169:4	O
,	POTIGA.xml:S3:5173:1	O
0.9%	POTIGA.xml:S3:5175:4	O
,	POTIGA.xml:S3:5179:1	O
and	POTIGA.xml:S3:5181:3	O
0.7%	POTIGA.xml:S3:5185:4	O
of	POTIGA.xml:S3:5190:2	O
patients	POTIGA.xml:S3:5193:8	O
on	POTIGA.xml:S3:5202:2	O
placebo	POTIGA.xml:S3:5205:7	O
,	POTIGA.xml:S3:5212:1	O
respectively	POTIGA.xml:S3:5214:12	O
.	POTIGA.xml:S3:5226:1	O

Because	POTIGA.xml:S3:5232:7	B-Factor
of	POTIGA.xml:S3:5240:2	O
the	POTIGA.xml:S3:5243:3	O
increased	POTIGA.xml:S3:5247:9	O
risk	POTIGA.xml:S3:5257:4	O
of	POTIGA.xml:S3:5262:2	O
urinary	POTIGA.xml:S3:5265:7	O
retention	POTIGA.xml:S3:5273:9	O
on	POTIGA.xml:S3:5283:2	O
POTIGA	POTIGA.xml:S3:5286:6	O
,	POTIGA.xml:S3:5292:1	O
urologic	POTIGA.xml:S3:5294:8	O
symptoms	POTIGA.xml:S3:5303:8	O
should	POTIGA.xml:S3:5312:6	O
be	POTIGA.xml:S3:5319:2	O
carefully	POTIGA.xml:S3:5322:9	O
monitored	POTIGA.xml:S3:5332:9	O
.	POTIGA.xml:S3:5341:1	O

Closer	POTIGA.xml:S3:5343:6	O
monitoring	POTIGA.xml:S3:5350:10	O
is	POTIGA.xml:S3:5361:2	O
recommended	POTIGA.xml:S3:5364:11	O
for	POTIGA.xml:S3:5376:3	O
patients	POTIGA.xml:S3:5380:8	O
who	POTIGA.xml:S3:5389:3	O
have	POTIGA.xml:S3:5393:4	O
other	POTIGA.xml:S3:5398:5	O
risk	POTIGA.xml:S3:5404:4	O
factors	POTIGA.xml:S3:5409:7	O
for	POTIGA.xml:S3:5417:3	O
urinary	POTIGA.xml:S3:5421:7	O
retention	POTIGA.xml:S3:5429:9	O
(	POTIGA.xml:S3:5439:1	O
e	POTIGA.xml:S3:5440:1	O
.	POTIGA.xml:S3:5441:1	O
g	POTIGA.xml:S3:5442:1	O
.	POTIGA.xml:S3:5443:1	O
,	POTIGA.xml:S3:5444:1	O
benign	POTIGA.xml:S3:5446:6	O
prostatic	POTIGA.xml:S3:5453:9	O
hyperplasia	POTIGA.xml:S3:5463:11	O
[	POTIGA.xml:S3:5475:1	O
BPH	POTIGA.xml:S3:5476:3	O
])	POTIGA.xml:S3:5479:2	O
,	POTIGA.xml:S3:5481:1	O
patients	POTIGA.xml:S3:5483:8	O
who	POTIGA.xml:S3:5492:3	O
are	POTIGA.xml:S3:5496:3	O
unable	POTIGA.xml:S3:5500:6	O
to	POTIGA.xml:S3:5507:2	O
communicate	POTIGA.xml:S3:5510:11	O
clinical	POTIGA.xml:S3:5522:8	O
symptoms	POTIGA.xml:S3:5531:8	O
(	POTIGA.xml:S3:5540:1	O
e	POTIGA.xml:S3:5541:1	O
.	POTIGA.xml:S3:5542:1	O
g	POTIGA.xml:S3:5543:1	O
.	POTIGA.xml:S3:5544:1	O
,	POTIGA.xml:S3:5545:1	O
cognitively	POTIGA.xml:S3:5547:11	O
impaired	POTIGA.xml:S3:5559:8	O
patients	POTIGA.xml:S3:5568:8	O
)	POTIGA.xml:S3:5576:1	O
,	POTIGA.xml:S3:5577:1	O
or	POTIGA.xml:S3:5579:2	O
patients	POTIGA.xml:S3:5582:8	O
who	POTIGA.xml:S3:5591:3	O
use	POTIGA.xml:S3:5595:3	O
concomitant	POTIGA.xml:S3:5599:11	O
medications	POTIGA.xml:S3:5611:11	O
that	POTIGA.xml:S3:5623:4	O
may	POTIGA.xml:S3:5628:3	O
affect	POTIGA.xml:S3:5632:6	O
voiding	POTIGA.xml:S3:5639:7	O
(	POTIGA.xml:S3:5647:1	O
e	POTIGA.xml:S3:5648:1	O
.	POTIGA.xml:S3:5649:1	O
g	POTIGA.xml:S3:5650:1	O
.	POTIGA.xml:S3:5651:1	O
,	POTIGA.xml:S3:5652:1	O
anticholinergics	POTIGA.xml:S3:5654:16	O
)	POTIGA.xml:S3:5670:1	O
.	POTIGA.xml:S3:5671:1	O

In	POTIGA.xml:S3:5673:2	O
these	POTIGA.xml:S3:5676:5	O
patients	POTIGA.xml:S3:5682:8	O
,	POTIGA.xml:S3:5690:1	O
a	POTIGA.xml:S3:5692:1	O
comprehensive	POTIGA.xml:S3:5694:13	O
evaluation	POTIGA.xml:S3:5708:10	O
of	POTIGA.xml:S3:5719:2	O
urologic	POTIGA.xml:S3:5722:8	O
symptoms	POTIGA.xml:S3:5731:8	O
prior	POTIGA.xml:S3:5740:5	O
to	POTIGA.xml:S3:5746:2	O
and	POTIGA.xml:S3:5749:3	O
during	POTIGA.xml:S3:5753:6	O
treatment	POTIGA.xml:S3:5760:9	O
with	POTIGA.xml:S3:5770:4	O
POTIGA	POTIGA.xml:S3:5775:6	O
may	POTIGA.xml:S3:5782:3	O
be	POTIGA.xml:S3:5786:2	O
appropriate	POTIGA.xml:S3:5789:11	B-Factor
.	POTIGA.xml:S3:5800:1	O

5.3	POTIGA.xml:S3:5809:3	O
Skin	POTIGA.xml:S3:5813:4	O
Discoloration	POTIGA.xml:S3:5818:13	O

POTIGA	POTIGA.xml:S3:5837:6	O
can	POTIGA.xml:S3:5844:3	B-Factor
cause	POTIGA.xml:S3:5848:5	O
skin	POTIGA.xml:S3:5854:4	B-AdverseReaction
discoloration	POTIGA.xml:S3:5859:13	I-AdverseReaction
.	POTIGA.xml:S3:5872:1	O

The	POTIGA.xml:S3:5874:3	O
skin	POTIGA.xml:S3:5878:4	B-AdverseReaction
discoloration	POTIGA.xml:S3:5883:13	I-AdverseReaction
is	POTIGA.xml:S3:5897:2	O
generally	POTIGA.xml:S3:5900:9	O
described	POTIGA.xml:S3:5910:9	O
as	POTIGA.xml:S3:5920:2	O
blue	POTIGA.xml:S3:5923:4	O
,	POTIGA.xml:S3:5927:1	O
but	POTIGA.xml:S3:5929:3	O
has	POTIGA.xml:S3:5933:3	O
also	POTIGA.xml:S3:5937:4	O
been	POTIGA.xml:S3:5942:4	O
described	POTIGA.xml:S3:5947:9	O
as	POTIGA.xml:S3:5957:2	O
grey	POTIGA.xml:S3:5960:4	O
-	POTIGA.xml:S3:5964:1	O
blue	POTIGA.xml:S3:5965:4	O
or	POTIGA.xml:S3:5970:2	O
brown	POTIGA.xml:S3:5973:5	O
.	POTIGA.xml:S3:5978:1	O

It	POTIGA.xml:S3:5980:2	O
is	POTIGA.xml:S3:5983:2	O
predominantly	POTIGA.xml:S3:5986:13	O
on	POTIGA.xml:S3:6000:2	O
or	POTIGA.xml:S3:6003:2	O
around	POTIGA.xml:S3:6006:6	O
the	POTIGA.xml:S3:6013:3	O
lips	POTIGA.xml:S3:6017:4	O
or	POTIGA.xml:S3:6022:2	O
in	POTIGA.xml:S3:6025:2	O
the	POTIGA.xml:S3:6028:3	O
nail	POTIGA.xml:S3:6032:4	O
beds	POTIGA.xml:S3:6037:4	O
of	POTIGA.xml:S3:6042:2	O
the	POTIGA.xml:S3:6045:3	O
fingers	POTIGA.xml:S3:6049:7	O
or	POTIGA.xml:S3:6057:2	O
toes	POTIGA.xml:S3:6060:4	O
,	POTIGA.xml:S3:6064:1	O
but	POTIGA.xml:S3:6066:3	O
more	POTIGA.xml:S3:6070:4	O
widespread	POTIGA.xml:S3:6075:10	O
involvement	POTIGA.xml:S3:6086:11	O
of	POTIGA.xml:S3:6098:2	O
the	POTIGA.xml:S3:6101:3	O
face	POTIGA.xml:S3:6105:4	O
and	POTIGA.xml:S3:6110:3	O
legs	POTIGA.xml:S3:6114:4	O
has	POTIGA.xml:S3:6119:3	O
also	POTIGA.xml:S3:6123:4	O
been	POTIGA.xml:S3:6128:4	O
reported	POTIGA.xml:S3:6133:8	O
.	POTIGA.xml:S3:6141:1	O

Discoloration	POTIGA.xml:S3:6143:13	B-AdverseReaction
of	POTIGA.xml:S3:6157:2	I-AdverseReaction
the	POTIGA.xml:S3:6160:3	I-AdverseReaction
palate	POTIGA.xml:S3:6164:6	I-AdverseReaction
,	POTIGA.xml:S3:6170:1	O
sclera	POTIGA.xml:S3:6172:6	I-AdverseReaction
,	POTIGA.xml:S3:6178:1	O
and	POTIGA.xml:S3:6180:3	O
conjunctiva	POTIGA.xml:S3:6184:11	I-AdverseReaction
has	POTIGA.xml:S3:6196:3	O
also	POTIGA.xml:S3:6200:4	O
been	POTIGA.xml:S3:6205:4	O
reported	POTIGA.xml:S3:6210:8	O
.	POTIGA.xml:S3:6218:1	O

Approximately	POTIGA.xml:S3:6224:13	O
10%	POTIGA.xml:S3:6238:3	O
of	POTIGA.xml:S3:6242:2	O
patients	POTIGA.xml:S3:6245:8	O
in	POTIGA.xml:S3:6254:2	O
long	POTIGA.xml:S3:6257:4	O
-	POTIGA.xml:S3:6261:1	O
term	POTIGA.xml:S3:6262:4	O
clinical	POTIGA.xml:S3:6267:8	O
trials	POTIGA.xml:S3:6276:6	O
developed	POTIGA.xml:S3:6283:9	O
skin	POTIGA.xml:S3:6293:4	B-AdverseReaction
discoloration	POTIGA.xml:S3:6298:13	I-AdverseReaction
,	POTIGA.xml:S3:6311:1	O
generally	POTIGA.xml:S3:6313:9	O
after	POTIGA.xml:S3:6323:5	O
2	POTIGA.xml:S3:6329:1	O
or	POTIGA.xml:S3:6331:2	O
more	POTIGA.xml:S3:6334:4	O
years	POTIGA.xml:S3:6339:5	O
of	POTIGA.xml:S3:6345:2	O
treatment	POTIGA.xml:S3:6348:9	O
and	POTIGA.xml:S3:6358:3	O
at	POTIGA.xml:S3:6362:2	O
higher	POTIGA.xml:S3:6365:6	O
doses	POTIGA.xml:S3:6372:5	O
(	POTIGA.xml:S3:6378:1	O
900	POTIGA.xml:S3:6379:3	O
mg	POTIGA.xml:S3:6383:2	O
or	POTIGA.xml:S3:6386:2	O
greater	POTIGA.xml:S3:6389:7	O
)	POTIGA.xml:S3:6396:1	O
of	POTIGA.xml:S3:6398:2	O
POTIGA	POTIGA.xml:S3:6401:6	O
.	POTIGA.xml:S3:6407:1	O

Among	POTIGA.xml:S3:6409:5	O
patients	POTIGA.xml:S3:6415:8	O
in	POTIGA.xml:S3:6424:2	O
whom	POTIGA.xml:S3:6427:4	O
the	POTIGA.xml:S3:6432:3	O
status	POTIGA.xml:S3:6436:6	O
of	POTIGA.xml:S3:6443:2	O
both	POTIGA.xml:S3:6446:4	O
skin	POTIGA.xml:S3:6451:4	B-AdverseReaction
,	POTIGA.xml:S3:6455:1	O
nail	POTIGA.xml:S3:6457:4	B-AdverseReaction
,	POTIGA.xml:S3:6461:1	O
lip	POTIGA.xml:S3:6463:3	B-AdverseReaction
,	POTIGA.xml:S3:6466:1	O
or	POTIGA.xml:S3:6468:2	O
mucous	POTIGA.xml:S3:6471:6	B-AdverseReaction
membrane	POTIGA.xml:S3:6478:8	I-AdverseReaction
discoloration	POTIGA.xml:S3:6487:13	I-AdverseReaction
and	POTIGA.xml:S3:6501:3	O
retinal	POTIGA.xml:S3:6505:7	B-AdverseReaction
pigmentary	POTIGA.xml:S3:6513:10	I-AdverseReaction
abnormalities	POTIGA.xml:S3:6524:13	I-AdverseReaction
are	POTIGA.xml:S3:6538:3	O
reported	POTIGA.xml:S3:6542:8	O
,	POTIGA.xml:S3:6550:1	O
approximately	POTIGA.xml:S3:6552:13	O
a	POTIGA.xml:S3:6566:1	O
quarter	POTIGA.xml:S3:6568:7	O
of	POTIGA.xml:S3:6576:2	O
those	POTIGA.xml:S3:6579:5	O
with	POTIGA.xml:S3:6585:4	O
skin	POTIGA.xml:S3:6590:4	B-AdverseReaction
,	POTIGA.xml:S3:6594:1	O
nail	POTIGA.xml:S3:6596:4	B-AdverseReaction
,	POTIGA.xml:S3:6600:1	O
lip	POTIGA.xml:S3:6602:3	B-AdverseReaction
,	POTIGA.xml:S3:6605:1	O
or	POTIGA.xml:S3:6607:2	O
mucous	POTIGA.xml:S3:6610:6	B-AdverseReaction
membrane	POTIGA.xml:S3:6617:8	I-AdverseReaction
discoloration	POTIGA.xml:S3:6626:13	I-AdverseReaction
had	POTIGA.xml:S3:6640:3	O
concurrent	POTIGA.xml:S3:6644:10	O
retinal	POTIGA.xml:S3:6655:7	B-AdverseReaction
pigmentary	POTIGA.xml:S3:6663:10	I-AdverseReaction
abnormalities	POTIGA.xml:S3:6674:13	I-AdverseReaction
[	POTIGA.xml:S3:6688:1	O
see	POTIGA.xml:S3:6689:3	O
Warnings	POTIGA.xml:S3:6693:8	O
and	POTIGA.xml:S3:6702:3	O
Precautions	POTIGA.xml:S3:6706:11	O
(	POTIGA.xml:S3:6718:1	O
5.1	POTIGA.xml:S3:6719:3	O
)]	POTIGA.xml:S3:6722:2	O
.	POTIGA.xml:S3:6726:1	O

Information	POTIGA.xml:S3:6732:11	O
on	POTIGA.xml:S3:6744:2	O
the	POTIGA.xml:S3:6747:3	O
consequences	POTIGA.xml:S3:6751:12	O
,	POTIGA.xml:S3:6763:1	O
reversibility	POTIGA.xml:S3:6765:13	O
,	POTIGA.xml:S3:6778:1	O
time	POTIGA.xml:S3:6780:4	O
to	POTIGA.xml:S3:6785:2	O
onset	POTIGA.xml:S3:6788:5	O
,	POTIGA.xml:S3:6793:1	O
and	POTIGA.xml:S3:6795:3	O
pathophysiology	POTIGA.xml:S3:6799:15	O
of	POTIGA.xml:S3:6815:2	O
the	POTIGA.xml:S3:6818:3	O
skin	POTIGA.xml:S3:6822:4	B-AdverseReaction
abnormalities	POTIGA.xml:S3:6827:13	I-AdverseReaction
remains	POTIGA.xml:S3:6841:7	O
incomplete	POTIGA.xml:S3:6849:10	O
.	POTIGA.xml:S3:6859:1	O

The	POTIGA.xml:S3:6861:3	O
possibility	POTIGA.xml:S3:6865:11	O
of	POTIGA.xml:S3:6877:2	O
more	POTIGA.xml:S3:6880:4	O
extensive	POTIGA.xml:S3:6885:9	O
systemic	POTIGA.xml:S3:6895:8	O
involvement	POTIGA.xml:S3:6904:11	O
has	POTIGA.xml:S3:6916:3	O
not	POTIGA.xml:S3:6920:3	O
been	POTIGA.xml:S3:6924:4	O
excluded	POTIGA.xml:S3:6929:8	O
.	POTIGA.xml:S3:6937:1	O

If	POTIGA.xml:S3:6939:2	O
a	POTIGA.xml:S3:6942:1	O
patient	POTIGA.xml:S3:6944:7	O
develops	POTIGA.xml:S3:6952:8	O
skin	POTIGA.xml:S3:6961:4	O
discoloration	POTIGA.xml:S3:6966:13	O
,	POTIGA.xml:S3:6979:1	O
serious	POTIGA.xml:S3:6981:7	O
consideration	POTIGA.xml:S3:6989:13	O
should	POTIGA.xml:S3:7003:6	O
be	POTIGA.xml:S3:7010:2	O
given	POTIGA.xml:S3:7013:5	O
to	POTIGA.xml:S3:7019:2	O
changing	POTIGA.xml:S3:7022:8	O
to	POTIGA.xml:S3:7031:2	O
an	POTIGA.xml:S3:7034:2	O
alternate	POTIGA.xml:S3:7037:9	O
medication	POTIGA.xml:S3:7047:10	O
.	POTIGA.xml:S3:7057:1	O

5.4	POTIGA.xml:S3:7066:3	O
Neuropsychiatric	POTIGA.xml:S3:7070:16	O
Symptoms	POTIGA.xml:S3:7087:8	O

Confusional	POTIGA.xml:S3:7101:11	B-AdverseReaction
state	POTIGA.xml:S3:7113:5	I-AdverseReaction
,	POTIGA.xml:S3:7118:1	O
psychotic	POTIGA.xml:S3:7120:9	B-AdverseReaction
symptoms	POTIGA.xml:S3:7130:8	I-AdverseReaction
,	POTIGA.xml:S3:7138:1	O
and	POTIGA.xml:S3:7140:3	O
hallucinations	POTIGA.xml:S3:7144:14	B-AdverseReaction
were	POTIGA.xml:S3:7159:4	O
reported	POTIGA.xml:S3:7164:8	O
more	POTIGA.xml:S3:7173:4	O
frequently	POTIGA.xml:S3:7178:10	O
as	POTIGA.xml:S3:7189:2	O
adverse	POTIGA.xml:S3:7192:7	O
reactions	POTIGA.xml:S3:7200:9	O
in	POTIGA.xml:S3:7210:2	O
patients	POTIGA.xml:S3:7213:8	O
treated	POTIGA.xml:S3:7222:7	O
with	POTIGA.xml:S3:7230:4	O
POTIGA	POTIGA.xml:S3:7235:6	O
than	POTIGA.xml:S3:7242:4	O
in	POTIGA.xml:S3:7247:2	O
those	POTIGA.xml:S3:7250:5	O
treated	POTIGA.xml:S3:7256:7	O
with	POTIGA.xml:S3:7264:4	O
placebo	POTIGA.xml:S3:7269:7	O
in	POTIGA.xml:S3:7277:2	O
placebo	POTIGA.xml:S3:7280:7	O
-	POTIGA.xml:S3:7287:1	O
controlled	POTIGA.xml:S3:7288:10	O
epilepsy	POTIGA.xml:S3:7299:8	O
trials	POTIGA.xml:S3:7308:6	O
(	POTIGA.xml:S3:7315:1	O
see	POTIGA.xml:S3:7316:3	O
Table	POTIGA.xml:S3:7320:5	O
2	POTIGA.xml:S3:7326:1	O
)	POTIGA.xml:S3:7327:1	O
.	POTIGA.xml:S3:7328:1	O

Discontinuations	POTIGA.xml:S3:7330:16	O
resulting	POTIGA.xml:S3:7347:9	O
from	POTIGA.xml:S3:7357:4	O
these	POTIGA.xml:S3:7362:5	O
reactions	POTIGA.xml:S3:7368:9	O
were	POTIGA.xml:S3:7378:4	O
more	POTIGA.xml:S3:7383:4	O
common	POTIGA.xml:S3:7388:6	O
in	POTIGA.xml:S3:7395:2	O
the	POTIGA.xml:S3:7398:3	O
drug	POTIGA.xml:S3:7402:4	O
-	POTIGA.xml:S3:7406:1	O
treated	POTIGA.xml:S3:7407:7	O
group	POTIGA.xml:S3:7415:5	O
(	POTIGA.xml:S3:7421:1	O
see	POTIGA.xml:S3:7422:3	O
Table	POTIGA.xml:S3:7426:5	O
2	POTIGA.xml:S3:7432:1	O
)	POTIGA.xml:S3:7433:1	O
.	POTIGA.xml:S3:7434:1	O

These	POTIGA.xml:S3:7436:5	O
effects	POTIGA.xml:S3:7442:7	O
were	POTIGA.xml:S3:7450:4	O
dose	POTIGA.xml:S3:7455:4	O
-	POTIGA.xml:S3:7459:1	O
related	POTIGA.xml:S3:7460:7	O
and	POTIGA.xml:S3:7468:3	O
generally	POTIGA.xml:S3:7472:9	O
appeared	POTIGA.xml:S3:7482:8	O
within	POTIGA.xml:S3:7491:6	O
the	POTIGA.xml:S3:7498:3	O
first	POTIGA.xml:S3:7502:5	O
8	POTIGA.xml:S3:7508:1	O
weeks	POTIGA.xml:S3:7510:5	O
of	POTIGA.xml:S3:7516:2	O
treatment	POTIGA.xml:S3:7519:9	O
.	POTIGA.xml:S3:7528:1	O

Half	POTIGA.xml:S3:7530:4	O
of	POTIGA.xml:S3:7535:2	O
the	POTIGA.xml:S3:7538:3	O
patients	POTIGA.xml:S3:7542:8	O
in	POTIGA.xml:S3:7551:2	O
the	POTIGA.xml:S3:7554:3	O
controlled	POTIGA.xml:S3:7558:10	O
trials	POTIGA.xml:S3:7569:6	O
who	POTIGA.xml:S3:7576:3	O
discontinued	POTIGA.xml:S3:7580:12	O
POTIGA	POTIGA.xml:S3:7593:6	O
due	POTIGA.xml:S3:7600:3	O
to	POTIGA.xml:S3:7604:2	O
hallucinations	POTIGA.xml:S3:7607:14	B-AdverseReaction
or	POTIGA.xml:S3:7622:2	O
psychosis	POTIGA.xml:S3:7625:9	B-AdverseReaction
required	POTIGA.xml:S3:7635:8	O
hospitalization	POTIGA.xml:S3:7644:15	O
.	POTIGA.xml:S3:7659:1	O

Approximately	POTIGA.xml:S3:7661:13	O
two	POTIGA.xml:S3:7675:3	O
-	POTIGA.xml:S3:7678:1	O
thirds	POTIGA.xml:S3:7679:6	O
of	POTIGA.xml:S3:7686:2	O
patients	POTIGA.xml:S3:7689:8	O
with	POTIGA.xml:S3:7698:4	O
psychosis	POTIGA.xml:S3:7703:9	B-AdverseReaction
in	POTIGA.xml:S3:7713:2	O
controlled	POTIGA.xml:S3:7716:10	O
trials	POTIGA.xml:S3:7727:6	O
had	POTIGA.xml:S3:7734:3	O
no	POTIGA.xml:S3:7738:2	O
prior	POTIGA.xml:S3:7741:5	O
psychiatric	POTIGA.xml:S3:7747:11	O
history	POTIGA.xml:S3:7759:7	O
.	POTIGA.xml:S3:7766:1	O

The	POTIGA.xml:S3:7768:3	O
psychiatric	POTIGA.xml:S3:7772:11	B-AdverseReaction
symptoms	POTIGA.xml:S3:7784:8	I-AdverseReaction
in	POTIGA.xml:S3:7793:2	O
the	POTIGA.xml:S3:7796:3	O
vast	POTIGA.xml:S3:7800:4	O
majority	POTIGA.xml:S3:7805:8	O
of	POTIGA.xml:S3:7814:2	O
patients	POTIGA.xml:S3:7817:8	O
in	POTIGA.xml:S3:7826:2	O
both	POTIGA.xml:S3:7829:4	O
controlled	POTIGA.xml:S3:7834:10	O
and	POTIGA.xml:S3:7845:3	O
open	POTIGA.xml:S3:7849:4	O
-	POTIGA.xml:S3:7853:1	O
label	POTIGA.xml:S3:7854:5	O
trials	POTIGA.xml:S3:7860:6	O
resolved	POTIGA.xml:S3:7867:8	O
within	POTIGA.xml:S3:7876:6	O
7	POTIGA.xml:S3:7883:1	O
days	POTIGA.xml:S3:7885:4	O
of	POTIGA.xml:S3:7890:2	O
discontinuation	POTIGA.xml:S3:7893:15	O
of	POTIGA.xml:S3:7909:2	O
POTIGA	POTIGA.xml:S3:7912:6	O
.	POTIGA.xml:S3:7918:1	O

Rapid	POTIGA.xml:S3:7920:5	O
titration	POTIGA.xml:S3:7926:9	O
at	POTIGA.xml:S3:7936:2	O
greater	POTIGA.xml:S3:7939:7	O
than	POTIGA.xml:S3:7947:4	O
the	POTIGA.xml:S3:7952:3	O
recommended	POTIGA.xml:S3:7956:11	O
doses	POTIGA.xml:S3:7968:5	O
appeared	POTIGA.xml:S3:7974:8	O
to	POTIGA.xml:S3:7983:2	O
increase	POTIGA.xml:S3:7986:8	O
the	POTIGA.xml:S3:7995:3	O
risk	POTIGA.xml:S3:7999:4	B-Factor
of	POTIGA.xml:S3:8004:2	O
psychosis	POTIGA.xml:S3:8007:9	B-AdverseReaction
and	POTIGA.xml:S3:8017:3	O
hallucinations	POTIGA.xml:S3:8021:14	B-AdverseReaction
.	POTIGA.xml:S3:8035:1	O

Table	POTIGA.xml:S3:8042:5	O
2	POTIGA.xml:S3:8048:1	O
.	POTIGA.xml:S3:8049:1	O

Major	POTIGA.xml:S3:8051:5	O
Neuropsychiatric	POTIGA.xml:S3:8057:16	B-AdverseReaction
Symptoms	POTIGA.xml:S3:8074:8	I-AdverseReaction
in	POTIGA.xml:S3:8083:2	O
Placebo	POTIGA.xml:S3:8086:7	O
-	POTIGA.xml:S3:8093:1	O
Controlled	POTIGA.xml:S3:8094:10	O
Epilepsy	POTIGA.xml:S3:8105:8	O
Trials	POTIGA.xml:S3:8114:6	O

Adverse	POTIGA.xml:S3:8129:7	O
Reaction	POTIGA.xml:S3:8137:8	O
Number	POTIGA.xml:S3:8151:6	O
(	POTIGA.xml:S3:8158:1	O
)	POTIGA.xml:S3:8160:1	O
with	POTIGA.xml:S3:8162:4	O
Adverse	POTIGA.xml:S3:8167:7	O
Reaction	POTIGA.xml:S3:8175:8	O
Number	POTIGA.xml:S3:8187:6	O
(	POTIGA.xml:S3:8194:1	O
)	POTIGA.xml:S3:8196:1	O
Discontinuing	POTIGA.xml:S3:8198:13	O

POTIGA	POTIGA.xml:S3:8218:6	O
(	POTIGA.xml:S3:8226:1	O
n	POTIGA.xml:S3:8227:1	O
813	POTIGA.xml:S3:8231:3	O
)	POTIGA.xml:S3:8234:1	O
Placebo	POTIGA.xml:S3:8240:7	O
(	POTIGA.xml:S3:8249:1	O
n	POTIGA.xml:S3:8250:1	O
427	POTIGA.xml:S3:8254:3	O
)	POTIGA.xml:S3:8257:1	O
POTIGA	POTIGA.xml:S3:8262:6	O
(	POTIGA.xml:S3:8270:1	O
n	POTIGA.xml:S3:8271:1	O
813	POTIGA.xml:S3:8275:3	O
)	POTIGA.xml:S3:8278:1	O
Placebo	POTIGA.xml:S3:8283:7	O
(	POTIGA.xml:S3:8292:1	O
n	POTIGA.xml:S3:8293:1	O
427	POTIGA.xml:S3:8297:3	O
)	POTIGA.xml:S3:8300:1	O

Confusional	POTIGA.xml:S3:8308:11	B-AdverseReaction
state	POTIGA.xml:S3:8320:5	I-AdverseReaction
75	POTIGA.xml:S3:8330:2	O
(	POTIGA.xml:S3:8333:1	O
9%	POTIGA.xml:S3:8334:2	O
)	POTIGA.xml:S3:8336:1	O
11	POTIGA.xml:S3:8351:2	O
(	POTIGA.xml:S3:8354:1	O
3%	POTIGA.xml:S3:8355:2	O
)	POTIGA.xml:S3:8357:1	O
32	POTIGA.xml:S3:8372:2	O
(	POTIGA.xml:S3:8375:1	O
4%	POTIGA.xml:S3:8376:2	O
)	POTIGA.xml:S3:8378:1	O
4	POTIGA.xml:S3:8389:1	O
(	POTIGA.xml:S3:8391:1	O
1%	POTIGA.xml:S3:8393:2	O
)	POTIGA.xml:S3:8395:1	O

Psychosis	POTIGA.xml:S3:8408:9	B-AdverseReaction
9	POTIGA.xml:S3:8430:1	O
(	POTIGA.xml:S3:8432:1	O
1%	POTIGA.xml:S3:8433:2	O
)	POTIGA.xml:S3:8435:1	O
0	POTIGA.xml:S3:8451:1	O
6	POTIGA.xml:S3:8472:1	O
(	POTIGA.xml:S3:8474:1	O
1%	POTIGA.xml:S3:8476:2	O
)	POTIGA.xml:S3:8478:1	O
0	POTIGA.xml:S3:8489:1	O

Hallucinationsa	POTIGA.xml:S3:8508:15	B-AdverseReaction
14	POTIGA.xml:S3:8530:2	O
(	POTIGA.xml:S3:8533:1	O
2%	POTIGA.xml:S3:8534:2	O
)	POTIGA.xml:S3:8536:1	O
2	POTIGA.xml:S3:8551:1	O
(	POTIGA.xml:S3:8553:1	O
1%	POTIGA.xml:S3:8555:2	O
)	POTIGA.xml:S3:8557:1	O
6	POTIGA.xml:S3:8572:1	O
(	POTIGA.xml:S3:8574:1	O
1%	POTIGA.xml:S3:8576:2	O
)	POTIGA.xml:S3:8578:1	O
0	POTIGA.xml:S3:8589:1	O

a	POTIGA.xml:S3:8619:1	O
Hallucinations	POTIGA.xml:S3:8622:14	B-AdverseReaction
includes	POTIGA.xml:S3:8637:8	O
visual	POTIGA.xml:S3:8646:6	B-AdverseReaction
,	POTIGA.xml:S3:8652:1	O
auditory	POTIGA.xml:S3:8654:8	B-AdverseReaction
,	POTIGA.xml:S3:8662:1	O
and	POTIGA.xml:S3:8664:3	O
mixed	POTIGA.xml:S3:8668:5	B-AdverseReaction
hallucinations	POTIGA.xml:S3:8674:14	I-AdverseReaction
.	POTIGA.xml:S3:8688:1	O

5.5	POTIGA.xml:S3:8697:3	O

Dizziness	POTIGA.xml:S3:8701:9	O
and	POTIGA.xml:S3:8711:3	O
Somnolence	POTIGA.xml:S3:8715:10	O

POTIGA	POTIGA.xml:S3:8731:6	O
causes	POTIGA.xml:S3:8738:6	O
dose	POTIGA.xml:S3:8745:4	O
-	POTIGA.xml:S3:8749:1	O
related	POTIGA.xml:S3:8750:7	O
increases	POTIGA.xml:S3:8758:9	O
in	POTIGA.xml:S3:8768:2	O
dizziness	POTIGA.xml:S3:8771:9	B-AdverseReaction
and	POTIGA.xml:S3:8781:3	O
somnolence	POTIGA.xml:S3:8785:10	B-AdverseReaction
[	POTIGA.xml:S3:8796:1	O
see	POTIGA.xml:S3:8797:3	O
Adverse	POTIGA.xml:S3:8801:7	O
Reactions	POTIGA.xml:S3:8809:9	O
(	POTIGA.xml:S3:8819:1	O
6.1	POTIGA.xml:S3:8820:3	O
)]	POTIGA.xml:S3:8823:2	O
.	POTIGA.xml:S3:8827:1	O

In	POTIGA.xml:S3:8829:2	O
placebo	POTIGA.xml:S3:8832:7	O
-	POTIGA.xml:S3:8839:1	O
controlled	POTIGA.xml:S3:8840:10	O
trials	POTIGA.xml:S3:8851:6	O
in	POTIGA.xml:S3:8858:2	O
patients	POTIGA.xml:S3:8861:8	O
with	POTIGA.xml:S3:8870:4	O
epilepsy	POTIGA.xml:S3:8875:8	O
,	POTIGA.xml:S3:8883:1	O
dizziness	POTIGA.xml:S3:8885:9	B-AdverseReaction
was	POTIGA.xml:S3:8895:3	O
reported	POTIGA.xml:S3:8899:8	O
in	POTIGA.xml:S3:8908:2	O
23%	POTIGA.xml:S3:8911:3	O
of	POTIGA.xml:S3:8915:2	O
patients	POTIGA.xml:S3:8918:8	O
treated	POTIGA.xml:S3:8927:7	O
with	POTIGA.xml:S3:8935:4	O
POTIGA	POTIGA.xml:S3:8940:6	O
and	POTIGA.xml:S3:8947:3	O
9%	POTIGA.xml:S3:8951:2	O
of	POTIGA.xml:S3:8954:2	O
patients	POTIGA.xml:S3:8957:8	O
treated	POTIGA.xml:S3:8966:7	O
with	POTIGA.xml:S3:8974:4	O
placebo	POTIGA.xml:S3:8979:7	O
.	POTIGA.xml:S3:8986:1	O

Somnolence	POTIGA.xml:S3:8988:10	B-AdverseReaction
was	POTIGA.xml:S3:8999:3	O
reported	POTIGA.xml:S3:9003:8	O
in	POTIGA.xml:S3:9012:2	O
22%	POTIGA.xml:S3:9015:3	O
of	POTIGA.xml:S3:9019:2	O
patients	POTIGA.xml:S3:9022:8	O
treated	POTIGA.xml:S3:9031:7	O
with	POTIGA.xml:S3:9039:4	O
POTIGA	POTIGA.xml:S3:9044:6	O
and	POTIGA.xml:S3:9051:3	O
12%	POTIGA.xml:S3:9055:3	O
of	POTIGA.xml:S3:9059:2	O
patients	POTIGA.xml:S3:9062:8	O
treated	POTIGA.xml:S3:9071:7	O
with	POTIGA.xml:S3:9079:4	O
placebo	POTIGA.xml:S3:9084:7	O
.	POTIGA.xml:S3:9091:1	O

In	POTIGA.xml:S3:9093:2	O
these	POTIGA.xml:S3:9096:5	O
trials	POTIGA.xml:S3:9102:6	O
6%	POTIGA.xml:S3:9109:2	O
of	POTIGA.xml:S3:9112:2	O
patients	POTIGA.xml:S3:9115:8	O
on	POTIGA.xml:S3:9124:2	O
POTIGA	POTIGA.xml:S3:9127:6	O
and	POTIGA.xml:S3:9134:3	O
1.2%	POTIGA.xml:S3:9138:4	O
on	POTIGA.xml:S3:9143:2	O
placebo	POTIGA.xml:S3:9146:7	O
discontinued	POTIGA.xml:S3:9154:12	O
treatment	POTIGA.xml:S3:9167:9	O
because	POTIGA.xml:S3:9177:7	O
of	POTIGA.xml:S3:9185:2	O
dizziness	POTIGA.xml:S3:9188:9	B-AdverseReaction
;	POTIGA.xml:S3:9197:1	O
3%	POTIGA.xml:S3:9199:2	O
of	POTIGA.xml:S3:9202:2	O
patients	POTIGA.xml:S3:9205:8	O
on	POTIGA.xml:S3:9214:2	O
POTIGA	POTIGA.xml:S3:9217:6	O
and	POTIGA.xml:S3:9224:3	O
1.0%	POTIGA.xml:S3:9229:4	O
on	POTIGA.xml:S3:9234:2	O
placebo	POTIGA.xml:S3:9237:7	O
discontinued	POTIGA.xml:S3:9245:12	O
because	POTIGA.xml:S3:9258:7	O
of	POTIGA.xml:S3:9266:2	O
somnolence	POTIGA.xml:S3:9269:10	B-AdverseReaction
.	POTIGA.xml:S3:9279:1	O

Most	POTIGA.xml:S3:9285:4	O
of	POTIGA.xml:S3:9290:2	O
these	POTIGA.xml:S3:9293:5	O
adverse	POTIGA.xml:S3:9299:7	O
reactions	POTIGA.xml:S3:9307:9	O
were	POTIGA.xml:S3:9317:4	O
mild	POTIGA.xml:S3:9322:4	O
to	POTIGA.xml:S3:9327:2	O
moderate	POTIGA.xml:S3:9330:8	O
in	POTIGA.xml:S3:9339:2	O
intensity	POTIGA.xml:S3:9342:9	O
and	POTIGA.xml:S3:9352:3	O
occurred	POTIGA.xml:S3:9356:8	O
during	POTIGA.xml:S3:9365:6	O
the	POTIGA.xml:S3:9372:3	O
titration	POTIGA.xml:S3:9376:9	O
phase	POTIGA.xml:S3:9386:5	O
.	POTIGA.xml:S3:9391:1	O

For	POTIGA.xml:S3:9393:3	O
those	POTIGA.xml:S3:9397:5	O
patients	POTIGA.xml:S3:9403:8	O
continued	POTIGA.xml:S3:9412:9	O
on	POTIGA.xml:S3:9422:2	O
POTIGA	POTIGA.xml:S3:9425:6	O
,	POTIGA.xml:S3:9431:1	O
dizziness	POTIGA.xml:S3:9433:9	B-AdverseReaction
and	POTIGA.xml:S3:9443:3	O
somnolence	POTIGA.xml:S3:9447:10	B-AdverseReaction
appeared	POTIGA.xml:S3:9458:8	O
to	POTIGA.xml:S3:9467:2	O
diminish	POTIGA.xml:S3:9470:8	O
with	POTIGA.xml:S3:9479:4	O
continued	POTIGA.xml:S3:9484:9	O
use	POTIGA.xml:S3:9494:3	O
.	POTIGA.xml:S3:9497:1	O

5.6	POTIGA.xml:S3:9506:3	O
QT	POTIGA.xml:S3:9510:2	O
Interval	POTIGA.xml:S3:9513:8	O
Effect	POTIGA.xml:S3:9522:6	O

A	POTIGA.xml:S3:9534:1	O
study	POTIGA.xml:S3:9536:5	O
of	POTIGA.xml:S3:9542:2	O
cardiac	POTIGA.xml:S3:9545:7	O
conduction	POTIGA.xml:S3:9553:10	O
showed	POTIGA.xml:S3:9564:6	O
that	POTIGA.xml:S3:9571:4	O
POTIGA	POTIGA.xml:S3:9576:6	O
produced	POTIGA.xml:S3:9583:8	O
a	POTIGA.xml:S3:9592:1	O
mean	POTIGA.xml:S3:9594:4	O
7.7	POTIGA.xml:S3:9599:3	B-Severity
-	POTIGA.xml:S3:9602:1	I-Severity
msec	POTIGA.xml:S3:9603:4	I-Severity
QT	POTIGA.xml:S3:9608:2	B-AdverseReaction
prolongation	POTIGA.xml:S3:9611:12	I-AdverseReaction
in	POTIGA.xml:S3:9624:2	O
healthy	POTIGA.xml:S3:9627:7	O
volunteers	POTIGA.xml:S3:9635:10	O
titrated	POTIGA.xml:S3:9646:8	O
to	POTIGA.xml:S3:9655:2	O
400	POTIGA.xml:S3:9658:3	O
mg	POTIGA.xml:S3:9662:2	O
3	POTIGA.xml:S3:9665:1	O
times	POTIGA.xml:S3:9667:5	O
daily	POTIGA.xml:S3:9673:5	O
.	POTIGA.xml:S3:9678:1	O

The	POTIGA.xml:S3:9680:3	O
QT	POTIGA.xml:S3:9684:2	B-AdverseReaction
-	POTIGA.xml:S3:9686:1	I-AdverseReaction
prolonging	POTIGA.xml:S3:9687:10	I-AdverseReaction
effect	POTIGA.xml:S3:9698:6	O
occurred	POTIGA.xml:S3:9705:8	O
within	POTIGA.xml:S3:9714:6	O
3	POTIGA.xml:S3:9721:1	O
hours	POTIGA.xml:S3:9723:5	O
.	POTIGA.xml:S3:9728:1	O

The	POTIGA.xml:S3:9730:3	O
QT	POTIGA.xml:S3:9734:2	O
interval	POTIGA.xml:S3:9737:8	O
should	POTIGA.xml:S3:9746:6	O
be	POTIGA.xml:S3:9753:2	O
monitored	POTIGA.xml:S3:9756:9	O
when	POTIGA.xml:S3:9766:4	O
POTIGA	POTIGA.xml:S3:9771:6	O
is	POTIGA.xml:S3:9778:2	O
prescribed	POTIGA.xml:S3:9781:10	O
with	POTIGA.xml:S3:9792:4	O
medicines	POTIGA.xml:S3:9797:9	O
known	POTIGA.xml:S3:9807:5	O
to	POTIGA.xml:S3:9813:2	O
increase	POTIGA.xml:S3:9816:8	O
QT	POTIGA.xml:S3:9825:2	O
interval	POTIGA.xml:S3:9828:8	O
and	POTIGA.xml:S3:9837:3	O
in	POTIGA.xml:S3:9841:2	O
patients	POTIGA.xml:S3:9844:8	O
with	POTIGA.xml:S3:9853:4	O
known	POTIGA.xml:S3:9858:5	O
prolonged	POTIGA.xml:S3:9864:9	O
QT	POTIGA.xml:S3:9874:2	O
interval	POTIGA.xml:S3:9877:8	O
,	POTIGA.xml:S3:9885:1	O
congestive	POTIGA.xml:S3:9887:10	O
heart	POTIGA.xml:S3:9898:5	O
failure	POTIGA.xml:S3:9904:7	O
,	POTIGA.xml:S3:9911:1	O
ventricular	POTIGA.xml:S3:9913:11	O
hypertrophy	POTIGA.xml:S3:9925:11	O
,	POTIGA.xml:S3:9936:1	O
hypokalemia	POTIGA.xml:S3:9938:11	O
,	POTIGA.xml:S3:9949:1	O
or	POTIGA.xml:S3:9951:2	O
hypomagnesemia	POTIGA.xml:S3:9954:14	O
[	POTIGA.xml:S3:9969:1	O
see	POTIGA.xml:S3:9970:3	O
Clinical	POTIGA.xml:S3:9974:8	O
Pharmacology	POTIGA.xml:S3:9983:12	O
(	POTIGA.xml:S3:9996:1	O
12.2	POTIGA.xml:S3:9997:4	O
)]	POTIGA.xml:S3:10001:2	O
.	POTIGA.xml:S3:10005:1	O

5.7	POTIGA.xml:S3:10014:3	O
Suicidal	POTIGA.xml:S3:10018:8	O
Behavior	POTIGA.xml:S3:10027:8	O
and	POTIGA.xml:S3:10036:3	O
Ideation	POTIGA.xml:S3:10040:8	O

Antiepileptic	POTIGA.xml:S3:10054:13	O
drugs	POTIGA.xml:S3:10068:5	O
(	POTIGA.xml:S3:10074:1	O
AEDs	POTIGA.xml:S3:10075:4	O
)	POTIGA.xml:S3:10079:1	O
,	POTIGA.xml:S3:10080:1	O
including	POTIGA.xml:S3:10082:9	O
POTIGA	POTIGA.xml:S3:10092:6	O
,	POTIGA.xml:S3:10098:1	O
increase	POTIGA.xml:S3:10100:8	O
the	POTIGA.xml:S3:10109:3	O
risk	POTIGA.xml:S3:10113:4	B-Factor
of	POTIGA.xml:S3:10118:2	O
suicidal	POTIGA.xml:S3:10121:8	B-AdverseReaction
thoughts	POTIGA.xml:S3:10130:8	I-AdverseReaction
or	POTIGA.xml:S3:10139:2	O
behavior	POTIGA.xml:S3:10142:8	I-AdverseReaction
in	POTIGA.xml:S3:10151:2	O
patients	POTIGA.xml:S3:10154:8	O
taking	POTIGA.xml:S3:10163:6	O
these	POTIGA.xml:S3:10170:5	O
drugs	POTIGA.xml:S3:10176:5	O
for	POTIGA.xml:S3:10182:3	O
any	POTIGA.xml:S3:10186:3	O
indication	POTIGA.xml:S3:10190:10	O
.	POTIGA.xml:S3:10200:1	O

Patients	POTIGA.xml:S3:10202:8	O
treated	POTIGA.xml:S3:10211:7	O
with	POTIGA.xml:S3:10219:4	O
any	POTIGA.xml:S3:10224:3	O
AED	POTIGA.xml:S3:10228:3	O
for	POTIGA.xml:S3:10232:3	O
any	POTIGA.xml:S3:10236:3	O
indication	POTIGA.xml:S3:10240:10	O
should	POTIGA.xml:S3:10251:6	O
be	POTIGA.xml:S3:10258:2	O
monitored	POTIGA.xml:S3:10261:9	O
for	POTIGA.xml:S3:10271:3	O
the	POTIGA.xml:S3:10275:3	O
emergence	POTIGA.xml:S3:10279:9	O
or	POTIGA.xml:S3:10289:2	O
worsening	POTIGA.xml:S3:10292:9	O
of	POTIGA.xml:S3:10302:2	O
depression	POTIGA.xml:S3:10305:10	O
,	POTIGA.xml:S3:10315:1	O
suicidal	POTIGA.xml:S3:10317:8	O
thoughts	POTIGA.xml:S3:10326:8	O
or	POTIGA.xml:S3:10335:2	O
behavior	POTIGA.xml:S3:10338:8	O
,	POTIGA.xml:S3:10346:1	O
and	POTIGA.xml:S3:10348:3	O
or	POTIGA.xml:S3:10352:2	O
any	POTIGA.xml:S3:10355:3	O
unusual	POTIGA.xml:S3:10359:7	O
changes	POTIGA.xml:S3:10367:7	O
in	POTIGA.xml:S3:10375:2	O
mood	POTIGA.xml:S3:10378:4	O
or	POTIGA.xml:S3:10383:2	O
behavior	POTIGA.xml:S3:10386:8	O
.	POTIGA.xml:S3:10394:1	O

Pooled	POTIGA.xml:S3:10400:6	O
analyses	POTIGA.xml:S3:10407:8	O
of	POTIGA.xml:S3:10416:2	O
199	POTIGA.xml:S3:10419:3	O
placebo	POTIGA.xml:S3:10423:7	O
-	POTIGA.xml:S3:10430:1	O
controlled	POTIGA.xml:S3:10431:10	O
clinical	POTIGA.xml:S3:10442:8	O
trials	POTIGA.xml:S3:10451:6	O
(	POTIGA.xml:S3:10458:1	O
mono	POTIGA.xml:S3:10459:4	O
-	POTIGA.xml:S3:10463:1	O
and	POTIGA.xml:S3:10465:3	O
adjunctive	POTIGA.xml:S3:10469:10	O
-	POTIGA.xml:S3:10479:1	O
therapy	POTIGA.xml:S3:10480:7	O
)	POTIGA.xml:S3:10487:1	O
of	POTIGA.xml:S3:10489:2	O
11	POTIGA.xml:S3:10492:2	O
different	POTIGA.xml:S3:10495:9	O
AEDs	POTIGA.xml:S3:10505:4	O
showed	POTIGA.xml:S3:10510:6	O
that	POTIGA.xml:S3:10517:4	O
patients	POTIGA.xml:S3:10522:8	O
randomized	POTIGA.xml:S3:10531:10	O
to	POTIGA.xml:S3:10542:2	O
one	POTIGA.xml:S3:10545:3	O
of	POTIGA.xml:S3:10549:2	O
the	POTIGA.xml:S3:10552:3	O
AEDs	POTIGA.xml:S3:10556:4	O
had	POTIGA.xml:S3:10561:3	O
approximately	POTIGA.xml:S3:10565:13	O
twice	POTIGA.xml:S3:10579:5	O
the	POTIGA.xml:S3:10585:3	O
risk	POTIGA.xml:S3:10589:4	B-Factor
(	POTIGA.xml:S3:10594:1	O
adjusted	POTIGA.xml:S3:10595:8	O
relative	POTIGA.xml:S3:10604:8	O
risk	POTIGA.xml:S3:10613:4	O
1.8	POTIGA.xml:S3:10618:3	O
,	POTIGA.xml:S3:10621:1	O
95%	POTIGA.xml:S3:10623:3	O
confidence	POTIGA.xml:S3:10627:10	O
interval	POTIGA.xml:S3:10638:8	O
[	POTIGA.xml:S3:10647:1	O
CI	POTIGA.xml:S3:10648:2	O
]	POTIGA.xml:S3:10650:1	O
:	POTIGA.xml:S3:10651:1	O
1.2	POTIGA.xml:S3:10653:3	O
,	POTIGA.xml:S3:10656:1	O
2.7	POTIGA.xml:S3:10658:3	O
)	POTIGA.xml:S3:10661:1	O
of	POTIGA.xml:S3:10663:2	O
suicidal	POTIGA.xml:S3:10666:8	B-AdverseReaction
thinking	POTIGA.xml:S3:10675:8	I-AdverseReaction
or	POTIGA.xml:S3:10684:2	O
behavior	POTIGA.xml:S3:10687:8	I-AdverseReaction
compared	POTIGA.xml:S3:10696:8	O
with	POTIGA.xml:S3:10705:4	O
patients	POTIGA.xml:S3:10710:8	O
randomized	POTIGA.xml:S3:10719:10	O
to	POTIGA.xml:S3:10730:2	O
placebo	POTIGA.xml:S3:10733:7	O
.	POTIGA.xml:S3:10740:1	O

In	POTIGA.xml:S3:10742:2	O
these	POTIGA.xml:S3:10745:5	O
trials	POTIGA.xml:S3:10751:6	O
,	POTIGA.xml:S3:10757:1	O
which	POTIGA.xml:S3:10759:5	O
had	POTIGA.xml:S3:10765:3	O
a	POTIGA.xml:S3:10769:1	O
median	POTIGA.xml:S3:10771:6	O
treatment	POTIGA.xml:S3:10778:9	O
duration	POTIGA.xml:S3:10788:8	O
of	POTIGA.xml:S3:10797:2	O
12	POTIGA.xml:S3:10800:2	O
weeks	POTIGA.xml:S3:10803:5	O
,	POTIGA.xml:S3:10808:1	O
the	POTIGA.xml:S3:10810:3	O
estimated	POTIGA.xml:S3:10814:9	O
incidence	POTIGA.xml:S3:10824:9	O
of	POTIGA.xml:S3:10834:2	O
suicidal	POTIGA.xml:S3:10837:8	B-AdverseReaction
behavior	POTIGA.xml:S3:10846:8	I-AdverseReaction
or	POTIGA.xml:S3:10855:2	O
ideation	POTIGA.xml:S3:10858:8	I-AdverseReaction
among	POTIGA.xml:S3:10867:5	O
27	POTIGA.xml:S3:10873:2	O
,	POTIGA.xml:S3:10875:1	O
863	POTIGA.xml:S3:10876:3	O
AED	POTIGA.xml:S3:10880:3	O
-	POTIGA.xml:S3:10883:1	O
treated	POTIGA.xml:S3:10884:7	O
patients	POTIGA.xml:S3:10892:8	O
was	POTIGA.xml:S3:10901:3	O
0.43%	POTIGA.xml:S3:10905:5	O
compared	POTIGA.xml:S3:10911:8	O
with	POTIGA.xml:S3:10920:4	O
0.24%	POTIGA.xml:S3:10925:5	O
among	POTIGA.xml:S3:10931:5	O
16	POTIGA.xml:S3:10937:2	O
,	POTIGA.xml:S3:10939:1	O
029	POTIGA.xml:S3:10940:3	O
placebo	POTIGA.xml:S3:10944:7	O
-	POTIGA.xml:S3:10951:1	O
treated	POTIGA.xml:S3:10952:7	O
patients	POTIGA.xml:S3:10960:8	O
,	POTIGA.xml:S3:10968:1	O
representing	POTIGA.xml:S3:10970:12	O
an	POTIGA.xml:S3:10983:2	O
increase	POTIGA.xml:S3:10986:8	O
of	POTIGA.xml:S3:10995:2	O
approximately	POTIGA.xml:S3:10998:13	O
1	POTIGA.xml:S3:11012:1	O
case	POTIGA.xml:S3:11014:4	O
of	POTIGA.xml:S3:11019:2	O
suicidal	POTIGA.xml:S3:11022:8	B-AdverseReaction
thinking	POTIGA.xml:S3:11031:8	I-AdverseReaction
or	POTIGA.xml:S3:11040:2	O
behavior	POTIGA.xml:S3:11043:8	I-AdverseReaction
for	POTIGA.xml:S3:11052:3	O
every	POTIGA.xml:S3:11056:5	O
530	POTIGA.xml:S3:11062:3	O
patients	POTIGA.xml:S3:11066:8	O
treated	POTIGA.xml:S3:11075:7	O
.	POTIGA.xml:S3:11082:1	O

There	POTIGA.xml:S3:11084:5	O
were	POTIGA.xml:S3:11090:4	O
4	POTIGA.xml:S3:11095:1	O
suicides	POTIGA.xml:S3:11097:8	B-AdverseReaction
in	POTIGA.xml:S3:11106:2	O
drug	POTIGA.xml:S3:11109:4	O
-	POTIGA.xml:S3:11113:1	O
treated	POTIGA.xml:S3:11114:7	O
patients	POTIGA.xml:S3:11122:8	O
in	POTIGA.xml:S3:11131:2	O
the	POTIGA.xml:S3:11134:3	O
trials	POTIGA.xml:S3:11138:6	O
and	POTIGA.xml:S3:11145:3	O
none	POTIGA.xml:S3:11149:4	O
in	POTIGA.xml:S3:11154:2	O
placebo	POTIGA.xml:S3:11157:7	O
-	POTIGA.xml:S3:11164:1	O
treated	POTIGA.xml:S3:11165:7	O
patients	POTIGA.xml:S3:11173:8	O
,	POTIGA.xml:S3:11181:1	O
but	POTIGA.xml:S3:11183:3	O
the	POTIGA.xml:S3:11187:3	O
number	POTIGA.xml:S3:11191:6	B-Factor
is	POTIGA.xml:S3:11198:2	I-Factor
too	POTIGA.xml:S3:11201:3	I-Factor
small	POTIGA.xml:S3:11205:5	I-Factor
to	POTIGA.xml:S3:11211:2	O
allow	POTIGA.xml:S3:11214:5	O
any	POTIGA.xml:S3:11220:3	O
conclusion	POTIGA.xml:S3:11224:10	O
about	POTIGA.xml:S3:11235:5	O
drug	POTIGA.xml:S3:11241:4	O
effect	POTIGA.xml:S3:11246:6	O
on	POTIGA.xml:S3:11253:2	O
suicide	POTIGA.xml:S3:11256:7	B-AdverseReaction
.	POTIGA.xml:S3:11263:1	O

The	POTIGA.xml:S3:11269:3	O
increased	POTIGA.xml:S3:11273:9	O
risk	POTIGA.xml:S3:11283:4	O
of	POTIGA.xml:S3:11288:2	O
suicidal	POTIGA.xml:S3:11291:8	B-AdverseReaction
thoughts	POTIGA.xml:S3:11300:8	I-AdverseReaction
or	POTIGA.xml:S3:11309:2	O
behavior	POTIGA.xml:S3:11312:8	I-AdverseReaction
with	POTIGA.xml:S3:11321:4	O
AEDs	POTIGA.xml:S3:11326:4	B-DrugClass
was	POTIGA.xml:S3:11331:3	O
observed	POTIGA.xml:S3:11335:8	O
as	POTIGA.xml:S3:11344:2	O
early	POTIGA.xml:S3:11347:5	O
as	POTIGA.xml:S3:11353:2	O
1	POTIGA.xml:S3:11356:1	O
week	POTIGA.xml:S3:11358:4	O
after	POTIGA.xml:S3:11363:5	O
starting	POTIGA.xml:S3:11369:8	O
treatment	POTIGA.xml:S3:11378:9	O
with	POTIGA.xml:S3:11388:4	O
AEDs	POTIGA.xml:S3:11393:4	O
and	POTIGA.xml:S3:11398:3	O
persisted	POTIGA.xml:S3:11402:9	O
for	POTIGA.xml:S3:11412:3	O
the	POTIGA.xml:S3:11416:3	O
duration	POTIGA.xml:S3:11420:8	O
of	POTIGA.xml:S3:11429:2	O
treatment	POTIGA.xml:S3:11432:9	O
assessed	POTIGA.xml:S3:11442:8	O
.	POTIGA.xml:S3:11450:1	O

Because	POTIGA.xml:S3:11452:7	O
most	POTIGA.xml:S3:11460:4	O
trials	POTIGA.xml:S3:11465:6	O
included	POTIGA.xml:S3:11472:8	O
in	POTIGA.xml:S3:11481:2	O
the	POTIGA.xml:S3:11484:3	O
analysis	POTIGA.xml:S3:11488:8	O
did	POTIGA.xml:S3:11497:3	O
not	POTIGA.xml:S3:11501:3	O
extend	POTIGA.xml:S3:11505:6	O
beyond	POTIGA.xml:S3:11512:6	O
24	POTIGA.xml:S3:11519:2	O
weeks	POTIGA.xml:S3:11522:5	O
,	POTIGA.xml:S3:11527:1	O
the	POTIGA.xml:S3:11529:3	O
risk	POTIGA.xml:S3:11533:4	O
of	POTIGA.xml:S3:11538:2	O
suicidal	POTIGA.xml:S3:11541:8	O
thoughts	POTIGA.xml:S3:11550:8	O
or	POTIGA.xml:S3:11559:2	O
behavior	POTIGA.xml:S3:11562:8	O
beyond	POTIGA.xml:S3:11571:6	O
24	POTIGA.xml:S3:11578:2	O
weeks	POTIGA.xml:S3:11581:5	O
could	POTIGA.xml:S3:11587:5	O
not	POTIGA.xml:S3:11593:3	O
be	POTIGA.xml:S3:11597:2	O
assessed	POTIGA.xml:S3:11600:8	O
.	POTIGA.xml:S3:11608:1	O

The	POTIGA.xml:S3:11614:3	O
risk	POTIGA.xml:S3:11618:4	B-Factor
of	POTIGA.xml:S3:11623:2	O
suicidal	POTIGA.xml:S3:11626:8	B-AdverseReaction
thoughts	POTIGA.xml:S3:11635:8	I-AdverseReaction
or	POTIGA.xml:S3:11644:2	O
behavior	POTIGA.xml:S3:11647:8	I-AdverseReaction
was	POTIGA.xml:S3:11656:3	O
generally	POTIGA.xml:S3:11660:9	O
consistent	POTIGA.xml:S3:11670:10	O
among	POTIGA.xml:S3:11681:5	O
drugs	POTIGA.xml:S3:11687:5	O
in	POTIGA.xml:S3:11693:2	O
the	POTIGA.xml:S3:11696:3	O
data	POTIGA.xml:S3:11700:4	O
analyzed	POTIGA.xml:S3:11705:8	O
.	POTIGA.xml:S3:11713:1	O

The	POTIGA.xml:S3:11715:3	O
finding	POTIGA.xml:S3:11719:7	O
of	POTIGA.xml:S3:11727:2	O
increased	POTIGA.xml:S3:11730:9	O
risk	POTIGA.xml:S3:11740:4	O
with	POTIGA.xml:S3:11745:4	O
AEDs	POTIGA.xml:S3:11750:4	O
of	POTIGA.xml:S3:11755:2	O
varying	POTIGA.xml:S3:11758:7	O
mechanism	POTIGA.xml:S3:11766:9	O
of	POTIGA.xml:S3:11776:2	O
action	POTIGA.xml:S3:11779:6	O
and	POTIGA.xml:S3:11786:3	O
across	POTIGA.xml:S3:11790:6	O
a	POTIGA.xml:S3:11797:1	O
range	POTIGA.xml:S3:11799:5	O
of	POTIGA.xml:S3:11805:2	O
indications	POTIGA.xml:S3:11808:11	O
suggests	POTIGA.xml:S3:11820:8	O
that	POTIGA.xml:S3:11829:4	O
the	POTIGA.xml:S3:11834:3	O
risk	POTIGA.xml:S3:11838:4	O
applies	POTIGA.xml:S3:11843:7	O
to	POTIGA.xml:S3:11851:2	O
all	POTIGA.xml:S3:11854:3	O
AEDs	POTIGA.xml:S3:11858:4	O
used	POTIGA.xml:S3:11863:4	O
for	POTIGA.xml:S3:11868:3	O
any	POTIGA.xml:S3:11872:3	O
indication	POTIGA.xml:S3:11876:10	O
.	POTIGA.xml:S3:11886:1	O

The	POTIGA.xml:S3:11888:3	O
risk	POTIGA.xml:S3:11892:4	O
did	POTIGA.xml:S3:11897:3	O
not	POTIGA.xml:S3:11901:3	O
vary	POTIGA.xml:S3:11905:4	O
substantially	POTIGA.xml:S3:11910:13	O
by	POTIGA.xml:S3:11924:2	O
age	POTIGA.xml:S3:11927:3	O
(	POTIGA.xml:S3:11931:1	O
5	POTIGA.xml:S3:11932:1	O
to	POTIGA.xml:S3:11934:2	O
100	POTIGA.xml:S3:11937:3	O
years	POTIGA.xml:S3:11941:5	O
)	POTIGA.xml:S3:11946:1	O
in	POTIGA.xml:S3:11948:2	O
the	POTIGA.xml:S3:11951:3	O
clinical	POTIGA.xml:S3:11955:8	O
trials	POTIGA.xml:S3:11964:6	O
analyzed	POTIGA.xml:S3:11971:8	O
.	POTIGA.xml:S3:11979:1	O

Table	POTIGA.xml:S3:11985:5	O
3	POTIGA.xml:S3:11991:1	O
shows	POTIGA.xml:S3:11993:5	O
absolute	POTIGA.xml:S3:11999:8	O
and	POTIGA.xml:S3:12008:3	O
relative	POTIGA.xml:S3:12012:8	O
risk	POTIGA.xml:S3:12021:4	O
by	POTIGA.xml:S3:12026:2	O
indication	POTIGA.xml:S3:12029:10	O
for	POTIGA.xml:S3:12040:3	O
all	POTIGA.xml:S3:12044:3	O
evaluated	POTIGA.xml:S3:12048:9	O
AEDs	POTIGA.xml:S3:12058:4	O
.	POTIGA.xml:S3:12062:1	O

Table	POTIGA.xml:S3:12069:5	O
3	POTIGA.xml:S3:12075:1	O
.	POTIGA.xml:S3:12076:1	O

Risk	POTIGA.xml:S3:12078:4	B-Factor
of	POTIGA.xml:S3:12083:2	O
Suicidal	POTIGA.xml:S3:12086:8	B-AdverseReaction
Thoughts	POTIGA.xml:S3:12095:8	I-AdverseReaction
or	POTIGA.xml:S3:12104:2	O
Behaviors	POTIGA.xml:S3:12107:9	I-AdverseReaction
by	POTIGA.xml:S3:12117:2	O
Indication	POTIGA.xml:S3:12120:10	O
for	POTIGA.xml:S3:12131:3	O
Antiepileptic	POTIGA.xml:S3:12135:13	O
Drugs	POTIGA.xml:S3:12149:5	O
in	POTIGA.xml:S3:12155:2	O
the	POTIGA.xml:S3:12158:3	O
Pooled	POTIGA.xml:S3:12162:6	O
Analysis	POTIGA.xml:S3:12169:8	O

Indication	POTIGA.xml:S3:12186:10	O
Placebo	POTIGA.xml:S3:12200:7	O
Patients	POTIGA.xml:S3:12208:8	O
with	POTIGA.xml:S3:12217:4	O
Events	POTIGA.xml:S3:12222:6	O
per	POTIGA.xml:S3:12229:3	O
1	POTIGA.xml:S3:12233:1	O
,	POTIGA.xml:S3:12234:1	O
000	POTIGA.xml:S3:12235:3	O
Patients	POTIGA.xml:S3:12239:8	O
Drug	POTIGA.xml:S3:12251:4	O
Patients	POTIGA.xml:S3:12256:8	O
with	POTIGA.xml:S3:12265:4	O
Events	POTIGA.xml:S3:12270:6	O
per	POTIGA.xml:S3:12277:3	O
1	POTIGA.xml:S3:12281:1	O
,	POTIGA.xml:S3:12282:1	O
000	POTIGA.xml:S3:12283:3	O
Patients	POTIGA.xml:S3:12287:8	O
Relative	POTIGA.xml:S3:12299:8	O
Risk	POTIGA.xml:S3:12308:4	O
:	POTIGA.xml:S3:12312:1	O
Incidence	POTIGA.xml:S3:12314:9	O
of	POTIGA.xml:S3:12324:2	O
Events	POTIGA.xml:S3:12327:6	O
in	POTIGA.xml:S3:12334:2	O
Drug	POTIGA.xml:S3:12337:4	O
Patients	POTIGA.xml:S3:12342:8	O
Incidence	POTIGA.xml:S3:12351:9	O
in	POTIGA.xml:S3:12361:2	O
Placebo	POTIGA.xml:S3:12364:7	O
Patients	POTIGA.xml:S3:12372:8	O
Risk	POTIGA.xml:S3:12384:4	O
Difference	POTIGA.xml:S3:12389:10	O
:	POTIGA.xml:S3:12399:1	O
Additional	POTIGA.xml:S3:12401:10	O
Drug	POTIGA.xml:S3:12412:4	O
Patients	POTIGA.xml:S3:12417:8	O
with	POTIGA.xml:S3:12426:4	O
Events	POTIGA.xml:S3:12431:6	O
per	POTIGA.xml:S3:12438:3	O
1	POTIGA.xml:S3:12442:1	O
,	POTIGA.xml:S3:12443:1	O
000	POTIGA.xml:S3:12444:3	O
Patients	POTIGA.xml:S3:12448:8	O

Epilepsy	POTIGA.xml:S3:12463:8	O
1.0	POTIGA.xml:S3:12476:3	O
3.4	POTIGA.xml:S3:12495:3	O
3.5	POTIGA.xml:S3:12514:3	O
2.4	POTIGA.xml:S3:12547:3	O

Psychiatric	POTIGA.xml:S3:12577:11	O
5.7	POTIGA.xml:S3:12592:3	O
8.5	POTIGA.xml:S3:12611:3	O
1.5	POTIGA.xml:S3:12630:3	O
2.9	POTIGA.xml:S3:12663:3	O

Other	POTIGA.xml:S3:12693:5	O
1.0	POTIGA.xml:S3:12706:3	O
1.8	POTIGA.xml:S3:12725:3	O
1.9	POTIGA.xml:S3:12744:3	O
0.9	POTIGA.xml:S3:12777:3	O

Total	POTIGA.xml:S3:12807:5	O
2.4	POTIGA.xml:S3:12820:3	O
4.3	POTIGA.xml:S3:12839:3	O
1.8	POTIGA.xml:S3:12858:3	O
1.9	POTIGA.xml:S3:12891:3	O

The	POTIGA.xml:S3:12930:3	O
relative	POTIGA.xml:S3:12934:8	O
risk	POTIGA.xml:S3:12943:4	B-Factor
for	POTIGA.xml:S3:12948:3	O
suicidal	POTIGA.xml:S3:12952:8	B-AdverseReaction
thoughts	POTIGA.xml:S3:12961:8	I-AdverseReaction
or	POTIGA.xml:S3:12970:2	O
behavior	POTIGA.xml:S3:12973:8	I-AdverseReaction
was	POTIGA.xml:S3:12982:3	O
higher	POTIGA.xml:S3:12986:6	O
in	POTIGA.xml:S3:12993:2	O
clinical	POTIGA.xml:S3:12996:8	O
trials	POTIGA.xml:S3:13005:6	O
in	POTIGA.xml:S3:13012:2	O
patients	POTIGA.xml:S3:13015:8	O
with	POTIGA.xml:S3:13024:4	O
epilepsy	POTIGA.xml:S3:13029:8	O
than	POTIGA.xml:S3:13038:4	O
in	POTIGA.xml:S3:13043:2	O
clinical	POTIGA.xml:S3:13046:8	O
trials	POTIGA.xml:S3:13055:6	O
in	POTIGA.xml:S3:13062:2	O
patients	POTIGA.xml:S3:13065:8	O
with	POTIGA.xml:S3:13074:4	O
psychiatric	POTIGA.xml:S3:13079:11	O
or	POTIGA.xml:S3:13091:2	O
other	POTIGA.xml:S3:13094:5	O
conditions	POTIGA.xml:S3:13100:10	O
,	POTIGA.xml:S3:13110:1	O
but	POTIGA.xml:S3:13112:3	O
the	POTIGA.xml:S3:13116:3	O
absolute	POTIGA.xml:S3:13120:8	O
risk	POTIGA.xml:S3:13129:4	O
differences	POTIGA.xml:S3:13134:11	O
were	POTIGA.xml:S3:13146:4	O
similar	POTIGA.xml:S3:13151:7	O
for	POTIGA.xml:S3:13159:3	O
epilepsy	POTIGA.xml:S3:13163:8	O
and	POTIGA.xml:S3:13172:3	O
psychiatric	POTIGA.xml:S3:13176:11	O
indications	POTIGA.xml:S3:13188:11	O
.	POTIGA.xml:S3:13199:1	O

Anyone	POTIGA.xml:S3:13205:6	O

considering	POTIGA.xml:S3:13212:11	O
prescribing	POTIGA.xml:S3:13224:11	O
POTIGA	POTIGA.xml:S3:13236:6	O
or	POTIGA.xml:S3:13243:2	O
any	POTIGA.xml:S3:13246:3	O
other	POTIGA.xml:S3:13250:5	O
AED	POTIGA.xml:S3:13256:3	O
must	POTIGA.xml:S3:13260:4	O
balance	POTIGA.xml:S3:13265:7	O
this	POTIGA.xml:S3:13273:4	O
risk	POTIGA.xml:S3:13278:4	O
with	POTIGA.xml:S3:13283:4	O
the	POTIGA.xml:S3:13288:3	O
risk	POTIGA.xml:S3:13292:4	O
of	POTIGA.xml:S3:13297:2	O
untreated	POTIGA.xml:S3:13300:9	O
illness	POTIGA.xml:S3:13310:7	O
.	POTIGA.xml:S3:13317:1	O

Epilepsy	POTIGA.xml:S3:13319:8	O
and	POTIGA.xml:S3:13328:3	O
many	POTIGA.xml:S3:13332:4	O
other	POTIGA.xml:S3:13337:5	O
illnesses	POTIGA.xml:S3:13343:9	O
for	POTIGA.xml:S3:13353:3	O
which	POTIGA.xml:S3:13357:5	O
AEDs	POTIGA.xml:S3:13363:4	O
are	POTIGA.xml:S3:13368:3	O
prescribed	POTIGA.xml:S3:13372:10	O
are	POTIGA.xml:S3:13383:3	O
themselves	POTIGA.xml:S3:13387:10	O
associated	POTIGA.xml:S3:13398:10	O
with	POTIGA.xml:S3:13409:4	O
morbidity	POTIGA.xml:S3:13414:9	O
and	POTIGA.xml:S3:13424:3	O
mortality	POTIGA.xml:S3:13428:9	O
and	POTIGA.xml:S3:13438:3	O
an	POTIGA.xml:S3:13442:2	O
increased	POTIGA.xml:S3:13445:9	O
risk	POTIGA.xml:S3:13455:4	O
of	POTIGA.xml:S3:13460:2	O
suicidal	POTIGA.xml:S3:13463:8	O
thoughts	POTIGA.xml:S3:13472:8	O
and	POTIGA.xml:S3:13481:3	O
behavior	POTIGA.xml:S3:13485:8	O
.	POTIGA.xml:S3:13493:1	O

Should	POTIGA.xml:S3:13495:6	O
suicidal	POTIGA.xml:S3:13502:8	O
thoughts	POTIGA.xml:S3:13511:8	O
and	POTIGA.xml:S3:13520:3	O
behavior	POTIGA.xml:S3:13524:8	O
emerge	POTIGA.xml:S3:13533:6	O
during	POTIGA.xml:S3:13540:6	O
treatment	POTIGA.xml:S3:13547:9	O
,	POTIGA.xml:S3:13556:1	O
the	POTIGA.xml:S3:13558:3	O
prescriber	POTIGA.xml:S3:13562:10	O
needs	POTIGA.xml:S3:13573:5	O
to	POTIGA.xml:S3:13579:2	O
consider	POTIGA.xml:S3:13582:8	O
whether	POTIGA.xml:S3:13591:7	O
the	POTIGA.xml:S3:13599:3	O
emergence	POTIGA.xml:S3:13603:9	O
of	POTIGA.xml:S3:13613:2	O
these	POTIGA.xml:S3:13616:5	O
symptoms	POTIGA.xml:S3:13622:8	O
in	POTIGA.xml:S3:13631:2	O
any	POTIGA.xml:S3:13634:3	O
given	POTIGA.xml:S3:13638:5	O
patient	POTIGA.xml:S3:13644:7	O
may	POTIGA.xml:S3:13652:3	O
be	POTIGA.xml:S3:13656:2	O
related	POTIGA.xml:S3:13659:7	O
to	POTIGA.xml:S3:13667:2	O
the	POTIGA.xml:S3:13670:3	O
illness	POTIGA.xml:S3:13674:7	O
being	POTIGA.xml:S3:13682:5	O
treated	POTIGA.xml:S3:13688:7	O
.	POTIGA.xml:S3:13695:1	O

Patients	POTIGA.xml:S3:13701:8	O
,	POTIGA.xml:S3:13709:1	O
their	POTIGA.xml:S3:13711:5	O
caregivers	POTIGA.xml:S3:13717:10	O
,	POTIGA.xml:S3:13727:1	O
and	POTIGA.xml:S3:13729:3	O
families	POTIGA.xml:S3:13733:8	O
should	POTIGA.xml:S3:13742:6	O
be	POTIGA.xml:S3:13749:2	O
informed	POTIGA.xml:S3:13752:8	O
that	POTIGA.xml:S3:13761:4	O
AEDs	POTIGA.xml:S3:13766:4	O
increase	POTIGA.xml:S3:13771:8	O
the	POTIGA.xml:S3:13780:3	O
risk	POTIGA.xml:S3:13784:4	O
of	POTIGA.xml:S3:13789:2	O
suicidal	POTIGA.xml:S3:13792:8	O
thoughts	POTIGA.xml:S3:13801:8	O
and	POTIGA.xml:S3:13810:3	O
behavior	POTIGA.xml:S3:13814:8	O
and	POTIGA.xml:S3:13823:3	O
should	POTIGA.xml:S3:13827:6	O
be	POTIGA.xml:S3:13834:2	O
advised	POTIGA.xml:S3:13837:7	O
of	POTIGA.xml:S3:13845:2	O
the	POTIGA.xml:S3:13848:3	O
need	POTIGA.xml:S3:13852:4	O
to	POTIGA.xml:S3:13857:2	O
be	POTIGA.xml:S3:13860:2	O
alert	POTIGA.xml:S3:13863:5	O
for	POTIGA.xml:S3:13869:3	O
the	POTIGA.xml:S3:13873:3	O
emergence	POTIGA.xml:S3:13877:9	O
or	POTIGA.xml:S3:13887:2	O
worsening	POTIGA.xml:S3:13890:9	O
of	POTIGA.xml:S3:13900:2	O
the	POTIGA.xml:S3:13903:3	O
signs	POTIGA.xml:S3:13907:5	O
and	POTIGA.xml:S3:13913:3	O
symptoms	POTIGA.xml:S3:13917:8	O
of	POTIGA.xml:S3:13926:2	O
depression	POTIGA.xml:S3:13929:10	O
;	POTIGA.xml:S3:13939:1	O
any	POTIGA.xml:S3:13941:3	O
unusual	POTIGA.xml:S3:13945:7	O
changes	POTIGA.xml:S3:13953:7	O
in	POTIGA.xml:S3:13961:2	O
mood	POTIGA.xml:S3:13964:4	O
or	POTIGA.xml:S3:13969:2	O
behavior	POTIGA.xml:S3:13972:8	O
;	POTIGA.xml:S3:13980:1	O
or	POTIGA.xml:S3:13982:2	O
the	POTIGA.xml:S3:13985:3	O
emergence	POTIGA.xml:S3:13989:9	O
of	POTIGA.xml:S3:13999:2	O
suicidal	POTIGA.xml:S3:14002:8	O
thoughts	POTIGA.xml:S3:14011:8	O
,	POTIGA.xml:S3:14019:1	O
behavior	POTIGA.xml:S3:14021:8	O
,	POTIGA.xml:S3:14029:1	O
or	POTIGA.xml:S3:14031:2	O
thoughts	POTIGA.xml:S3:14034:8	O
about	POTIGA.xml:S3:14043:5	O
self	POTIGA.xml:S3:14049:4	O
-	POTIGA.xml:S3:14053:1	O
harm	POTIGA.xml:S3:14054:4	O
.	POTIGA.xml:S3:14058:1	O

Behaviors	POTIGA.xml:S3:14060:9	O
of	POTIGA.xml:S3:14070:2	O
concern	POTIGA.xml:S3:14073:7	O
should	POTIGA.xml:S3:14081:6	O
be	POTIGA.xml:S3:14088:2	O
reported	POTIGA.xml:S3:14091:8	O
immediately	POTIGA.xml:S3:14100:11	O
to	POTIGA.xml:S3:14112:2	O
healthcare	POTIGA.xml:S3:14115:10	O
providers	POTIGA.xml:S3:14126:9	O
.	POTIGA.xml:S3:14135:1	O

5.8	POTIGA.xml:S3:14144:3	O
Withdrawal	POTIGA.xml:S3:14148:10	O
Seizures	POTIGA.xml:S3:14159:8	O

As	POTIGA.xml:S3:14173:2	O
with	POTIGA.xml:S3:14176:4	O
all	POTIGA.xml:S3:14181:3	O
AEDs	POTIGA.xml:S3:14185:4	O
,	POTIGA.xml:S3:14189:1	O
when	POTIGA.xml:S3:14191:4	O
POTIGA	POTIGA.xml:S3:14196:6	O
is	POTIGA.xml:S3:14203:2	O
discontinued	POTIGA.xml:S3:14206:12	O
,	POTIGA.xml:S3:14218:1	O
it	POTIGA.xml:S3:14220:2	O
should	POTIGA.xml:S3:14223:6	O
be	POTIGA.xml:S3:14230:2	O
withdrawn	POTIGA.xml:S3:14233:9	O
gradually	POTIGA.xml:S3:14243:9	O
when	POTIGA.xml:S3:14253:4	O
possible	POTIGA.xml:S3:14258:8	O
to	POTIGA.xml:S3:14267:2	O
minimize	POTIGA.xml:S3:14270:8	O
the	POTIGA.xml:S3:14279:3	O
potential	POTIGA.xml:S3:14283:9	O
of	POTIGA.xml:S3:14293:2	O
increased	POTIGA.xml:S3:14296:9	O
seizure	POTIGA.xml:S3:14306:7	O
frequency	POTIGA.xml:S3:14314:9	O
[	POTIGA.xml:S3:14324:1	O
see	POTIGA.xml:S3:14325:3	O
Dosage	POTIGA.xml:S3:14329:6	O
and	POTIGA.xml:S3:14336:3	O
Administration	POTIGA.xml:S3:14340:14	O
(	POTIGA.xml:S3:14355:1	O
2.1	POTIGA.xml:S3:14356:3	O
)]	POTIGA.xml:S3:14359:2	O
.	POTIGA.xml:S3:14363:1	O

The	POTIGA.xml:S3:14365:3	O
dosage	POTIGA.xml:S3:14369:6	O
of	POTIGA.xml:S3:14376:2	O
POTIGA	POTIGA.xml:S3:14379:6	O
should	POTIGA.xml:S3:14386:6	O
be	POTIGA.xml:S3:14393:2	O
reduced	POTIGA.xml:S3:14396:7	O
over	POTIGA.xml:S3:14404:4	O
a	POTIGA.xml:S3:14409:1	O
period	POTIGA.xml:S3:14411:6	O
of	POTIGA.xml:S3:14418:2	O
at	POTIGA.xml:S3:14421:2	O
least	POTIGA.xml:S3:14424:5	O
3	POTIGA.xml:S3:14430:1	O
weeks	POTIGA.xml:S3:14432:5	O
,	POTIGA.xml:S3:14437:1	O
unless	POTIGA.xml:S3:14439:6	O
safety	POTIGA.xml:S3:14446:6	O
concerns	POTIGA.xml:S3:14453:8	O
require	POTIGA.xml:S3:14462:7	O
abrupt	POTIGA.xml:S3:14470:6	O
withdrawal	POTIGA.xml:S3:14477:10	O
.	POTIGA.xml:S3:14487:1	O
